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Abstract
DISCI (Disrupted in Schizophrenia) was identified at the breakpoint of a
chromosomal translocation associated with schizophrenia and other psychiatric
illnesses in a large Scottish family. Recent linkage studies have also identified the
DISCI locus as a susceptibility factor for schizophrenia in Finnish families and
DISCI is emerging as a candidate gene for psychiatric illness. At the time of
identification DISCI was novel and the function of the DISCI protein was
completely unknown. To characterise the function of DISCI, antibodies were raised
against the DISCI protein using both a peptide and bacterially expressed
recombinant protein as the antigen. The resulting antibodies were characterised
thoroughly to ensure their specificity for DISCI. Multiple transcripts ofDISCI had
been identified and the initial aim was to determine which of the transcripts were
translated into functional proteins. Multiple DISCI-related proteins were found to
exist in human but only a single isoform was identified in mouse and rat. In addition
the protein expression levels of DISCI were examined in lymphoblastoid cell lines
derived from members of the original translocation family. No evidence for a
truncated protein resulting from the translocated chromosome was found but
preliminary results suggest that levels of DISCI are significantly reduced in
translocation carriers. The subcellular localisation of DISCI was studied in human
neuroblastoma and glioblastoma cell lines. DISCI was found to colocalise with
mitochondria in a cytoskeletal associated pattern, and in differentiated neuroblastoma
cells DISCI localised to the tips of developing neurites suggesting a possible role in
neurite outgrowth. Further characterisation of the function of DISCI should now
focus on its relationship with the mitochondria to ascertain the significance of this
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My thesis was performed within a research group, investigating the genetic cause of
psychiatric illness. The family our research has been based upon (section 1.6.1),
present with a number of different psychiatric disturbances, of which schizophrenia
and recurrent major depression are the most common. The appearance of depression
and other psychiatric illnesses is often found in the relatives of schizophrenics,
therefore schizophrenia is believed to be the predominant phenotype within the
family. Thus the aim of this introduction is to provide an overview of the current
knowledge and understanding of schizophrenia research. There is extensive
literature on all aspects of schizophrenia, yet the key findings appear consistently in
many review papers. Consequently in this introduction, original papers for many of
the "facts" about schizophrenia have not been referenced, and in general appropriate
review papers are provided.
1.2 Schizophrenia
Schizophrenia was first described in the late 19th century, by the psychiatrist Ernil
Kraeplin, who named it dementia praecox to reflect both the cognitive and
behavioural impairment (dementia) associated with the early age of onset (praecox)
of the disease. The disorder was renamed schizophrenia in the early 20th century by
Eugen Bleuler, deriving its name from the Greek words for split (schiz) and mind
(phrenia) (Andreasen, 1995). The choice of words was to highlight the severe
fragmentation of the mind, but has led to the general misconception that
schizophrenics have a split personality, which is by no means characteristic of
schizophrenia.
Schizophrenia affects 1% of the population worldwide, and its frequency of
occurrence is fairly consistent across countries, cultures and genders (Lewis and
Lieberman, 2000). The typical age of onset is between 15 and 25 year for males
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while for females the onset is usually about 5 years later (Lewis, 2000). In addition
to the earlier age of onset, some data suggest males also show a poorer response to
treatment and more marked neuropathological abnormalities (Lewis and Lieberman,
2000), implying a more severe manifestation of the disorder.
The impact schizophrenia has on both a social and economic level cannot be
underestimated. In the UK alone there are 185400 people receiving medical
treatment for schizophrenia, and the annual cost of schizophrenia is estimated at
more than £1.7 billion. Although the effect on the individual is difficult to quantify,
a measure called the Disability Adjusted Life Year (DALY) was implemented by the
World Health Organisation, World Bank and Harvard School of Public Health, to
attempt to calculate the relationship between disease and its economic and social
impact. The DALY is equivalent to healthy years of life lost to premature mortality
or disability, and for schizophrenia, it is estimated 4.7% of an individual's life will be
lost to the disabling effect of illness (Hyman, 2000). Furthermore eight of the ten
leading causes of disability in the United States are neuropsychiatric disorders,
highlighting the importance for an increased understanding into the development of
these disorders.
1.2.1 Symptoms
Schizophrenia is a heterogenous disorder characterised by a large number of
symptoms. The presentation and severity of these symptoms varies from person to
person, and it is probable that schizophrenia is an umbrella term for several different
disorders (Heyman and Murray, 1992). Psychiatric diagnoses included within the
spectrum of schizophrenia include schizoaffective disorder, atypical psychosis,
delusional disorder and personality disorders (schizotypical, schizoid and paranoid)
(Prescottand Gottesman, 1993).
The diagnosis of schizophrenia is currently based on two diagnostic systems: the
fourth edition of the American Psychiatric Association's Diagnostic and Statistical
3
Manual (DSM-IV), and the tenth International Classification of Disease (ICD-10)
(Andreasen, 1995). Based on these diagnostic criteria, the core symptoms are
divided into two categories based on the perceived exaggeration (positive) or loss
(negative) of normal brain function. Positive symptoms include hallucinations,
delusions and disorganized thought, while the negative symptoms refer to the loss of
motivation and emotional vibrancy. The negative symptoms of schizophrenia have
been largely neglected to date (Brown and Pluck, 2000), yet these are the most
disabling, showing considerable resistance to current drug therapies (section 1.2.2).
In addition to deficits in emotional and perceptual processes, schizophrenia involves
cognitive, motor and social disturbances (Lewis and Lieberman, 2000), suggesting
the involvement of multiple brain regions. This is in contrast to most other
psychiatric illnesses where a specific brain function or system is affected, for
example, mood in depression and appetite drive in anorexia nervosa. Some of the
symptoms of schizophrenia represent premorbid features of the illness, and although
not diagnostically informative, are present well before the ascertainment of
schizophrenia. These include reduced IQ, antisocial behaviour and subtle motor
abnormalities (Frith, 1995; Chua and Murray, 1996; Lewis and Lieberman, 2000).
1.2.1.1 Overlap with bipolar disorder
No single symptom is unique to schizophrenia and there is considerable diagnostic
overlap with bipolar disorder. Bipolar disorder, or manic depression, is characterised
by cyclic episodes of mania and depression, which can be related to the positive and
negative symptoms of schizophrenia, respectively. The frequency of occurrence,
disease prognosis and familial clustering are also similar between the two disorders.
Furthermore recent findings from linkage studies suggest there are common
chromosomal loci for schizophrenia and bipolar disorder susceptibility genes on
22ql 1-13, 18pl 1.2, 13q32 and 10pl4 (Berrettini, 2000). This suggests that though
there are pathological features unique to either schizophrenia or bipolar disorder
(Baumann and Bogerts, 1999; Knable, 1999; Knable et al., 2001), there may be a
common aetiological origin for the disorders, with the exact phenotype being
dependent on interacting genetic and environmental factors.
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1.2.1.2 Endophenotypes
The heterogeneity of schizophrenia has hampered attempts to identify susceptibility
genes. In an attempt to simplify the schizophrenic phenotype, endophenotypes have
been examined. Endophenotypes are heritable traits that can be correlated with the
disease, and must be quantifiable but can be biological (anatomical,
electrophysiological, biochemical) or cognitive (neuropsychological) (Leboyer et ah,
1998). Event related potentials (ERPs) are an example of a physiological
endophenotype for schizophrenia. ERP's represent externally measured electrical
signals of the brain, induced in response to a specific auditory, visual or
somatosensory stimulus. In schizophrenics the most consistent ERP differences are a
decrease in amplitude of signals and an increased time between stimulus and signal
peaks. The most pronounced differences have been observed with the P300 ERP that
typically occurs approximately 300ms following auditory or visual stimulus (Ford,
1999; Blackwood, 2000).
Endophenotypes have begun to show success in refining diagnostic categories for
linkage studies (Freedman et al., 1997). Additional applications of endophenotypes
include determining the suitability of animal models for schizophrenia and
identifying candidate genes (section 1.5.2) (Pulver, 2000).
1.2.2 Treatment
Treatment for schizophrenia is at present not wholly efficacious. In general, the
positive symptoms are responsive to drug treatment, while the negative symptoms
remain largely drug resistant (Andreasen, 1995). The incomplete efficacy of the
drugs reflects the current lack of knowledge regarding the underlying pathology, and
there is a definite need for the development ofmore specific drugs.
The drugs used to treat schizophrenia are known as neuroleptics or antipsychotics,
and are primarily designed to antagonise dopamine receptors (section 1.3.1.1). There
are two classes of neuroleptics, typical and atypical, the classification of which is
based upon the pharmacological profile of the two drug classes, and the apparent
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reduction in certain unwanted side effects of the atypical neuroleptics (Rang and
Dale, 1991).
1.2.2.1 Typical neuroleptics
Typical neuroleptics, such as chlorpromazine, are non-selective drugs, antagonising
dopamine receptors, as well as a-adrenergic, serotonin (5-HT), muscarinic
acetylcholine and histamine receptors (Stone, 1995). Typical neuroleptics are
associated with unpleasant extrapyramidal side-effects due to unwanted dopamine
receptor antagonism within the nigrostriatal pathway. The development of
Parkinsonism-like symptoms, including muscle rigidity, loss of mobility and tremor,
is closely related to the dose of drug used. Parkinsonism-like symptoms develop
rapidly in a large number of patients yet are reversible. On the other hand, tardive
dyskinesia is irreversible and linked to long term neuroleptic treatment. Tardive
dyskinesia is a serious movement disorder, akin to Huntington's chorea, and involves
involuntary movements of the face, tongue, trunk and limbs.
1.2.2.2 Atypical neuroleptics
The atypical neuroleptics show a reduction in extrapyramidal side effects, and
although still dopamine receptor antagonists, are known to have increased potency at
5-HT receptors (Stone, 1995). In addition, the atypical neuroleptic, clozapine, is
more effective in treating the negative symptoms of schizophrenia, particularly in
patients who have shown previous drug resistance (Sawa and Snyder, 2002).
Nonetheless clozapine is associated with the fatal blood disorders, leukopenia
(reduction in white blood cells) and agranulocytosis (absence of neutrophils),
therefore requiring regular blood monitoring.
1.2.2.3 Psychosocial treatment
Finally the use of psychosocial treatments (Kane and McGlashan, 1995) to aid the
individual in returning to a normal life must not be forgotten. Treatments include
social skills training, cognitive behavioural therapies and family intervention
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strategies. The combined approach of drug and psychosocial treatment will no doubt
be the most successful way to tackle schizophrenia.
1.3 The neurobiology of schizophrenia
Schizophrenia has largely been neglected as a neurobiological disease, nevertheless
the biology of schizophrenia is beginning to take shape. Evidence of brain
abnormalities in schizophrenic individuals has come from three main areas of
research: the pharmacology of neurotransmitters (section 1.3.1), brain imaging
(section 1.3.2) and post-mortem studies (section 1.3.3).
1.3.1 Involvement of neurotransmitters
1.3.1.1 Dopamine
Initial theories regarding the pathogenesis of schizophrenia came from the use of
psychotropic drugs. LSD (lysergic acid diethylamide), mescaline and amphetamine
cause schizophrenic-like symptoms in humans (Sedvall and Farde, 1995), mimicking
the positive side of schizophrenia. In animals, amphetamine induces a number of
schizophrenic-like effects including increased motor activity, alertness and
grooming, deficits in sensorimotor function, aggressive and stereotyped behaviours
(Gainetdinov et al., 2001). These effects are ameliorated with neuroleptic treatment,
and the amphetamine model of schizophrenia has long been the benchmark for
determining the efficacy of novel neuroleptics. LSD and amphetamine are both
monoamine agonists, predominantly associated with dopamine (amphetamine) and 5-
HT (LSD) neurotransmission (Harrison, 1999). With the advent of chlorpromazine
(section 1.2.2.1), a dopamine receptor antagonist, the dopamine hypothesis of
schizophrenia came into play. The main tenet of this hypothesis is hyperactivity
within the dopaminergic mesolimbic system is responsible for the positive symptoms
of schizophrenia.
Ligand binding PET (positron emission tomography) enabled dopamine
neurotransmission to be examined directly in schizophrenic patients, and initial
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studies reported increases in dopamine D2 receptors (Sedvall and Farde, 1995).
However two factors in particular have hampered conclusive results (Harrison,
1999). Firstly, all neuroleptics are dopamine receptor antagonists and therefore have
a profound effect on dopamine receptor number. Consequently it is unclear if
reported increases in dopamine receptor number in schizophrenic patients are a
consequence of disease or due to neuroleptic treatment. Secondly, within the brain
there are five dopamine receptor subtypes, with several variants of each subtype
(Sealfon and Olanow, 2000). Elucidating the involvement of a specific receptor
subtype, in the absence of receptor specific drugs is a difficult task, yet one which
requires further investigation. Recent molecular dissection of the function of the D2
receptor subtypes, D2L and D2S, found involvement of the D2L receptor only in the
antipsychotic effect of haloperidol (Usiello et al., 2000). The receptors act at
different sites and are either predominantly presynaptic (D2S) or postsynaptic (D2L).
It has been suggested (Harrison, 1999; Lewis and Lieberman, 2000) that
abnormalities in presynaptic dopamine function may be the proximal cause of illness,
therefore selective targeting of the D2S receptor may be therapeutically beneficial.
The dopamine hypothesis has been the predominant influence in schizophrenia
research, but it is now clear that dopamine dysfunction does not account for all the
symptoms of schizophrenia. It would be unwise to exclude dopamine completely but
disturbances in other neurotransmitter systems are also likely to be involved. Good
candidates include 5-HT, glutamate (section 1.3.1.2) and GABA (Carlsson et al.,
2001). The involvement of multiple neurotransmitters seems probable given the
intricate interdependence ofneurotransmitter systems.
1.3.1.2 Glutamate
The suggested involvement of glutamate in schizophrenia is again based largely on
the effect of psychotropic drugs. NMDA receptor antagonists, including PCP
(phencyclidine) and ketamine, produce psychotomimetic effects in humans
(Tamminga, 1998; Sharp et al., 2001). Crucially both positive symptoms and
cognitive disturbances, indicative of negative symptomology, are induced. PCP
induced animal models cause behaviours similar to amphetamine (section 1.3.1.1),
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for example increased motor activity, sensorimotor deficits and stereotyped
behaviour, but social behaviour and cognitive functions are also affected
(Gainetdinov et al., 2001). These effects are reversed with neuroleptic treatment. In
contrast to the hypothesis of dopamine hyperactivity, it is glutamate hypoactivity that
is suggested to be of importance in the pathogenesis of schizophrenia.
The glutamate hypothesis is at an earlier stage of investigation than the dopamine
hypothesis of schizophrenia. Nonetheless evidence is emerging to support the
involvement of glutamate in schizophrenia. Post-mortem brain studies report
alterations in expression of glutamate receptors, including AMPA and kainate
receptors (Tamminga, 1998; Harrison, 1999), and abnormalities in glutamate
metabolism (Tsai et al., 1995). Furthermore transgenic mice with NMDA receptor
subunits knocked out (Miyamoto et al., 2001) or knocked down (Mohn et al., 1999)
show schizophrenic-like phenotypes. Of particular note, mice lacking the NR2A
subunit (Miyamoto et al., 2001), show increased motor activity and learning deficits,
coupled to glutamate hypoactivity and dopamine and 5-HT hyperactivity.
As for the dopamine hypothesis it does not look like there will be a simple
conclusion regarding the apparent glutamatergic deficit in schizophrenia. It is likely
that neurotransmitter disturbances are not the primary cause of schizophrenia but
reflect the consequence of an as yet unidentified pathology.
1.3.2 Macroscopic brain abnormalities
Brain imaging technologies allow direct structural (1.3.2.1) and functional (1.3.2.2)
information to be gleaned about the pathology of schizophrenia. Furthermore,
representative schizophrenia associated pathology would be a useful diagnostic tool,
and also enable the suitability of animal models to be determined.
9
1.3.2.1 Structural brain imaging
The most consistent structural observation is enlargement of the lateral and third
ventricles in schizophrenics. The initial study performed in 1976 using computed
tomography (CT) has since been replicated many times, using both CT and the
higher resolution afforded by magnetic resonance imaging (MRI) (Cannon, 1996;
Chua and Murray, 1996; Harrison, 1999). With the enlargement of the cerebral
ventricles, there is a concomitant reduction in brain volume. Brain volume, in
particular cortical and subcortical grey matter, is reduced 5-10% in schizophrenic
patients (Weinberger, 1995). This is reflected by an associated decrease in post¬
mortem brain weight (Cannon, 1996; Chua and Murray, 1996).
The most consistent reductions in grey matter volume are within the temporal lobe
and associated limbic structures (hippocampus and amygdala) (McCarley et al.,
1999). Less consistent reductions are reported for the dorsolateral prefrontal cortex
with evidence for the involvement of subcortical regions such as thalamus. These
brain regions are well placed for the pathogenesis of schizophrenia: the temporal
lobe is associated with auditory halluncinations (Frith, 1995), while the hippocampus
and amygdala are studied for their involvement in memory and emotion respectively.
The prefrontal cortex is involved in complex behaviours, including cognitive
processes and emotional behaviours (Fuster, 2001), while the thalamus plays an
important role in the processing of sensory information.
At present, neither the increased ventricles nor the reduction in grey matter can be
used as diagnostic tools, as considerable overlap between patient and control groups
is observed (Cannon, 1996; Harrison, 1999). Nonetheless the possibility remains
that people at risk of developing schizophrenia can be identified: in a group of
individuals at high genetic risk of developing schizophrenia, with two or more first
or second degree relatives affected, the volume of the left amygdala-hippocampal
complex and both thalamic nuclei were reported to be smaller (Lawrie et al., 1999).
Future objectives would be to provide preventive or coping measures for individuals
at risk.
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1.3.2.2 Functional brain imaging
Functional brain imaging offers the advantage of monitoring brain activity while a
cognitive task is performed or a symptom occurs. During a learning and recall task,
a reduction in blood flow within the preffontal-thalamic-cerebellar circuitry was
found in schizophrenic subjects (Andreasen et ai, 1996). Furthermore the functional
basis of hallucinations has also been examined (Silbersweig et al., 1995). PET
performed while subjects were experiencing an auditory hallucination, again
implicated multiple brain regions, both cortical (including limbic cortex) and
subcortical (including thalamus and striatum). With the recent development of fMRI
(functional MRI), offering increased temporal and spatial resolution, the possibility
of identifying a diagnostic disturbance remains.
Brain regions implicated with both structural and functional abnormalities are
beginning to emerge, but regions of less obvious involvement with schizophrenia are
also showing evidence of dysfunction. The cerebellum has long been associated with
motor functions, and indeed premorbid features of schizophrenia (section 1.2.1)
include motor abnormalities, such as abnormal gait and clumsiness. Furthermore the
cerebellum has also been implicated in cognitive function (Fiez, 1996), and
highlights the importance of viewing schizophrenia as a systemic brain disorder.
1.3.3 Microscopic brain abnormalities
The search for defining pathological features of schizophrenia is fraught with
limitations, not least because of restrictions regarding the procurement and use of
human brain tissue. One of the main priorities is ruling out chronic neuroleptic
treatment in any potential pathological alteration, which can partly be achieved by
neuroleptic administration in animals. With the considerable phenotypic
heterogeneity of schizophrenia (section 1.2.1), and overlap with other psychiatric
(section 1.2.1.1) and neurological diseases (Brown and Pluck, 2000), the chances of
finding a pathological feature unique to schizophrenia are slim.
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1.3.3.1 Cytoarchitecture
The cytoarchitectural findings are not as reproducible as the structural abnormalities
(section 1.3.2) but there is growing consensus on a number of abnormalities. Firstly
schizophrenic brains show a distinct absence of gliosis (Weinberger, 1995; Harrison,
1999). Gliosis is commonly associated with neurodegenerative diseases, and not
with pathological insults that occur early in development. Consequently the absence
of gliosis, and other features not discussed (Heyman and Murray, 1992; Raedler et
al., 1998), has led to the hypothesis that schizophrenia is a neurodevelopmental
disorder. Secondly cells of the dorsolateral prefrontal cortex and hippocampus show
decreased neuronal cell body size (Harrison, 1999), with a reported increase in
neuronal density. Finally disarray of pyramidal hippocampal neurons and disordered
laminar architecture of entorhinal cortex are often quoted as being indicative of
schizophrenic brains. To date the evidence for these abnormalities has not been
unequivocally determined (Harrison, 1999; Weinberger, 1999).
1.3.3.2 Molecular phenotype
Post-mortem brain tissue has been used to examine a large number of molecules, at
the level of mRNA or protein. Techniques adopted include immunoblotting,
immunohistochemistry, RT-PCR and more recently microarrays. A vast number of
changes have been reported in schizophrenic brain with dorsolateral prefrontal cortex
and hippocampus again producing the most suggestive results (Harrison, 1999;
Weinberger, 1999), although these regions are also likely to be the most well studied.
The examination of widespread brain regions, such as cerebellum, is warranted
(Katsetos et al., 1997). Coupled to the massive number of molecules implicated
from recent microarray studies (Mimics et al., 2000; Hakak et al., 2001; Vawter et
al., 2001; Mimmack et al., 2002), the challenge will be in validation and replication
of results. In turn the need for good positional genetic targets (sections 1.4 & 1.5) is
emphasised.
Although as suspected, no diagnostic pathological feature has been identified for
schizophrenia, the neuropathological findings have begun to offer support to the
notion that synaptic disturbances are involved. First, synaptic protein measurements
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are assumed to reflect synaptic density, therefore reductions in synaptic markers
reported in schizophrenia, indicate a decrease in the number of synapses. Second,
neuronal cell body size is proportional to the dendritic and axonal arborizations
(Harrison, 1999; Weinberger, 1999), therefore smaller cell bodies (section 1.3.3.1)
indicate less complex dendritic and axonal trees. Third, cortical grey matter volume
is reduced in schizophrenics (section 1.3.2.1), suggesting the increase in neuronal
density (section 1.3.3.1) reflects an alteration in cell packing, in turn related to the
synaptic connections between neurons (Raedler et al., 1998; Selemon and Goldman-
Rakic, 1999). Therefore at present one view of schizophrenia could be of reduced
synaptic connectivity resulting in impaired brain function.
1.4 Evidence for a genetic component to schizophrenia
It is apparent from the familial clustering of schizophrenia that a component of the
disease is inherited, reflected in the 80% heritability estimate for schizophrenia
(Owen and Cardno, 1999). The lifetime risk for schizophrenia is approximately 10
times greater in siblings or children of schizophrenics than in the general population,
and the risk increases with the number of relatives affected (McGuffm et al., 1995).
Unequivocal support for a genetic contribution to schizophrenia came from a series
of classical twin and adoption studies.
1.4.1 Twin studies
Monozygotic (MZ) twins are genetically identical, while dizygotic (DZ) twins share
50% of their genes. Twins share a common environment during foetal development
and consequently twin studies are very powerful methods of investigating the extent
of genetic contribution to a phenotype. Twin studies are assessed in terms of
concordance rates, the probability that a twin is affected given that the co-twin is
affected. For any given disorder, a significantly higher concordance rate in MZ
compared to DZ twins indicates a genetic aetiology. For schizophrenia, the
concordance rates are 46% for MZ and 14% for DZ twins (McGuffin et al., 1995;
O'Donovan and Owen, 1996). This indicates genes are major aetiological factors in
schizophrenia. The lack of 100% concordance for MZ twins implicates
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environmental factors as well, with the contribution from nonshared environment
calculated to be ofprimary importance (Tsuang, 2000; Tandon and McGuffin, 2002).
1.4.2 Adoption studies
Twin studies suggest that both genes and environment play a role in the development
of schizophrenia. A second social paradigm has been used to further examine the
relationship between genes and the environment. Adoptions studies were used to
determine the occurrence of schizophrenia in adoptees born to schizophrenic parents
compared with those born to nonschizophrenic parents. The conclusion was that the
biological relatives of schizophrenics have an increased risk of schizophrenia and
related disorders, compared to adoptive relatives or control adoptees (McGuffin et
al., 1995; O'Donovan and Owen, 1996). Thus adoption studies again point strongly
towards a genetic contribution to schizophrenia.
1.4.3 Pattern of inheritance
Simple Mendelian diseases are caused by highly penetrant but rare functional
polymorphisms in a single gene. This enables tracking of the disease gene through
generations of a family. Unlike Mendelian diseases, schizophrenia shows no such
genetically tractable mutation, and the pattern of inheritance within a single family is
complex (Lander and Schork, 1994), suggesting that it is a susceptibility to develop
psychiatric illness that is inherited.
Genetic models of schizophrenia, favour oligogenic (several genes of modest effect)
or polygenic (many genes ofminor effect) inheritance, with the additive effect of the
genes determining the final phenotype. Alternatively, a number of independent
single genes of major effect, showing either reduced penetrance or interaction with
several modifier genes, could account for the complex pattern of inheritance
(McGuffin et al., 1995; O'Donovan and Owen, 1996). Another layer of complexity
is added by the interaction between genes and the environment (Tsuang, 2000). With
all models, the inheritance of increasing numbers of genetic mutations could account
for the spectrum of disorders associated with schizophrenia (section 1.2.1), and
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depending on the mutations inherited could explain the phenotypic similarity with
bipolar disorder (section 1.2.1.1).
1.5 Genetic approaches to identify susceptibility genes for
schizophrenia
To identify the genetic component of an inherited disease, a number of approaches
are used. Positional cloning (section 1.5.1) and the candidate gene approach (section
1.5.2) have been the predominant methods of choice in psychiatric genetics. An
alternative has been to use cytogenetic abnormalities (section 1.5.3) as a gross
signpost to the underlying genetic lesion. As yet, no mutation or polymorphism has
been convincingly demonstrated to contribute to the genetic basis of schizophrenia.
Attempts to define the genetic aetiology are confounded in part by the unclear mode
of inheritance (section 1.4.3) and phenotypic heterogeneity (section 1.2.1) of the
disease.
1.5.1 Positional cloning
Positional cloning is the use of naturally occurring DNA polymorphisms to identify
regions of the genome that are shared among affected relatives and tend to differ
between affected and unaffected. The general strategy involves first establishing
linkage between a disease and a specific chromosomal region. Linkage
disequilibrium (LD) is then used to fine map the locus followed by association
studies to further define the locus and identify the functional polymorphism
(O'Donovan and Owen, 1996; Karayiorgou and Gogos, 1997).
Linkage assigns an approximate chromosomal location to a disease gene by looking
for cosegregation between the disease and genetic markers spread evenly at
appropriate intervals across the genome. Linkage has been successfully utilized in
the identification of single genes of major effect, yet in order to detect genes of
minor or modest effect (section 1.4.3) with sufficient power, large families with
multiple affected individuals are needed (Moldin, 1997), a considerable drawback to
15
linkage studies in schizophrenia. Despite positive linkage reports of schizophrenia to
almost every human chromosome, independent replication of positive linkage
findings coupled to meta-analysis has begun to identify loci that are likely to harbour
schizophrenia susceptibility genes. Promising chromosomal loci include 1 q21 -22,
8p21-22 and 22ql 1-12 (Jurewicz et al., 2001; Badner and Gershon, 2002; Waterwort
et al., 2002). As these genomic regions are large and likely to contain many genes,
the next step is to use LD to narrow down the target region.
1.5.2 Candidate genes
Candidate genes are implicated in the genetic basis of a disease due to either their
location in a genomic region linked to the disease (positional candidate) or their
proposed involvement in the phenotype (model based or hypothesis driven
candidates) (Glatt and Freimer, 2002). The majority of candidate genes for
schizophrenia have fallen into the latter category.
Candidate genes are tested using association studies, and the most frequently used
method is the case-control association study which is based on the comparison of
allele frequencies in a group of cases versus controls (Karayiorgou and Gogos,
1997). Association studies offer several advantages over linkage: they do not require
large families with multiple affected individuals or any prior knowledge about the
mode of inheritance. However an obvious limitation to association studies is that
they require candidate genes as well as functional polymorphisms within the genes,
and are based on the assumption that there is a common ancient mutation within the
gene conferring susceptibility.
Candidate genes for schizophrenia have included NOTCH4 (Wei and Hemmings,
2000; McGinnis et al., 2001; Sklar et al., 2001), dopamine D3 and 5-HT2a receptors
(O'Donovan and Owen, 1999). To date though there has been no replicated
significant finding of association of schizophrenia with any gene.
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1.5.3 Cytogenetics
The final and less common approach to identifying the genetic component of an
inherited illness is to use chromosomal rearrangements as markers for positional
cloning. This approach has been successfully utilized in cancer genetics, and a
number of chromosomal rearrangements have been described in association with
psychiatric illness (Maclntyre et al., 2003).
Chromosomes have traditionally been detected by Giemsa staining to produce the
"G-band" profile. FISH (fluorescent in situ hybridisation) is the method of choice
nowadays, allowing detection of specific nuclei acid regions of the chromosome
(Elseth and Baumgardner, 1995). Chromosomal rearrangements include balanced or
unbalanced translocations, inversions or the formation of ring structures (Bassett,
1992). Balanced translocations result in rearrangement of the chromosome with no
alteration in the total amount of chromosomal material. On the other hand
unbalanced translocations involve duplication or deletion of the chromosome. A
balanced translocation found to cosegregate with schizophrenia (St Clair et al., 1990)
will be described (section 1.6).
1.6 A translocation associated with schizophrenia
The group within which my PhD project was undertaken, has used the less orthodox
genetic approach to identify susceptibility genes for schizophrenia (section 1.5.3),
and work within the group has focussed on the characterisation of a translocation
cosegregating with psychiatric illness.
The MRC Cytogenetics Registry (Edinburgh) contains karyotypic and clinical data
on 282 pedigrees with familial autosomal anomalies. This resource was surveyed to
determine if any pedigrees were associated with the presence of psychiatric illness
(St Clair et al., 1990). A single pedigree was identified with a balanced translocation
cosegregating with schizophrenia and other related psychiatric diagnoses in a large
Scottish family. The translocation occurs between the q arms of chromosomes 1 and
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11 (Figure 1.1B). Recent high resolution FISH mapped the breakpoint regions to
chromosome lq42.1 and llql4.3 (Millar et al., 2001).
1.6.1 t(1;11) family
The pedigree is referred to within the group, and this thesis, as the t( 1; 11) family. A
total of 87 family members have been karyotyped (Blackwood et al., 2001). 37
members carried the translocation while 50 are noncarriers, including 18 married-in
relatives (Figure 1.1A). The family shows a spectrum of psychiatric disturbances
with schizophrenia and recurrent major depression as the predominant phenotypes
(Table 1.1). A psychiatric evaluation has been performed for 29 carriers and 38
noncarriers. It is important to note that both the primary (St Clair et al., 1990) and
follow up psychiatric diagnoses (Blackwood et al., 2001) were carried out by
psychiatrists blind to karyotype status. Of the 29 carriers, with both karyotype and
clinical data, 21 (72%) show a psychiatric diagnosis. Conversely of the 38
noncarriers, none have a major psychiatric disturbance. Indeed the major psychiatric
diagnoses of schizophrenia, recurrent major depression and bipolar disorder only
occur when the translocation is present. There are also family members who are
t( 1; 11) carriers but show no psychiatric disturbance. Incomplete penetrance of the








♦ schizophrenia ♦ adolescent conduct disorder
♦ recurrent major depression ♦ anxiety, alcoholism, minor depression
♦ bipolar disorder t translocation t1 ;11 carrier
Chr1 Deri
FIGURE 1.1: A translocation cosegregates with psychiatric illness in a Scottish
family
A: Part of the t(l;l 1) family. The members shown are those for whom karyotype status is
known and psychiatric evaluation has been performed.
B: The karyotype of the balanced translocation cosegregating with psychiatric illness in the
t( 1; 11) family. Normal chromosomes 1 (black) and 11 (blue), and the derived (der)
chromosomes are shown. The translocation occurs between lq42.1 and 11 q 14.3.
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TABLE 1.1: Psychiatric diagnoses within the t(l;ll) family
DIAGNOSIS t(l;ll) CARRIER NON CARRIER
schizophrenia 7 0
bipolar affective disorder 1 0
recurrent major depression 10 0
adolescent conduct disorder 2 1
minor depression 1 3
alcoholism 0 1
no psychiatric diagnosis 8 33
TOTAL 29 38
The psychiatric diagnoses present in the t( 1; 11) family (Figure 1.1) have been summarised.
The individuals included represent family members for whom both karyotype and clinical
data is available.
Linkage analysis determines the likelihood of a chance association between the
translocation and psychiatric illness within the family. Linkage results are reported
as LOD scores; LOD scores of >1.9 and >3.3 have been proposed as minimum
thresholds for suggestive and significant linkage respectively (Lander and Kruglyak,
1995). Utilization of a number of different phenotypic models allows the
relationship between phenotype and translocation to be determined. In the initial
study (St Clair et al., 1990), schizophrenia and schizoaffective disorder alone
generated a maximum LOD of 2.19. Including recurrent major depression increased
the maximum LOD to 3.33 while adolescent conduct and emotional disorder
increased the maximum LOD to 4.34. Inclusion of minor psychiatric phenotypes
(generalised anxiety, minor depressive episode and chronic alcoholism), substantially
reduced the maximum LOD to 1.49. In the recent follow up study (Blackwood et al.,
2001), a maximum LOD score of 7.1 was obtained based on a clinical phenotype of
schizophrenia, bipolar disorder and recurrent major depression. Restricting the
phenotype to schizophrenia or bipolar affective disorder and recurrent major
depression generated maximum LOD scores of 3.6 and 4.5 respectively. This
highlights the importance of this locus for depression and bipolar disorder as well.
The highly significant correlation between the t( 1; 11) translocation and psychiatric
illness in this family has lead to the following hypothesis. A gene or genes located at
or near the breakpoint on chromosome 1 or 11 is a gene(s) of major effect in
20
conferring susceptibility to psychiatric illness in this family. In the best case
scenario, a gene would be directly disrupted by the breakpoint, while a second
possibility would be that the translocation has indirect effects on a neighbouring
gene.
1.6.2 Chromosome 11
The initial search for genes disrupted by the translocation began on chromosome 11,
as chromosome llq had been implicated in two other translocations associated with
psychiatric illness (Muir et al., 1995 & references therein). The chromosome 11
breakpoint region has been completely sequenced, and although a number of genes
were identified within the vicinity of the breakpoint (Figure 1.2), no genes were
found to be directly disrupted by the translocation (Semple et al., 2001 & references
therein). The closest gene to the breakpoint, a processed a-tubulin pseudogene, lies
over 300kb from the translocation (Devon et al., 1997). Of the remaining genes
identified, two are involved in glutamate transmission (section 1.3.1.2), the
metabotropic glutamate receptor subtype 5 (mGluR5) and NAALADase II, a
peptidase involved in glutamate production.
Investigation of mGluR5 within the group, using a case-control association study,
identified a significant difference in mGluR5 allele frequency between
schizophrenics and controls (Devon et al., 2001). Furthermore, reduced
NAALADase (N-acetyl-alpha-linked acidic dipeptidase) NAALADase activity was
reported in post-mortem brain (Tsai et al., 1995). Thus this region does contain a
number of functionally interesting genes, but as none are directly disrupted by the
translocation, long-range position effects on gene expression would need to be
invoked.
1.6.3 Chromosome 1
The translocation breakpoint region on chromosome 1 has also been fully sequenced
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(Disrupted-In-Schizophrenia 1 & 2), were found to be directly disrupted by the
translocation (Figure 1.3). In addition TRAX (Translin-Associated Factor X), a
previously described gene was identified upstream from the translocation (Millar et
al., 2000a). Due to their direct disruption by the translocation, DISCI and DISC2,
became our best candidate genes for the development of psychiatric illness in this
family. DISCI is the focus ofmy PhD and will be discussed in detail (section 1.7).
1.6.3.1 DISC2
DISC2 is transcribed antisense to exon 9 of DISCI (Figure 1.3). The 3' end of
DISC2 is tagged by the UniGene cluster Hs.96883, yet to date the 5' end of DISC2
has not been identified. Multiple tissue Northern blots detected DISC2 transcripts in
adult heart only, but RT-PCR indicated DISC2 was also transcribed in foetal brain,
kidney and spleen (Millar et al., 2000b). No open reading frame has been identified
within the incomplete 15kb DISC2 transcript, suggesting the gene lacks protein
coding potential. DISC2 does share structural similarities to non-coding RNA's,
indicating a putative role for the transcript. Non-coding RNA's are an emerging
group ofmolecules which are reported to have roles in post-transcriptional regulation
of gene expression, guiding RNA modifications and gene dosage (Kelley and
Kuroda, 2000; Eddy, 2001; Lehner et al., 2002). DISC2 orthologues were detected
in mouse and primate cell lines (K.Millar, personal communication), but were not
detected in puffer fish (Taylor et al., 2003).
1.6.3.2 TRAX
TRAX had previously been identified (Aoki et al., 1997) and was mapped to
chromosome lq42.1 approximately 150 - 250kb upstream from the translocation
breakpoint (Millar et al., 2000a). TRAX shares homology to Translin (Aoki et al.,
1997) and additionally, both proteins localise to the same neuronal location
(Finkenstadt et al., 2000) and form a protein complex in brain (Finkenstadt et al.,
2002). Translin is involved in mRNA translation in dendrites (Kobayashi et al.,
1998), and by analogy TRAX has been suggested to have a role in similar functions.
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intergenic transcripts containing TRAX spliced to DISCI were identified (Millar et
al., 2000a). In one of the transcripts the open reading frame was maintained,
therefore it is possible that a functional TRAX-DISC1 fusion protein is produced or
alternatively the intergenic transcripts may have a regulatory role.
1.7 DISC1
Full-length DISCI is comprised of 13 exons and covers >50kb of genomic sequence.
The first ATG start codon ofDISCI is not strongly predicted as the site of translation
initiation, and it is possible that a downstream start codon is utilized (Millar et al.,
2000b). NIX (Nucleotide Identity X) identified two potential promoters 55 and
359bp upstream from the 5' end ofDISCI. The translocation disrupts DISCI within
intron 8, the effect of this on DISCI expression is not known (potential effects will
be discussed in chapter 6).
1.7.1 DISC1 transcripts
DISCI transcripts were detected in all foetal and adult tissues tested, suggesting
DISCI is ubiquitously expressed (Millar et al., 2000b). A major transcript of 7.5kb
and a less abundant transcript of 4kb (K.Millar, personal communication) were
detected on adult human multiple tissue Northern blots. In foetal tissue the
transcripts were only detectable by RT-PCR indicating they are of lower abundance.
The full-length or long (L) transcript utilizes all 13 exons. At the time of
identification, a commonly spliced variant of full-length DISCI was detected. The
splice variant or long variant (Lv) utilizes a proximal splice site in exon 11, thereby
reducing the transcript by 66 nucleotides. Since the initial identification ofDISCI, a
number of putative alternative transcripts have been identified (Figure 1.4). The
short 1 (SI) transcript utilizes an alternative terminal exon 9 (exon 9a) and 3'
untranslated region (UTR), while a similar transcript short 2 (S2), splices from exon
9 into intron 9 before terminating (K.Millar, personal communication). The
extremely short (Es) transcript utilizes an alternative 3'UTR after exon 3 and may
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Lv | I I I I I I II
S1 | I I I I II
S2 | I I I I I
Es
FIGURE 1.4: Alternative DISCI transcripts in human
The exon structure of the five putative DISCI transcripts, L, Lv, SI, S2 and Es, are
indicated. Black and grey boxes represent exons and the 3'UTR of each transcript,
respectively. The exact composition of the Es transcript remains to be determined and in the
present study the Es transcript was assumed to be comprised of an alternative (alt) exon 1 in
conjunction with the alternative 3'UTR as suggested from the available cDNA clone EMBL:
AK025293.
also utilize an alternative exon 1 (GenBank: AK025293). UniGene clusters
representing the Es (Hs.376142) and SI (Hs.212335) transcripts provide in-silico
support. In addition, the SI transcript had been detected by RT-PCR in human foetal
liver and adult heart (M.Taylor, personal communication) but there was no in-vivo
support for the Es and S2 transcripts.
1.7.2 DISC1 protein
In-silico analysis was performed on the protein sequence of the L DISCI isoform
(Millar et al., 2000b; Taylor et al., 2003). DISCI consists of N- and C-terminal
domains. The two termini approximate to exon boundaries, with the first two exons
encoding the N-terminus and the remainder of the gene encoding the C-terminus.
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The two termini can also be distinguished based on secondary structure prediction
and levels of conservation between species (section 1.7.3).
The N-terminus is comprised of one or more globular domains, with a weakly
predicted nuclear localisation signal (NLS) (Taylor et al., 2003). It shares no
homologies to any known proteins. Conversely, the C-terminus consists of alpha
helical and looped structures, interspersed with regions of coiled coil forming
potential. Similarities exist between the C-terminus and structural proteins or
proteins involved in transport and motility (Millar et al., 2000b). However these are
due to the coiled-coil regions and are unlikely to be functionally relevant. Due to the
modular structure of the coiled-coils, these are anticipated to represent the protein
interaction domains of DISCI (Taylor et al., 2003). In addition two leucine zippers
are present within the C-terminus (K.Millar, personal communication) and may also
have a role in mediating DISCI protein interactions.
If the DISCI transcripts utilize exons 1 and 2, the consequence of alternative
splicing, would be to generate proteins with the same N-terminus but slightly varied
C-termini. The C-termini would differ by the absence of amino acids, presence of
novel amino acids and the number of coiled-coils present (Figure 1.5). The Lv
isoform is identical to the L isoform, and differs by the loss of 22 amino acids only.
The SI, S2 and Es isoforms are all truncated with respect to the full-length isoforms,
and contain novel residues at the C-termini: 18 (SI) or 1 (S2 and Es) amino acids. If
the Es transcript utilizes the alternative exon 1, a novel 14 amino acids would be
generated at the N-terminus. Furthermore if a truncated protein were generated due




FIGURE 1.5: DISCI protein isoforms
The predicted protein structure of the DISCI isoforms. The boundary between the N- and C-
terminus is indicated by the black line. The N-terminal NLS is indicated by the vertical red
line. Horizontal red bars represent the seven coiled-coil regions within the C-terminus. C-
terminal leucine zippers are indicated by purple lines. Novel or spliced amino acid residues
are highlighted above the structure. Both the N- and C-terminus show regions of
hydrophobicity. Furthermore putative glycosylation and phosphorylation sites were
identified within both termini, while glycosaminoglycan and myristoylation sites were
identified within the N-terminus. For detailed annotation of these sites see Figure 3.1
(Taylor, 2002).
1.7.3 DISC1 orthologues
Recently three papers, including one from our group, were published describing
DISCI orthologues in mouse, rat and fish species (Ma et al., 2002; Ozeki et al.,
2003; Taylor et al., 2003). Unlike DISC2 (section 1.6.3.1), DISCI is present in all
species examined including chimpanzee and other primates (K.Millar, personal
communication). The overall gene structure is maintained although there is evidence
for alternative splicing strategies in mouse, rat (described in section 7.2) and
pufferfish (Taylor et al., 2003). DISCI is poorly conserved across species with the
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N-terminus being less well conserved than the C-terminus. Between human and
mouse the N-terminus shows 52% identity, 63% similar and the C-terminus 61%
identity, 78% similar (Taylor et al., 2003). The maintenance of distinct N- and C-
termini is maintained between species, as are the N-terminal NLS and C-terminal
coiled coil regions, suggesting these are functionally important. An alternative exon
1 was reported for mouse (Ozeki et al., 2003). The in-silico detection of an
alternative exon 1 in both mouse and human (section 1.7.1), increases the likelihood
that this exon is real.
1.7.4 Independent association of the DISC locus with
schizophrenia
The use of single large families to identify susceptibility genes has one main
concern: it is possible the gene identified may be rare or unique to the single family,
and though still potentially informative, not relevant to the disease in the widespread
population. In such cases validation of findings from independent linkage or
association studies is vital.
Therefore it was with great encouragement that a Finnish group published positive
linkage of schizophrenia to chromosome lq, including the DISC locus (Ekelund et
al., 2001). A total of 558 affected and 1206 unaffected individuals from 221 families
were genotyped. The strongest evidence for linkage (LOD = 3.21) was with a
microsatellite marker located within intron 9 of DISCI. A follow-up study found
strongest association for a marker within exon 13 (Ekelund, 2002). Thus
encouragingly, DISCI is emerging as a candidate gene for schizophrenia in
independent populations.
1.8 Aims of thesis
The aim of this thesis was to investigate the function of DISCI through the
development of antibodies. The focus has been on human DISCI due to the potential
for species differences.
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The antibodies were generated using both recombinant protein expression and
peptide selection (chapter 3). Extensive characterisation of the antibodies was
performed (chapter 4), using a number of methodologies, including specificity for
recombinant DISCI, possible detection of a DISCI negative cell line, utilization of
tagged proteins and independent DISCI antibodies.
Following successful characterisation of the antibodies, the first goal was to
determine the protein expression pattern of human DISCI (chapter 5). The
availability of lymphoblastoid cell lines derived from t(1; 11) family members
enabled an initial investigation into the effect of the translocation on DISCI (chapter
6). Preliminary efforts were also made to examine DISCI in mouse and rat (chapter
7).
The second goal was to examine the subcellular localisation pattern of DISCI in
cultured human cells (chapter 8). In addition the phenotype of differentiated
neuroblastoma cell lines was examined (chapter 9) to allow DISCI to be examined in





2. Materials & Methods
2.1 Materials
All general use chemicals were from Sigma and cell culture reagents from
Invitrogen, unless otherwise stated.
2.2 Methods
2.2.1 Prokaryotic Cell Culture
2.2.1.1 Transformation of plasmid DNA into bacterial cells by heat-
shock
Transformation of plasmid DNA was performed for all recombinant protein
expression experiments. The E.coli cells used are summarised in Table 2.1. All
competent cells were obtained as gifts from either David Elliott (MRC Human
Genetics Unit) or Scott Bader (CRC Labs, MMC, University of Edinburgh) and were
prepared as described (section 2.2.1.3). Transformations were performed using a
standard heat-shock protocol as follows. An aliquot of competent cells was thawed
on ice. lpl of plasmid DNA was added to 1 OOjul of competent cells and the cells
were cooled on ice for 30 minutes. Next, the cells were heated to 42°C for 45
seconds and then cooled on ice for a further 2 minutes. For growth of the cells (and
to allow expression of the antibiotic resistance of the plasmid), 900pl of LB-Broth
was added and the cells were grown at 37°C for 1 hour with shaking. Typically
lOOpl of transformed cells were plated onto LB-agar plates with the appropriate
antibiotics added. Plates were grown overnight at 37°C. Following successful
growth, colonies on the plates were picked immediately. The plates were never
stored, as storage of the plates was found to reduce or completely abolish protein
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LB-agar LB broth with 15 g of Bacto-Agar (Difco) per litre
autoclave
2.2.1.2 Transformation of plasmid DNA into bacterial cells by
electroporation
Electroporation of plasmid DNA was performed for all standard DNA procedures
including subcloning and preparation of plasmid DNA. DH5a electrocompetent
E.coli cells were obtained from Sheila Christie (Medical Genetics Section). The use
of electrocompetent DH5a cells ensures high transformation efficiency. To
transform the plasmid DNA into DH5a cells, an aliquot of cells was thawed on ice
and lpl of dialysed DNA (section 2.2.5.7) was added to 50pl cells. The cells were
cooled on ice for 2 minutes and then transferred to an electroporation cuvette. Cells
were electroporated at 2.5V, 25jiF and 2000 using a GenePulser™ apparatus
(BIORAD). A time signal of approximately 4.8 seconds was obtained with
successful transformations. Following electroporation of the cells, 1ml of LB-Broth
was added and the cells were incubated at 37°C for 1 hour with shaking. Finally,
cells were plated onto LB-agar plates with the appropriate antibiotics added. For
subcloning, the whole transformation was plated (typically in batches of lOOpl,
200pl and 500pl), whilst for plasmid DNA preparation usually only lOOpl of cells
were plated. Plates were grown overnight at 37°C and then stored at 4°C for a
maximum of 1 month.
2.2.1.3 Preparation of competent E.coli cells
BL21, BL21(DE3) and BLR(DE3) competent cells were prepared using a standard
calcium chloride method. For BLR(DE3) cells, all cell growth steps included
tetracycline (at a final concentration of 12.5pg / ml) in the growth medium. This is
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necessary to maintain the tetracycline resistance marker, which is also associated
with the recA mutation in this strain. Cells were streaked onto LB-agar plates and
grown overnight at 37°C. A single colony was picked into 5ml of LB-Broth and
grown overnight at 37°C with shaking. The following day, 1ml of the overnight
culture was innoculated into 200ml of LB-Broth and grown at 37°C with shaking
until the OD = 0.6 when read at a wavelength of 600nm. The culture was cooled on
ice for 30 minutes and then centrifuged for 5 minutes at 1700xg, 4°C. The cell pellet
was resuspended gently in 100ml of 50mM calcium chloride and left on ice for 1
hour. Next the cells were centrifuged for 5 minutes at 1700xg, 4°C and then
resuspended in 10ml of freezing mix (50mM calcium chloride / 20% (v:v) glycerol).
Finally the cells were aliquoted into 200pl samples and snap-frozen on dry-ice /
ethanol, before storing at -70°C. The transformation efficiency of the cells was
tested by transforming with a plasmid of known concentration.
2.2.1.4 Preparation and recovery of bacterial glycerol stocks
Glycerol stocks were prepared for long-term storage of bacterial cells. Cells were
frozen in cryotubes by adding 300pl of 50% (v:v) glycerol to 700pl of bacterial
culture. The tube was vortexed before snap-freezing in dry-ice / ethanol and storing
at -70°C. To recover the cells, a loop was scraped across the surface and then
streaked onto LB-agar plates with the appropriate antibiotics if necessary.
2.2.1.5 Antibiotics
Antibiotics were added to the growth medium at the concentrations outlined in Table
2.2. Ampicillin and carbenicillin were prepared in dFLO while tetracycline and
chloramphenicol were prepared in ethanol. Antibiotics were stored at 4°C as
recommended by the manufacturers.
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TABLE 2.2: Concentrations of antibiotics used for E.coli cell culture
ANTIBIOTIC STOCK FINAL
CONCENTRATION CONCENTRATION
ampicillin 50mg / ml 50pg / ml
tetracycline 5mg / ml 12.5pg / ml
chloramphenicol 25mg / ml 25 pg / ml
carbenicillin 50mg / ml 50pg / ml
2.2.1.6 Expression of recombinant protein in bacterial cells
Both the pET and pGEX protein expression systems are chemically inducible by the
addition of IPTG. To induce recombinant protein expression from both constructs,
the following protocol was adapted to ensure an optimal yield of recombinant
protein. A single colony was picked from a LB-agar plate into 5ml of LB-Broth with
the appropriate antibiotics added. The culture was grown overnight at 37°C with
shaking and the next day 1ml of the overnight culture was innoculated into 100ml of
LB-Broth with the appropriate selection. The cultures were grown at 37°C with
shaking until the OD was between 0.4 - 0.6 when read at a wavelength of 600nm.
lml of cells was removed at this stage to be used as a pre-induced sample to aid
identification of the induced protein. IPTG was added to the LB-Broth, to a final
concentration of ImM and the cells were induced for between 3-6 hours by
continued growth at 37°C with shaking, lml samples of cells were taken when
necessary with a final sample taken at the end of the induction period. After
induction, the cells were centrifuged for 20 minutes at 1700xg, 4°C. The cell pellets
were stored at -20°C until expression levels of the recombinant protein had been
determined by analysis of the pre-induced and induced samples. Pellets were not
stored for longer than 2 weeks at -20°C as degradation of the recombinant proteins
began to occur after this time period. The samples that were removed to determine
the expression level of the recombinant protein, were centrifuged for 5 minutes at
16000xg, 4°C and the cell pellets resuspended in a final volume of 100pl (50pl 2x
protein sample buffer / lOpl 1M DTT / 40pl dH20). The lysate was then boiled for 5
minutes followed by centrifugation for 5 minutes at 16000xg, 4°C. Cell lysates were
stored at -20°C until SDS-PAGE analysis (section 2.2.3.1).
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2.2.1.7 Purification ofHis-tagged recombinant proteins
The following purification protocol was adapted from the QIAGEN
QIAexpressionist™ handbook (4th edition). The cell pellet had been stored at -20°C
(section 2.2.1.6). The pellet was resuspended in lml of lysis buffer with lx
complete™ protease inhibitors (Roche), and sonicated on ice, at a wave amplitude of
approximately 10 microns for 1 - 2 minutes, to release the bacterial cell proteins. 5pi
of the lysate was removed for subsequent analysis by SDS-PAGE, before separating
the soluble (supernatant) and insoluble (pellet) proteins by centrifugation for 15
minutes at 30000xg, 4°C. To determine whether the fusion protein had been
successfully solubilised, 5pl of the soluble fraction was removed for SDS-PAGE
analysis. To purify the His tagged protein, 0.25ml ofNi-NTA Superflow was added
to the soluble supernatant and the slurry was rotated for 1 hour at 4°C to allow
binding of the His-tagged proteins. The beads were pelleted by centrifugation for 5
minutes at 16000xg and the flow-through removed. 5pl of the flow-through was
stored for SDS-PAGE analysis, representing the unbound protein. The beads were
washed 4 times in 0.5ml ofwash buffer, and 5pl of each wash was removed for SDS-
PAGE analysis. To elute the His-tagged proteins, the beads were resuspended in
0.5ml of elution buffer, incubated for 5 minutes at room-temperature before
centrifuging the beads for 5 minutes at 16000xg. The eluted protein was removed
and the procedure repeated a total of four times. 5pl of each elution was removed for
SDS-PAGE analysis, whilst the rest of each elution was stored at -70°C. All 5pi
samples were prepared for SDS-PAGE analysis in a final volume of 15pl (7.5pl 2x
protein sample buffer / 1.5pi 1M DTT / lpl dH20). The samples were boiled for 5
minutes, centrifuged for 5 minutes at 16000xg, 4°C and then analysed by SDS-
PAGE (section 2.2.3.1) to determine the success of the purification.
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2.2.1.8 Purification ofGST-tagged recombinant proteins
For purification of GST-tagged proteins, the protocol outlined above for His-tagged
proteins (section 2.2.1.7) was followed with a few adjustments, namely in the buffers
and matrix used but also in the elution conditions. The lysis, wash and elution
buffers are outlined below. The matrix used for purification was glutathione agarose
(Sigma) which was prepared for use by pelleting the beads at 16000xg for 5 minutes,
washing in PBS and then resuspending in PBS to give a 1:1 slurry (w:v). To elute
the GST-tagged protein from the glutathione agarose, the elution step was repeated
only three times.








Elution buffer lOmM reduced glutathione
50mM Tris-HCl (pH8.0)
autoclave
2.2.2 Eukaryotic Cell Culture
2.2.2.1 Growth of cells
Manipulation of eukaryotic cells was performed in an Envair Class II
Microbiological Safety Cabinet. Cells were typically grown in T.25 or T.75 tissue-
culture flasks with filter caps (CellStar®; greiner bio-one). Cells were maintained in
a 37°C incubator with 5% carbon dioxide and were generally fed every 3-4 days
using the appropriate growth medium (Table 2.3).
2.2.2.2 Passage of surface-adherent cells
The growth medium was aspirated from the flask and the cells were washed once in
PBS Dulbecco's. An appropriate volume of trypsin:versene (1:1) was added to the
cells and the flask was incubated at 37°C until the cells had begun to dissociate from
the flask. The flask was washed out using a 4-fold volume of medium to
trypsin:versene and the cell suspension was centrifuged for 3 minutes at lOOxg. The
cell pellet was then resuspended in an appropriate volume of growth medium and the
cells re-plated at a suitable density, typically 1:20 or 1:50 for the SH-SY5Y, LAN-5
and U373 MG cell lines.
2.2.2.3 Passage of suspension cells
The cells were washed from the flask in a suitable volume of medium and
centrifuged for 3 minutes at lOOxg. The cell pellet was resuspended in an
appropriate volume of growth medium and the cells re-plated at a suitable density,
typically 1:3 for all of the lymphoblastoid cell lines.
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SH-SY5Y4 brain (neuroblastoma) DMEM : HamF12 (1:1) / lx
NEAA
LAN-5 5 brain (neuroblastoma) RPMI 1640/ lx NEAA/
ImM sodium pyruvate
TE671 5 brain (cerebellar
medulloblastoma)
DMEM / 4mM L-glutamine /
ImM sodium pyruvate
U373 MG 6 brain (glioblastoma) DMEM / 2mM L-glutamine
MOG-G-CCM 6 brain (astrocytoma) DMEM / 2mM L-glutamine
HepG2 7 liver (hepatocellular
carcinoma)
DMEM
MCF7 7 mammary gland
(adenocarcinoma)
DMEM
293 8 embryonic kidney DMEM / 2mM L-glutamine
MAFLI 9 lymphoblastoid RPMI 1640
KK47 9 lymphoblastoid RPMI 1640/2mM L-
glutamine
ROMAR 9 lymphoblastoid RPMI 1640
CACO-2 y colon (colorectal
carcinoma)
DMEM / 2mM L-glutamine
/ lx NEAA
CHO 9 ovary RPMI 1640
' all cell lines are of human origin, except the CHO cell line which is derived from Chinese
hamster
2 all cell lines are surface adherent except the three lymphoblastoid cell lines which grow as
suspension cultures
3 in addition, all cells were grown in 10% FBS with 100U / ml penicillin & lOOpg / ml
streptomycin
4
initially obtained from Organon Laboratories NY but latterly from ECACC
5 obtained from Organon Laboratories
6 obtained from Helen Bell; Department of Clinical Neurosciences, University of Edinburgh
7 obtained from Karen Chapman; Molecular Endocrinology Section, MMC, University of
Edinburgh
8 obtained from Ian Simpson; Genes & Development Group, University of Edinburgh
9 available within the Medical Genetics Section
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2.2.2.4 Preparation and recovery of cell stocks
For long-term storage cells were stored in liquid nitrogen. Stocks were made of all
cell lines obtained. The cells were pelleted and the cell pellet resuspended in an
appropriate volume of freeze-mix (90% FBS / 10% DMSO): 3ml (T.25) or 9ml
(T.75) depending on the size of the flask. 1ml of cell suspension per vial was
aliquoted into NUNC™ cryotubes (Nalge Nunc International) and the cells slow-
frozen at -70°C before transferring to liquid nitrogen the next day. To resuscitate
the cells, a cryotube was removed from liquid nitrogen into a beaker ofwarm (37°C)
water and transferred to the safety cabinet. The cells were thawed using pre-warmed
medium and plated into a T.25 flask.
2.2.2.5 Differentiation of neuroblastoma cell lines
Retinoic acid induced differentiation of the LAN-5 and SFI-SY5Y cell lines was
performed as described (Hill and Robertson, 1998; Guarneri et al., 2000; Magni et
al., 2000; Tucholski et al., 2001). The LAN-5 cells were plated at a density of 4 x
103 cells / cm2 and SH-SY5Y cells were plated at a density of 1.3 x 103 cells / cm2.
Retinoic acid (Sigma) was prepared as a 1M stock solution in 100% ethanol and
stored for a maximum of 2 weeks at -70°C, protected from the light. The day after
plating, retinoic acid was added to the growth medium at a final concentration of
ImM. The retinoic acid-containing growth medium was changed every 2 days and
the cells were typically exposed to retinoic acid for a maximum of 7 days. Control
wells were set up with only ethanol added to the growth medium.
The extended BDNF-induced differentiation of the SH-SY5Y cell line was
performed as described (Encinas et al., 2000). Rat-tail collagen (Sigma) was used to
coat the coverslips or wells. The collagen was diluted to a final concentration of 0.05
mg / ml and left to evaporate overnight. As above, cells were plated at a density of
3 21.3 x 10 cells / cm . The initial part of the protocol was as above for retinoic-acid
differentiation. After 5 days in retinoic acid, 50ng / ml BDNF (Sigma) was added to
serum-free growth medium and the cells were cultured in the presence of BDNF for
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an additional 7 days. The BDNF-containing growth medium was changed every 3
days. Again control wells were set up which did not undergo differentiation.
2.2.2.6 Cytoskeletal disruption of cell lines
Microtubule disruption was performed using nocodazole (methyl-(5-[2-
thienylcarbonyl]-lH-benzimidazol-2-yl)carbamate) and taxol (paclitaxel).
Microfilament disruption was performed using cytochalasin B. All three drugs were
obtained from Sigma. Stock concentrations were prepared in DMSO and stored
according to the manufacturer's instructions.
Initial experiments were performed to determine the optimal concentration of drug to
use. The concentrations tested were: 0.5, 2, 5 & lOpg / ml nocodazole; 1, 10, 50 &
lOOpM taxol; 10, 20, 50 & lOOpM cytochalasin B. The drugs were added to fresh
growth medium and the cells were incubated at 37°C for two hours. The cells were
then fixed and processed as usual (section 2.2.4.10). To ensure the DMSO was
having no adverse effect on the cells, control wells were incubated in the appropriate
volume ofDMSO alone.
2.2.2.7 Exposure ofmicrotubules to cold
The following protocol was modified from those published by Job et al (Denarier et
al., 1998; Bosc et al., 2001; Andrieux et al., 2002). The cells were exposed to the
cold by packing the plates in ice for 30 - 60 minutes. The cells were then fixed and
processed as usual (section 2.2.4.10).
2.2.2.8 Reformation of the tubulin network
This protocol was adapted from one published by Zmuda & Rivas for location of the
centrosome after microtubule depolymerization (Zmuda and Rivas, 1998). In the
present study the protocol was used to examine reformation of the tubulin network.
Cells were incubated in 2ug / ml nocodazole for 90 minutes and then incubated in
drug-free medium for a defined time period (section 8.6). After two rinses in
cytoskeletal buffer (CB), the cells were extracted for 1 minute in 0.2% (v:v) Triton-
X-100 / 0.25% (v:v) gluteraldehyde / lpM taxol in CB. Finally the cells were rinsed
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once in CB buffer and fixed in methanol for processing as usual (section 2.2.4.10).
Appropriate controls were set up to determine the effect of the extraction step on
cells that had not been treated with nocodazole.






Discontinuous SDS-PAGE was performed using the BIORAD Mini-Protean® 3
electrophoresis cell. The separating and stacking gels were prepared as described
(Harlow and Lane, 1999a). In general separating gels of 8% and 15% were used for
resolution of large and small molecular weight proteins respectively, whilst a
stacking gel of 4.3% was used for all gels. Protein was loaded into the wells in lx
Laemmli sample buffer with ImM DTT added for reduction of the protein. The
markers used were either the Precision Broad Range Protein Standards™ (BIORAD)
or Mark 12™ Wide Range Protein Standard (Invitrogen). Typically 10pl of marker
was loaded per marker lane for a gel that was to be Coomassie stained (section
2.2.3.2), while 15pl of marker was loaded per marker lane for a gel that was to be
Western blotted (section 2.2.4.7). The gel was submerged in lx Laemmli running
buffer and a constant voltage (approximately 100V) passed through the buffer to
allow migration of the protein through the gel.
Laemmli Protein Sample Buffer (2x) Laemmli Running Buffer (lOx)
4% (v:v) SDS
20% (v:v) glycerol
120mM Tris pH 6.8







2.2.3.2 Coomassie staining of SDS-PAGE gels
After SDS-PAGE (section 2.2.3.1) protein bands were visualised by staining the gel
in Coomassie for 20 - 60 minutes with gentle agitation. The gel was destained until
the protein bands were clearly visible with a low blue background; usually the gel
was destained overnight. Next, the gel was vacuum-dried to provide a permanent
record. To prevent cracking of the gel whilst drying, the gel was submerged in dH20
for one hour with agitation. The gel was then sandwiched between a piece of
cellophane membrane (BIORAD) and filter paper, and dried for 90 minutes at 80°C
using a Model 583 gel dryer (BIORAD).
Coomassie stain 40% (v:v) methanol
10% (v:v) glacial acetic acid
0.1% (w:v) Brilliant Blue R250
filter
Destain 20% (v:v) isopropanol
7.5% (v:v) glacial acetic acid
2.2.3.3 Preparation ofprotein lysates from cell lines
Cells were grown in an appropriate size of flask. The cells were pelleted and the cell
pellet resuspended in RIPA buffer with lx complete™ protease inhibitors (Roche)
added: for a T.75 flask, 0.5ml RfPA buffer was used. The cell lysate was sonicated
on ice to reduce the viscosity of the lysate and then incubated at 100°C for 5 minutes.
Finally the lysate was cleared by centrifugation for 5 minutes at 16000xg and the
supernatant was aliquoted and stored at -70°C. The quality of each lysate was
determined by SDS-PAGE analysis (section 2.2.3.1).
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RIPA buffer 50mM Tris-HCl (pH 7.5)
150mM NaCl
1% (v:v) NP 40




2.2.3.4 Preparation ofprotein lysates from human tissue
The tissue was weighed and finely ground under liquid nitrogen using a pestle and
mortar. The tissue was transferred to a bijou tube on dry-ice and a volume of human
tissue lysis buffer with complete™ protease inhibitors (Roche) was added: 1Ojul lysis
buffer per mg of tissue was used. Next the sample was homogenized and incubated
on ice for 15 minutes with RNase A (200pg / ml). The lysate was then sonicated on
ice and cleared by centrifugation for 5 minutes at 16000xg. The supernatant was
aliquoted and stored at -70°C. The quality of each lysate was determined by SDS-
PAGE analysis (section 2.2.3.1).
Human tissue lysis buffer 2x PBS
0.1% (v:v) SDS
1% (v:v) NP 40




2.2.3.5 Preparation ofprotein lysates from mouse & rat tissue
The tissue was weighed and homogenized in ice-cold 0.32M sucrose with lx
complete™ protease inhibitors (Roche) added: lOpl sucrose solution per mg of tissue
was used. Following homogenization the samples were aliquoted and stored at -
70°C. Tissue lysates were only subjected to centrifugation if the lysates contained
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lots of tissue debris. The quality of each lysate was determined by SDS-PAGE
analysis (section 2.2.3.1).
2.2.3.6 Quantification ofprotein by UV detection
The following equation is from Using Antibodies (Harlow and Lane, 1999b). The
protein concentration of purified antibodies was determined by measuring the OD280
and then calculating the antibody concentration using the approximation below:
OD280 of IgG at lmg / ml = 1.35
2.2.3.7 Quantification of protein by use of the BIORAD DC Protein
Assay
The concentration of protein lysates was determined by using the BIORAD DC
Protein Assay. This assay is similar to the Lowry assay and measures the protein
concentration of the sample at an optical density of 750nm. The assay has been
developed to ensure compatibility with a number of detergents. The protein
concentration was calculated as outlined in the manufacturer's guidelines. A BSA
standard curve was generated each time the assay was performed. Standard curves
were produced using Excel (Microsoft) and the straight line equation was used to
calculate the concentration of the protein lysates.
2.2.3.8 Dialysis
Dialysis tubing (Sigma) was prepared by boiling the tubing for 10 minutes in ImM
EDTA / 2% (w:v) NaHCCb, followed by boiling for 10 minutes in dH20. The tubing
was then washed repeatedly in dH20 and stored in 50% (v:v) ethanol at 4°C. Before
use the tubing was washed in d^O.
Protein samples were dialysed in a 10-20 times excess of dialysis solution and were
dialysed overnight at 4°C with constant stirring. The dialysis solution was changed
at least once.
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2.2.4 Antibody and related methods
2.2.4.1 Preparation ofpurified protein for antigen injection
To prepare the recombinant DISCI protein for antigen injection, the purified protein
was separated on a SDS-PAGE gel. Once the protein had migrated sufficiently
through the gel, the gel was washed in dH20 for 10 minutes. The wash step was
repeated 2 times before staining the gel for 1 hour in an aqueous Coomassie blue
solution. The gel was then destained using lx Laemmli running buffer without SDS,
until the appropriate band was visible. The band was cut out of the gel and ground to
a fine powder under liquid nitrogen using a pestle and mortar. The powder was
transferred to an eppendorf in PBS and sent on dry-ice to SAPU for antigen injection.
Typically, 250pg of purified protein was loaded per gel and 1ml of PBS was used to
resuspend the protein powder.
Aqueous Coomassie 0.1% (w:v) Brilliant Blue R250
in lx Laemmli running buffer (without SDS)
2.2.4.2 Storage of antisera and purified antibodies
To avoid repeated freeze-thawing, crude antisera and purified antibodies (section
2.2.4.5) were aliquoted into appropriate volumes and stored at -20°C. To use, the
antisera or antibodies were thawed and stored at 4°C for a maximum of 6 months.
2.2.4.3 Immunoglobin preparation by caprylic acid fractionation
The antiserum to be purified was thawed and 2 x volume of 60mM sodium acetate
(pH4.0) was added. The solution was mixed vigorously using a magnetic stirrer
before slowly adding an appropriate volume of caprylic acid (n-octanoic acid;
Sigma) through a 19 gram needle. The volume of caprylic acid added depends on
the animal the antiserum was raised in. For sheep and rabbits, 700pl or 750pl
caprylic acid per 10ml of the original serum volume was added respectively. The
solution was mixed for a further 30 minutes, after which it was subjected to
centrifugation for 20 minutes at 3000xg, room temperature. The resulting
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supernatant was filtered through 59714 filter paper (Schleicher & Schuell) and then
the filtrate was dialysed (section 2.2.3.8) against 0.154M sodium chloride solution
for 1 day. The caprylic acid purified antibodies were stored at 4°C until further use.
2.2.4.4 Preparation of SulfoLink column for antibody purification
For immunoaffmity purification of both the anti-peptide and anti-protein antibodies,
columns were prepared with the DISCI peptide and fusion protein bound to a
sulfhydrl activated resin (SulfoLink® Coupling Gel; Pierce). The SulfoLink coupling
gel was packed into a 5ml polypropylene column (Pierce) according to the
manufacturer's guidelines. The DISCI peptide and fusion protein were bound to the
column as recommended in the manufacturer's guidelines: lmg of DISCI peptide
and lOmg of purified DISCI fusion protein was bound to the SulfoLink coupling gel.
The coupling efficiency was determined by either measuring the optical density of
the peptide solution at 250nm or SDS-PAGE analysis (section 2.2.3.1) of the fusion
protein before and after passing through the column. All of the peptide and protein
applied bound to the SulfoLink coupling gel. The columns were stored at 4°C with
an overlay of 0.05% (w:v) sodium azide in PBS. The columns were stored for a
maximum of one year.
2.2.4.5 Immunoaffinity purification of antibodies
Immunoaffinity purification of the antibodies was performed as described in Using
Antibodies (Harlow and Lane, 1999c). The initial purifications were performed
using both acid and base-sensitive elution conditions, however for both the anti-
peptide and anti-protein antibodies, the acid elution conditions were found to be
sufficient for elution of the majority of the antibodies, consequently the steps relating
to the basic elution conditions were omitted. The DISCI peptide or protein bound
Sulfolink column (section 2.2.4.4) was washed with 10 bed-volumes of lOmM Tris
pH 7.5 followed by 10 bed-volumes of lOOmM glycine pH 2.5. Next the column
was washed repeatedly in lOmM Tris pH 8.8 until the final pH reached 8.8. The
column was then washed in 10 bed-volumes of lOOmM triethylamine pH 11.5
followed by repeated washing in lOmM Tris pH 7.5 until the final pH reached 7.5.
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The caprylic acid purified serum (section 2.2.4.3) was passed through the column 3
times. The remaining serum was stored at -20°C. A volume of the caprylic acid
purified serum both before and after immunoaffmity purification was removed and
stored at 4°C for subsequent analysis. The column was washed with 20 bed volumes
of lOmM Tris pH 7.5 followed by 20 bed-volumes of 0.5M NaCl / lOmM Tris pH
7.5. The acid-sensitive antibodies were eluted by passing 850pl lOOmM glycine pH
2.5 through the column and collecting the eluate in eppendorfs containing 150pl 1M
Tris pH 8.0. This step was repeated 10 times and the eluates collected in individual
eppendorfs. The column was then washed with lOmM Tris pH 8.8 until the final pH
reached 8.8. The base-sensitive antibodies were eluted as described above, but 850pl
lOOmM triethylamine pH 11.5 was passed through the column 10 times and collected
in 150pl 1M Tris pH 8.0. The column was finally washed in lOmM Tris pH 7.5 until
a final pH of 7.5 was reached. The column was stored as usual with an overlay of
0.05% (w:v) sodium azide. To determine the elutions containing the antibodies, 5pl
of each elution was analysed by SDS-PAGE (section 2.2.3.1). An aliquot of the
caprylic acid purified antibodies before and after purification were also analysed.
The elutions containing the antibodies were dialysed (section 2.2.3.8) in appropriate
volumes against 0.02% (w:v) sodium azide in PBS. The concentration of the
purified antibodies was determined by measuring the OD28o (section 2.2.3.6) of the
antibodies. If the concentration of the antibodies was <lmg / ml, 1% (w:v) BSA was
added before long-term storage at -20°C. Following immunoaffinity purification of
DISCI-specific antibodies, any comparison between the pre-immune serum and the
purified DISCI antibodies was performed by diluting the pre-immune serum to the
same starting concentration as the purified DISCI antibodies, before diluting further
as appropriate.
2.2.4.6 Peptide preabsorption of antibodies
Preabsorption of DISCI anti-peptide antibodies was performed as described
(Yamamoto et al., 2000). The DISCI anti-peptide antibody was diluted at the
appropriate concentration (Table 2.4) in blocking buffer. DISCI peptide (5mg / ml)
was added to the antibody solution in increasing concentrations to determine the
minimal concentration of peptide needed to completely abolish the antibody signal.
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The solution was incubated overnight at 4°C with rotation. Before use the antibody
solution was subjected to centrifugation at 800xg for 30 minutes. Control pre-
absorptions were always set up without any peptide added.
2.2.4.7 Western blotting
Western blotting was performed using the BIORAD Trans-Blot Semi-Dry
Electrophoretic Transfer Cell. The protein was transferred to PVDF membrane.
Following electrophoretic transfer of proteins (section 2.2.3.1), the gel was
equilibrated in transfer buffer for 3 washes of 10 minutes each. The membrane was
pre-wetted in methanol before incubating in transfer buffer for 15 minutes. A
transfer sandwich was assembled as described in the manufacturer's instructions.
Optimal transfer conditions were determined for each protein as necessary, and
typical transfer times were 30 - 45 minutes for an 8% and 1.5 hours for a 15% SDS-
PAGE gel, at a constant voltage of 20V. Following transfer, the membrane was
given 2 washes of 10 minutes each in dH20 and then stained in Ponceau S for a few
seconds before washing in dH20 to allow visualization of the protein. The
membrane was air-dried and stored at room-temperature. If necessary, the gel was
stained in Coomassie (section 2.2.3.2) to determine the amount of protein remaining
after transfer.









in 2% (v:v) glacial acetic acid
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2.2.4.8 Immunoblotting
Following protein transfer (section 2.2.4.7), the air-dried membrane was pre-wetted
in methanol and the Ponceau S washed from the membrane by successive washes in
dH20. The membrane was then incubated overnight in blocking buffer at 4°C. The
next day, the membrane was rinsed twice in PBS-T (PBS with 0.1% (v:v) Tween 20)
followed by 1 wash for 15 minutes and 2 washes for 5 minutes each in PBS-T. The
primary antibody was diluted appropriately (Table 2.4) in blocking buffer and
incubated with the membrane for a minimum of 1 hour. The membrane was washed
again as above, before incubating in the appropriate HRP-conjugated secondary
antibody. The secondary antibody was also diluted (Table 2.5) in blocking buffer but
the incubation period was usually shorter than for the primary antibody, typically 40
minutes. Finally the membrane was rinsed twice in PBS-T followed by 1 wash for
15 minutes and 4 washes of 5 minutes each in PBS-T. The signal was detected using
either Fast DAB (diaminobenzidine) tablets (Sigma) or ECL Plus (Amersham
Biosciences). Both were applied according to the manufacturer's instructions. For
ECL Plus, the membrane was exposed to autoradiography film. If necessary
membranes were stored at 4°C until further use (section 2.2.4.9). DAB stained blots
were never reused.
Blocking buffer 5% (w:v) nonfat milk (Marvel)
in PBS-T
2.2.4.9 Stripping immunoblots
The membrane was pre-wetted in methanol and washed two times in dH20 for 10
minutes each wash. The membrane was then incubated in stripping buffer for 30
minutes - 1 hour at 50°C with rotation, after which the blot was washed 2 times in
PBS-T for 10 minutes each wash. Immunoblotting was performed as described
(section 2.2.4.8), starting with the blocking step. Immunoblots were only stripped
once to avoid removal of the protein from the membrane.
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Coverslips (BDH) were sterilised by autoclaving and placed in individual wells of
12-well plates (Corning Incorporated). Cells were grown on the coverslips for a
minimum of 24 hours. Before fixing the cells were washed once in PBS and fixed
for 5 minutes in ice-cold methanol or 15 minutes in 4% (w:v) paraformaldehyde.
Following fixation the cells were washed three times in PBS and paraformaldehyde
fixed cells were permeabilised by incubating in 0.5% (v:v) Triton-X-100 for 20
minutes. The cells were then blocked for 30 minutes in blocking buffer. The
primary antibody was diluted in blocking buffer (Table 2.4) and incubated on the
cells for the appropriate time. The cells were washed 3 times for 2 minutes each
wash in PBS-T (PBS with 0.2% (v:v) Tween 20). Next, the secondary antibody was
diluted in blocking buffer (Table 2.5) and incubated on the cells for 40 minutes. The
secondary antibody was subjected to centrifugation for 20 minutes at 16000xg to
remove any protein aggregates that may have formed during storage. Following
incubation with the secondary antibody, the cells were washed 3 times for 2 minutes
each wash and the coverslips were mounted onto SuperFrost slides (BDH). Mowial
mounting medium with DAPI was used to mount the coverslips. Slides were stored
at 4°C protected from the light. Appropriate controls were set up: the cells were
tested for autofluorescence by omitting both the primary and secondary antibodies,
as well as determining the background fluorescence from the secondary antibody by
omitting the primary antibody only. The slides were analysed with an Axioskop 2
MOT epifluorescence microscope (Zeiss) using 16x and lOOx plan-NEOFLUAR oil
objectives (Zeiss).





Mix 7.5g Mowial 40-88 (Aldrich) and 10ml glycerol then add 25ml dH20, cover and
leave overnight at room temperature. The next day, add 50ml 0.2M Tris-HCl (pH
8.5) and mix. Heat the mixture in a boiling water bath for 20 minutes with periodic
mixing and allow to cool. Add 1.75g Dabco™ (triethylenediamine; Sigma) and mix
until dissolved. Finally add DAPI to a final concentration of 250ng / ml. Store at
4°C or at -20°C for long term storage.
2.2.4.10.1 Dual immunofluorescence
For dual immunofluorescence, the antibodies were diluted together in blocking
buffer. In addition, the length of the washes was increased to 5 minutes each wash.
To ensure the specificity of the secondary antibodies, controls were set up to test the
secondary antibody on the wrong primary antibody, for example, a rabbit primary
antibody with a mouse secondary antibody.
2.2.4.10.2 Dual immunofluorescence using primary antibodies derived
from the same host animal
In some of the colocalisation studies (section 8.4), both of the primary antibodies
were derived from rabbit. To enable dual immunofluorescence to be performed, the
DISCI anti-peptide antibody was directly conjugated to the fluorochrome Alexa-
Fluor 488 (performed by K.Millar). The immunofluorescence protocol was
performed as usual (section 2.2.4.10), applying the unconjugated primary antibody
followed by the anti-rabbit secondary antibody. After the secondary antibody
incubation, the cells were then blocked with rabbit serum for 30 minutes before
applying the conjugated primary antibody.
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DISCI anti-peptide in-house* 1:1000 1:500 MeOH / PFA
DISCI anti-peptide
AF488 conjugated
in-house* n.d. 1:50 MeOH*
DISC 1 anti-protein in-house* 1:500 n.d.
anti-DISC 1-C2 A.Sawa* 1:200 1:100 MeOH / PFA










a-tubulin (B-5-1-2) Sigma 1:1000 1:3000 MeOH / PFA
P-actin (AC-15) Sigma n.d. 1:3000 MeOH+
y-tubulin (GTU-88) Sigma n.d. 1:2000 MeOH
NF (2F11) DAKO n.d. 1:100 MeOH / PFA







IB immunoblotting; IF immunofluorescence; n.d. not determined;
MeOH methanol; PFA paraformaldehyde
+
PFA not tested; *DISCI antibodies generated in this project or
independently by the Sawa lab
TABLE 2.5: Secondary antibody dilutions
ANTIBODY COMPANY DILUTION
anti-rabbit HRP conjugated DAKO 1:3000
anti-goat HRP conjugated DAKO 1:2000
anti-rabbit Alexa Fluor 594 Molecular Probes 1:1000
anti-mouse Alexa Fluor 488 Molecular Probes 1:1000
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2.2.4.11 Fluorescent probes
For fluorescent detection of mitochondria and the endoplasmic reticulum,
flurorescent probes (Molecular Probes) were obtained from Jianghui Hou (Molecular
Endocrinology Section, MMC). MitoTracker® Deep Red 633 was used for detection
of mitochondria and was applied as outlined in the manufacturer's instructions for
the staining of fixed cells. However this procedure did not produce the expected
mitochondrial staining pattern (section 8.4.3.3). Rhodamine B, hexyl ester,
percholate (R6) was used for detection of the ER. The dye was applied to fixed cells
at a final concentration of 0.5pg / ml for 1 minute. The cells were then washed 3
times for 5 minutes each wash and mounted as before (section 2.2.4.10).
2.2.4.12 Image analysis
Images were captured using SmartCapture 2 version 2.3.1 (Digital Scientific Ltd).
Appropriate exposure times were set for the FITC and TxRed filters, typically 0.01 -
0.5s. No exposure time was set for the DAPI filter. The gain of the camera was set
to 1.0 and 12-bit images were captured to enable direct comparisons between images.
SmartCapture and Adobe PhotoShop 5.5 (Adobe Systems Incorporated) were used
for adjustment of the final image. For images requiring direct comparisons, for
example DISCI anti-peptide antibody ± DISCI peptide (Figure 4.8), all image
capture and any subsequent steps were exactly the same.
2.2.5 Standardmolecular biology methods
2.2.5.1 Agarose gel electrophoresis
Agarose gels were prepared by heating agarose MP (Invitrogen) in lx TAE buffer.
After dissolution of the agarose, ethidium bromide was added to the gel at a final
concentration of 0.4 pg / ml. In general, 1.8% and 0.8% agarose gels were used for
resolution of small and large DNA fragments respectively. DNA was loaded into the
wells in lx STOP loading buffer. The markers used were lkb DNA ladder, A DNA/
Hind III fragments or cpX174 RF DNAIHae III fragments (Invitrogen). Typically
500ng of DNA was loaded per marker lane. The gel was submerged in lx TAE
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buffer and a current of 50 - 100V was passed through the buffer to allow migration
of the DNA through the gel. Following electrophoresis DNA was visualised by UV
transillumination and images captured using a digital imager, UviTec (Thistle
Scientific, Uddingston, Glasgow G71 6NZ).
TAE (20x) 0.8 M Tris-HCl (pH 8.0)
20 mM EDTA
0.4 M acetic acid
autoclave
STOP loading buffer (lOx) 10% (w:v) Ficoll
ImM EDTA
Orange G to colour
2.2.5.2 Miniprep preparation of DNA
A single bacterial colony was used to innoculate 3ml of LB-Broth with the
appropriate antibiotics added. The culture was grown overnight at 37°C with
shaking and the next day DNA was prepared using QIAGEN buffers. 1.5ml of the
culture was centrifuged for 2 minutes at 16000xg. The pellet was resuspended in
300pl Buffer PI before adding 300pl Buffer P2 and incubating for 5 minutes at room
temperature. Next, 300pl Buffer P3 was added and the lysate incubated for 30
minutes on ice before centrifugation for 2 minutes at 18000xg. The supernatant was
removed for phenol-chloroform extraction (section 2.2.5.8) and an equal volume of
isopropanol was added to the aqueous layer. The DNA was pelleted by
centrifugation for 10 minutes at 16000xg and washed in 70% (v:v) ethanol followed
by 100% ethanol. The pellet was then air-dried and the DNA resuspended in
approximately 50pl dEEO. DNA was stored at -20°C. The quality of the DNA was
determined by agarose gel analysis (section 2.2.5.1) and an appropriate restriction
digest (section 2.2.5.10) was performed to confirm the identity of the DNA.
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Buffer PI 50mM Tris-HCl (pH8.0)
lOmM EDTA
1 OOjag / ml Rnase A
Buffer P3 3M potassium acetate
pH5.5
2.2.5.3 Midiprep preparation of DNA
A single bacterial colony was used to innoculate 50ml of LB-Broth with the
appropriate antibiotics added. The culture was grown overnight at 37°C with
shaking and the next day DNA was prepared using the QIAGEN Plasmid
Purification Midiprep Kit, as described by the manufacturer's. DNA was typically
resuspended in 200pl dH20 and stored at -20°C. The quality of the DNA was
determined by agarose gel analysis (section 2.2.5.1) and an appropriate restriction
digest (section 2.2.5.10) was performed to confirm the identity of the DNA.
2.2.5.4 Preparation of RNA
Preparation of RNA was performed in a designated Envair Class II Microbiological
Safety Cabinet. RNA was prepared from cell lines and tissue using RNAzol B
(Biogenesis), according to the manufacturer's instructions. RNA was resuspended in
DEPC-treated dH20, aliquoted and stored at -70°C.
DEPC-treated dH20
50pl DEPC (diethyl polycarbonate) was added to 500ml dH20 and allowed to
evaporate overnight in a fume hood. The DEPC-treated dH20 was autoclaved before
use.
2.2.5.5 Preparation of cDNA
Preparation of cDNA was performed in a designated Envair Class II Microbiological
Safety Cabinet. cDNA synthesis was carried out using the Roche™ 1st strand cDNA
synthesis kit, as described by the manufacturer, using random hexameric primers.
Buffer P2 200mM NaOH
1% SDS
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Approximately 8pg of total RNA was DNase treated (section 2.2.5.11) prior to 1st
strand synthesis. For every reaction, a control reaction was performed that lacked the
reverse transcriptase (RT) enzyme, for use as a negative RT-PCR control. cDNA
was stored at -20°C.
2.2.5.6 Quantification of DNA & RNA
Quantification ofDNA and RNA was performed by measuring the optical density at
260nm. The following equations were used for determining the concentration:
DNA (pg / ml) = OD26o x 50 x dilution factor
RNA (pg / ml) = OD26o x 40 x dilution factor
In addition the purity of the nucleic acid was measured by determining OD26o/ OD280.
A value of <1.8 or 2.0 indicated the nucleic acid was contaminated with phenol or
protein.
2.2.5.7 Dialysis of DNA
To adjust the salt content ofDNA solutions, either before electroporation of plasmid
DNA (section 2.2.1.2) or between a double restriction digest (section 2.2.5.10), an
appropriate volume of DNA was placed on nitrocellulose filter discs of 0.025pm
pore size (Millipore), which were floating on a pool of dH20. The DNA was left for
30 minutes to allow equilibration and the DNA recovered from the disc by pipetting.
2.2.5.8 Phenol-chloroform extraction ofDNA
A 0.5 x volume of phenol and 0.5 x volume of chloroform was added to the nucleic
acid solution. The solution was vortexed before centrifugation for 5 minutes at
16000xg. The upper aqueous layer containing the nucleic acids was removed and an
equal volume of chloroform added. The solution was again vortexed and
centrifugated for 5 minutes at 16000xg. The upper layer was removed and the
nucleic acids precipitated (section 2.2.5.9)
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2.2.5.9 Ethanol precipitation
DNA was precipitated from solution in a 2 x volume of 100% ethanol and 0.1 x
volume of 3 M sodium acetate (pH5.0). The solution was incubated for a minimum
of 30 minutes at -70°C and the DNA precipitated by centrifugation for 20 minutes at
16000xg. The DNA was washed in 70% (v:v) ethanol and air-dried before
resuspending in dfEO.
2.2.5.10 Restriction digest ofDNA
An appropriate concentration or volume of DNA was digested: typically 5pg of
plasmid DNA or an entire volume of amplified or ligated DNA. All restriction
enzymes were from Roche, enabling double digests to be performed in one reaction.
DNA was digested in lx buffer with 2U enzyme per pg DNA and incubated for at
least 4 hours at the optimal temperature for enzyme activity. Digested plasmid DNA
was analysed by agarose gel analysis (section 2.2.5.1) to ensure complete digestion
of the DNA.
2.2.5.11 Dnasel digestion of RNA
Typically 8pg RNA was treated to ensure enough RNA for both ±RT reactions
during cDNA synthesis (section 2.2.5.5). The RNA was incubated with 20U of
DNasel (Roche) and 20U RNase inhibitor (Roche) in lx DNasel buffer (lOOmM
sodium acetate (pH 5.0) / 5mM magnesium sulphate), for 30 minutes at 37°C. The
DNasel was removed by phenol-chloroform extraction (section 2.2.5.8) and the RNA
ethanol precipitated in 3 x volume of 100% ethanol and 0.1 x volume of 7.5M
ammonium acetate, followed by a 75% (v:v) ethanol wash. The RNA was
resuspended in an appropriate volume of DEPC-treated dH20 and stored at -70°C
until cDNA synthesis.
2.2.5.12 Ligation ofDNA
All ligations were performed in a 3:1 molar ratio of insert:vector. The digested DNA
substrates (section 2.2.5.10) were incubated with 1U T4 DNA Ligase (Roche) in lx
ligase buffer (supplied by the manufacturer's). An overnight incubation at 16°C was
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performed. The ligation reaction was dialysed (section 2.2.5.7) before digestion with
Sail (section 2.2.5.10). Both of the protein expression vectors contain Sail cloning
sites that are destroyed following correct ligation of the insert into the vector.
Consequently only vector without the insert will digest, as linear plasmids are not as
well transformed as circular plasmids, therefore background from recircularised
plasmid will be reduced. The total ligation was electroporated (section 2.2.1.2) for
selection of positive subclones (section 2.2.5.14).
2.2.5.13 Purification of DNA from agarose gel
DNA was purified from agarose gels using the QIAGEN QIAquick Gel Extraction
kit which is suitable for the recovery of 70bp - lOkb DNA fragments. DNA was
separated on a LMP agarose gel (section 2.2.5.1). The target band was illuminated
by short-wave UV transillumination, excised and DNA extracted according to the
manufacturer's instructions.
2.2.5.14 Bacterial colony lifts
Bacterial colonies were transferred from LB-agar plates to circular gridded
nitrocellulose filters (Schleicher & Schuell) by placing the filters on the plates,
leaving for 10 seconds and then carefully removing the filters. The filters were
placed colony side up sequentially on 3MM (Whatman) filter paper soaked in 10%
SDS (2-3 minutes), denaturation and renaturation solution (3-5 minutes each).
The filters were rinsed in 2x SSC and air-dried before baking for 2 hours at 80°C.
LB-agar plates were incubated at 37°C for 2 hours to allow regrowth of the colonies.
Denaturation solution 1.5M NaCl SSC (20x) 3M NaCl
0.5M NaOH 0.3M trisodium citrate
pH7.0
autoclave




A gel slice containing the DISCI 980bp exon 2 was used as a probe for detection of
subclones. The gel slice was melted by heating at 70°C and 13pl removed for
labelling. The DNA was denatured by incubating at 100°C for 5 minutes. Next, 4pl
ofHigh Prime nucleic acid labelling system (Roche) and 3pl 10 pCi/ pl[a- P]-dCTP
(Amersham Biosciences) was added to the denatured DNA and the reaction mix was
incubated at 37°C for 15 minutes. Finally 80pi TE was added to the reaction mix
and the DNA denatured again for 5 minutes at 100°C. The radiolabelled probe was
kept on ice until use (section 2.2.5.16).
TE 1OmM Tris-HCl (pH7.6)
ImM EDTA (pH8.0)
2.2.5.16 Hybridisation of radiolabelled probes to membrane bound DNA
Gridded filters (section 2.2.5.14) were layered between gauze, soaked in 2x SSC and
transferred to a hybridisation tube (Hybaid). 20ml hybridisation mix was added and
the filters incubated for 30 minutes at 68°C. Radiolabelled probe (section 2.2.5.15)
was added to the hybridisation mix and incubated overnight at 68°C. The next day,
the filters were washed in 10 minute batches, in pre-warmed (68°C) O.lx SSC / 0.1%
SDS. The filters were exposed overnight to autoradiography film at -70°C. Positive
subclones were identified by aligning the autoradiography film with the gridded
nitrocellulose filter.
Hybridisation mix 5x SSC
10% (w:v) dextran sulphate
0.5% (v:v) SDS
in 5x Denhardf s solution
filter
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Denhardt's solution (5x) 0.1% (w:v) Ficoll
0.1% (w:v) PVP (polyvinylpyrolidine)
0.1% (w:v) BSA
2.2.5.17 Primer design
Oligonucleotide primers for PCR and RT-PCR (section 2.2.5.20) were selected
manually. Typically oligonucleotides were 18 to 24 nucleotides long with
approximately 50% G+C content and similar melting temperatures (Tm).
Oligonucelotides were commercially synthesized (Sigma Genosys), at 0.3pM scale
with standard purification. Oligonucleotides were resuspended in dH^O, aliquoted
and stored at -20°C.
2.2.5.18 Sequencing ofplasmid DNA
Primers used for sequencing of the protein expression constructs are outlined in
Table 2.6. Each sequencing reaction was performed in a 20pl volume, containing
5pl plasmid DNA (approx. 0.5 - lpg), 4pl rhodamine sequencing mix (ABGene), 4pl
half-term buffer (200mM Tris-HCl (pH 9.0) / 5mM MgCE), lpl primer (lOng / pi )
and 6pl dTEO. Half-term buffer was added to maximise use of the rhodamine
sequencing mix. Each sequencing reaction was set up in duplicate and was carried
out on a MJ Research Peltier Thermal Cycler. The amplification cycle consisted of
an initial denaturing step for 1 minute at 96°C, followed by 25 cycles of 30 seconds
at 96°C and 4 minutes at 60°C or 66°C. Following amplification, the product was
ethanol precipitated in 2pl 3M sodium acetate, 50pl ethanol (95% sequencing
• (r)
quality; Sigma) and 0.5pl pellet paint coprecipitant (Novagen). The reaction was
precipitated on ice for 10 minutes before centrifuging at 16000xg for 30 minutes at
4°C. The DNA was washed in 70% (v:v) ethanol and air dried. The use of pellet
paint ensured the DNA pellet was visible. The pellets were sequenced using an in-
house sequencing service and analysed (section 2.2.5.19).
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TABLE 2.6: Primers for sequencing of protein expression vectors































+ Nucleotide sequences were obtained from GenBank, pGEX-5X-l (U13856) and DISCI
(AF222980), or the manufacturer, pET-32a(+)
(http://www.novagen.com/SharedImages/TechnicalLiterature/7_pet32as.htm).
*As stated in the text (section 2.2.5.18), sequencing reactions were performed with 25 cycles
of 30 seconds at 96°C and 4 minutes at 60°C, apart from this primer which was performed
with 25 cycles of 30 seconds at 96°C and 4 minutes at 66°C.
2.2.5.19 Analysis of sequencing data
Sequencing files were imported into Consed (version 11.0), and assembled using the
PhredPhrap script. The sequence was analysed and regions with poor quality
sequence or with conflicting consensus sequence were re-sequenced. The consensus
sequence was exported to HGMP-RC and aligned against DISCI (GenBank
AF222980) and the appropriate plasmid (pGEX-5X-l GenBank U13856; pET-32a
http://www.novagen.com/SharedImages/TechnicalLiterature/7_pet32as.htm)
sequences using the FASTA2 (version 2.0) alignment package. FASTA2 was
available within the GCG Sequence Analysis package. The sequence was manually
checked to identify any mutations.
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2.2.5.20 PCR & RT-PCR
Primers used for PCR (Table 2.7) and RT-PCR (Table 2.8) are shown. RT-PCRs
were set up in a designated Envair Class II Microbiological Safety Cabinet. For PCR
and RT-PCR from exon 1 to exon 2 of DISCI, the Advantage®-GC 2 PCR kit (BD
Biosciences Clontech) was used due to the high GC content of this region. For all
other RT-PCRs, ThermoStart Taq (ABGene) was used. 25pi reactions were set up
containing lpl plasmid DNA (diluted 1:100) or cDNA, 150ng each primer, 200pM
dNTPs in a lx buffer (supplied by the manufacturer's). For PCRs across GC rich
regions, lx GC polymerase and 1M GC-melt was also added. For all other PCRs,
1U ThermoStart Taq and a minimum of 1.5mM MgCl2 was added. A negative
control, containing dH20 instead of DNA, was always set up and positive controls
for the primers were used when available. PCRs were carried out in a MJ Research
Peltier Thermal Cycler and involved an initial denaturation step at 94°C for 1 minute
(GC) or 15 minutes (ThermoStart) followed by denaturation, annealing and extension
cycles as indicated (Tables 2.7 & 2.8). Optimisation for each primer pair was
performed by altering the magnesium concentration or the annealing temperature of
the reaction. 5pl of each PCR was analysed on an agarose gel (section 2.2.5.1).
TABLE 2.7: Primers for amplification ofDISCI inserts



































For amplification ofDISCI cDNA inserts for cloning of protein expression vectors (sections
3.3.2 & 3.3.3), the same forward primer was used in conjunction with one of three reverse
primers. The primers have restriction enzyme sites (bold black nucleotides) incorporated
into the sequence to enable digestion of the PCR product for subcloning. The enzymes
incorporated are FcoRI and Not! for the forward and reverse primers respectively. In
addition, the reverse primers also include a stop nucleotide (red nucleotides) and a cysteine
residue (blue nucleotides). The cysteine residue is to aid in purification of the recombinant
protein. * GenBank AF222980.
TABLE 2.8: Primers for detection ofDISCI transcripts



























Lv 94°C 30 sec








SI 94°C 30 sec
































All primers were designed from the full-length DISCI cDNA sequence, GenBank
AF222980, except 'incyte clone r2320731r6, 2in-house cDNA plasmid FH1, 3GenBank
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AK025293 and 4GenBank M33197. * was designed from within the alternatively spliced
exon 11 sequence and f was designed to span the alternatively spliced exon 11 sequence.
















THE GENERATION OF DISC1 ANTI-PEPTIDE AND
ANTI-PROTEIN ANTISERA
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3. The generation of DISC1 anti-peptide and anti-
protein antisera
3.11ntroduction
Antibodies are an essential tool for determining the distribution of a protein and can
be used in a variety of applications to glean insights into a protein of interest. For a
protein of unknown function, such as DISCI, the use of antibodies is an obvious first
step in unravelling its biological role. There are no commercially available
antibodies to DISCI, so the generation of DISCI antibodies was the initial aim of
this project.
3.1.1 The advantages & disadvantages of polyclonal anti-
peptide and anti-protein antibodies
Antibodies may be either polyclonal or monoclonal. Polyclonal antibodies contain a
mixed population of antibody molecules whereas monoclonal antibodies contain only
a single antibody molecule, thereby simplifying interpretation of the antibody signal.
However the time and technical expertise required setting up a facility for
monoclonal antibody production made the use ofpolyclonal antibodies the method of
choice for the generation ofDISCI antibodies.
Polyclonal antibodies are commonly raised using either a short peptide sequence or
purified protein as the antigen. The decision as to what should be used as the antigen
usually involves two main considerations: the time constraints of the project, and
cost (Harlow and Lane, 1988a). Anti-peptide antibodies have the advantage of being
quick to produce, as the time taken to synthesize a peptide, immunize an animal and
harvest the antibodies can be as little as 6 months. The resulting antibodies are
highly specific and depending on the length of the peptide sequence will only bind to
one or two epitopes in the native protein. In this respect anti-peptide antibodies are
similar in specificity to monoclonal antibodies. The specificity of anti-peptide
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antibodies for a single peptide sequence allows their use in the high-resolution
identification of proteins, for example, differentiating between closely related
proteins or identifying post-translational modifications of proteins. The main
disadvantage of anti-peptide antibodies is the uncertainty that the chosen peptide
sequence constitutes an antigenic epitope in the native protein. Consequently the
cost involved in producing a usable antibody may prove to be very expensive, as
numerous peptides can be tested before identifying one that will recognise the native
protein. To avoid these problems, purified protein can be used as the antigen, as
utilization of a larger proportion of the protein will increase the likelihood of
producing a successful antibody. Anti-protein antibodies are often stronger in
immunoassays due to the larger number of epitopes that are identified by the
antibody population, and once immunoaffinity purified, can again be as specific as
monoclonal antibodies. However the expression and purification of protein is a time
consuming process and considerable optimisation is needed to produce enough
antigen for an immunization program.
At the starting of this project, no antibodies to DISCI were available, or being made.
Therefore the aim was to produce both anti-peptide and anti-protein antibodies to
maximise the chances of success. In addition, the generation of two independent
DISCI antibodies is likely to enable verification of the antibody signals and avoid
erroneous conclusions being made, which is essential when characterising a novel
protein.
3.1.2 Initial considerations in the generation of DISC1
antibodies
As described earlier (section 1.7.2), the DISCI protein can be divided into two
specific domains: an N-terminal head domain and a C-terminus of potentially
varying size. For the production ofDISCI antibodies the N-terminus was considered
a better choice for two reasons. First, the N-terminus shares no homologies to any
known proteins and it was predicted that antibodies generated to this region would be
less likely to cross-react with other proteins. This concern is less of a problem with
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the anti-peptide antibodies as it is possible to design a DISCI-specific peptide from
within the C-terminus. The second consideration in generating both antibodies to the
N-terminus was to make sure the antibodies would be able to confirm one another in
the immunoassays performed. The C-terminus was not considered such a good
candidate for validation due to the potential for DISCI protein isoforms with
different C-termini. This is particularly an issue when determining the subcellular
localisation of DISCI as it is possible that the different isoforms have specific
functions within the cell and will potentially show different subcellular localisation
patterns. However as a consequence of selecting the N-terminus for antibody
production, the DISCI antibodies generated in this project are unable to discriminate
between the potential DISCI protein isoforms.
3.2 Considerations in choosing an antigenic peptide
The production of anti-peptide antibodies that are successfully able to recognise the
native protein is dependent on being able to predict the regions of the protein that are
most likely to be antigenic. A number of computer programs are available that
predict the antigenicity of a protein from its primary and secondary structure (Stem,
1991). The algorithms that these programs use are based on the assumption that it is
the surface exposed regions of a protein that are accessible to antibodies and
consequently antigenic. Hydrophilic residues are generally surface exposed and
deemed to be good antigenic sites whereas hydrophobic residues are usually buried
within the interior of the protein and unlikely to be antigenic. In addition, the
flexibility or mobility of the protein is also strongly correlated with antigenicity
(Jameson and Wolf, 1988; Stem, 1991), as highly flexible turn or loop structures are
more likely to be surface exposed. Therefore the hydrophilic residues found within
turn or loop structures are more likely to be antigenic compared to the hydrophilic
residues found within the more rigid P-sheet and a-helical structures.
Selecting a successful peptide sequence also depends on the size of the peptide and
although an antigenic site can consist of only 6 amino acids, it is generally
recommended that 10-15 amino acids should be used (Harlow and Lane, 1988b).
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3.2.1 Determining antigenic peptides from DISC1 protein
sequence
DISCI protein sequence was analysed to determine which region of the protein
would be most suitable for antibody production. The analysis was performed using
two computer programs: PeptideStructure (performed by Colin Semple, Medical
Genetics Section) and "antigenic" (performed by Martin Taylor, Medical Genetics
Section). PeptideStructure is part of the GCG Sequence Analysis package and is
based on the method of Jameson & Wolf (Jameson and Wolf, 1988).
PeptideStructure uses the predicted hydophilicity, flexibility and surface probability
of the protein, in conjunction with secondary structure predictions to calculate the
antigenic index across the protein. The antigenic index is reported per amino acid
and gives an indication of how antigenic that residue is within a specific sequence.
Alternatively, "antigenic" uses a method developed by Kolaskar and Tongaonkar
(Kolaskar and Tongaonkar, 1990) to predict the antigenic regions of a protein based
on the physicochemical properties of amino acid residues and their frequency of
occurrence in segmental epitopes. The predicted antigenic sequences are reported
and a value is given for the antigenicity of the whole peptide sequence, "antigenic"
is available as part of the Emboss package.
"antigenic" identified nine potential antigenic sequences from within the N-terminus
of DISCI (Figure 3.1). The antigenic index reported in PeptideStructure was
obtained for each of the amino acids in the peptide sequences: the amino acids with a
high antigenic index (>1) are shown in blue whilst those unlikely to be antigenic (an
antigenic index of <0) are shown in red. The antigenic index cut-off points were set
arbitrarily, but analysis of the data from PeptideStructure ascertained that no well
predicted turn structure occurred with an antigenic index of <0. Most of the amino
acids with a negative antigenic index (highlighted in red) are predicted by the
secondary structure prediction programs of PeptideStructure (Chou-Fasman and
Garnier-Osguthorpe-Robson; (Jameson and Wolf, 1988) to be buried residues and
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more than one method to identify antigenic sites as a number of discrepancies
between the two programs can be seen.
Next the putative antigenic peptide sequences were checked against the secondary
structure of DISCI as determined using the PHD secondary structure prediction
programs, PHDsec and PHDacc. These programs are deemed to be the most reliable
of the all the secondary structure prediction programs (C.Semple, personal
communication) and ensured the chosen peptide sequences were comprised of
residues predicted to be surface-exposed and in regions of looped structure. Four
peptide sequences were identified which were predicted by all three methods to be
good antigenic sites (Figure 3.1). Cross-reactivity of the peptides was determined
using BLAST searches against the appropriate protein databases: SWISSPROT
(blastp), PDB (blastp) and NR (tblastn). None of the selected peptides showed
matches to any other proteins apart from DISCI.
A thirteen amino acid peptide sequence, CGPEVPPTPPGSH, was chosen. The
peptide covers residues 191 - 203 of the DISCI protein (Figure 3.1). The reasons for
selecting this peptide are three-fold. Firstly the length of the antigenic site enabled a
longer peptide to be selected than for the other regions. Secondly a naturally
occurring cysteine residue was able to be incorporated into the peptide sequence.
The cysteine residue was included to ensure the peptide would bind to the matrix to
be used for immunoaffmity purification of the antibodies (section 4.2). Finally, the
peptide sequence is not conserved in mouse, therefore the resulting antibodies should
be human-specific.
It should be noted that as outlined above, BLAST searches were performed to ensure
the peptide did not share any homologies to known proteins. At the time of peptide
design, no matches, other than to DISCI, were found for the peptide sequence
chosen. However a recent BLAST search using the parameters now available for
searching for short nearly exact sequence matches revealed that the peptide does
show a number of matches to many different proteins. Nevertheless, no match of
greater than four consecutive amino acids was identified and the majority ofmatches
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are due to the presence of the proline residues. Furthermore other than DISCI, none
of these matches are reported to be of statistical significance (E=<0) and it is
probable that these are chance observations expected with BLAST searching of any
sequence. Thus as with any information gleaned from database searches, it is not
clear how much emphasis can be placed on the findings.
3.2.2 Production ofDISC1 anti-peptide antiserum
Small peptides are unlikely to be immunogenic on their own, and in order for the
peptide to be recognised by the immune system of the host animal, the peptide is
synthesized with a carrier protein attached. Carrier proteins are of high molecular
weight and are usually from a species that is unrelated to the host animal in order to
ensure an optimal immune response. Carrier proteins that are frequently used
include bovine serum albumin (BSA) and the mollusc protein keyhole limphet
hemocyanin (KLH) (Harlow and Lane, 1988c). KLH was chosen as a carrier protein
for the DISCI peptide and was conjugated to the peptide through the N-terminal
cysteine residue.
The peptide was synthesized as a KLH-conjugate and the antibodies were raised in
two New Zealand white rabbits. The whole process was carried out by Research
Genetics, Inc (Huntsville, Alabama, USA). The immunization program involved an
initial injection of O.lmg peptide in complete Freund's adjuvant, followed by three
boosters of O.lmg peptide in incomplete Freund's adjuvant, at 2, 6 and 8 weeks.
Freund's adjuvant, in complete (with addition of killed mycobacterium) or
incomplete forms, is used to increase the magnitude and duration of the immune
response to injected antigen. Complete Freund's adjuvant should only be used for the
initial inoculation, to minimize animal discomfort. All inoculations were
administered subcutaneously. A pre-immune test bleed was taken before the start of
immunization, and production bleeds were taken at 4, 8 and 10 week intervals. After
initial characterisation of the antisera, an additional booster of peptide was given and
terminal bleeds were taken from both of the rabbits after 16 weeks.
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3.3 Bacteria as a choice for recombinant protein expression
The main consideration when producing recombinant DISCI protein for use as an
antigen was to ensure a reproducibly high level of protein expression. In this regard,
bacterial protein expression systems show several advantages over the more
specialised insect or mammalian protein expression systems. Bacterial expression
systems are in routine use and there are many commercially available vector systems
which utilize tightly regulated promoters suitable for achieving high level protein
expression. In addition, the number of fusion partners available offers a wide range
of tools for improved protein folding, solubility and yield, as well as for the detection
and purification of recombinant proteins (Makrides, 1996). However bacteria do not
have the protein machinery for certain eukaryotic post-translational modifications
and if these modifications are important to the function of the protein, the resulting
recombinant protein may be functionally (and structurally) different to the native
protein.
3.3.1 Two distinct purification tags to enable the production
ofDISC1-specific antibodies
For production and purification of the anti-protein antibodies, two recombinant
DISCI proteins were expressed, with each recombinant protein having a unique
purification tag to ensure that the antibodies purified would be DISCI-specific
(Figure 3.2). The vectors chosen for protein expression were the pGEX-5X-l vector
from Amersham Biosciences and the pET-32a(+) vector from Novagen. The pGEX-
5X-1 vector encodes a GST (glutathione-S-transferase) tag at the N-terminus of the
recombinant protein for purification purposes, while the pET-32a(+) vector encodes
both a His-tag and an S-tag for purification of the recombinant protein. The His-tag
is expressed at both the N and C-terminus of the recombinant protein whilst the S-tag
is expressed only at the N-terminus. For purification of the recombinant DISCI
protein, the His-tag was used since the presence of two tags increases the chances of
a successful purification. As well as fusion proteins to aid purification of the
75
recombinant protein, the pET-32a(+) vector contains a thioredoxin tag to increase the
solubility of the recombinant protein (Makrides, 1996).
Both of the vectors chosen are chemically inducible using IPTG. The pGEX-5X-l
vector contains a tac promoter which is directly induced by fPTG to cause expression
of the target gene. In contrast, the pET-32a(+) vector is indirectly induced by IPTG
through the T7 promoter, when the vector is grown in a bacterial strain that contains
the T7 RNA polymerase gene (ADE3 lysogen). The vectors were obtained as gifts
from David Elliott (MRC Human Genetics Unit).
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FIGURE 3.2: Production and purification ofDISCI-specific anti-protein antibodies
The expression of two recombinant DISCI proteins with unique purification tags (1), will enable one
of the proteins to be used for antibody production (2) while the second fusion protein will be used for
purification of the antibodies (3). The polyclonal antibodies generated to the first fusion protein will
contain antibodies to both DISCI and the tag protein. However as the tag protein on the second
fusion protein is different, only the DISCI antibodies should be purified ensuring a DISCI-specific
pool of antibodies. It should be noted that a less complex strategy for the immunoaffinity purification
of antibodies could have been adopted.
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3.3.2 Protein expression using an 875bp DISC1 cDNA insert
As stated above (section 3.1.2), it had been decided that the DISCI antibodies would
be generated to the N-terminus of the human DISCI protein. The N-terminus spans
1041bp of cDNA sequence equivalent to 347 amino acids (aa). At the distal portion
of the N-terminus (293aa - 325aa), there is a serine rich region (Figure 3.3). This
region was not included in the recombinant protein to be used for antibody
production, as it was deemed more likely to generate non-specific antibodies. The
first 875bp of cDNA sequence (292aa) was selected for protein expression.
The 875bp fragment was PCR amplified, using an in-house plasmid clone (FH1)
containing the human DISCI cDNA sequence as template. The primers were
designed to incorporate EcoRl (forward primer) and Notl (reverse primer) restriction
sites compatible with the cloning sites from both of the vectors (Table 2.7). In
addition the reverse primer included the nucleotide sequence for a cysteine residue to
enable binding of the recombinant protein to the matrix to be used for purification of
the antibodies (section 4.2). The fragment was cloned into both of the vectors and
positive subclones were fully sequenced to ensure no mutations had been introduced
into either the DISCI coding sequence or the regulatory regions of the vectors.
Initial protein expression levels from each of the constructs were determined using
BL21(DE3) cells. Small-scale cultures were induced as outlined in section 2.2.1.6,
but using 5ml of LB-Broth instead of 100ml. A typical experiment involved the
induction of >1 colony as it had been observed that the protein expression levels
from individual colonies can differ greatly (D.Elliott, personal communication). A
control using vector lacking the DISCI insert was always performed to ensure that
the induction had worked.
3.3.2.1 Expression of GST-tagged DISC1 protein
The typical expression levels of GST-tagged DISCI protein following a three-hour
induction at 37°C is shown in Figure 3.4. The DISCI fusion protein is predicted to














FIGURE 3.3: The regions of the N-terminus of DISCI used for protein
expression
The amino acid sequence of the N-terminus is shown with the boundary between the N- and
C-termini indicated by the black arrowhead. The serine rich region at the distal portion of
the N-terminus is shaded (with the serine residues in bold). For expression of recombinant
DISCI protein a total of three expression constructs per vector were made, containing either
426bp (first arrowhead), 606bp (second arrowhead) or 875bp (third arrowhead) of DISCI
cDNA sequence. The C-terminus of the protein expressed from these constructs is indicated
by the blue arrowheads. Protein expression using the 875bp construct (section 3.3.2) and the
426 & 606bp constructs (section 3.3.3) is described in the appropriate section. For
production of the anti-protein antibodies, the protein expressed from the 606bp construct
(second arrowhead) was used. In addition, the peptide sequence used for generation of the
DISCI anti-peptide antibodies is highlighted in red.
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FIGURE 3.4: Expression of GST-tagged DISCI protein using the 875bp
construct
Equivalent volumes of bacterial cell lysates were analysed on an 8% SDS-PAGE gel. A
sample of the cells was removed before IPTG addition (lane 1) and at 30 minutes intervals
after IPTG addition (lanes 2 - 7). The GST-DISCI fusion protein was successfully
expressed (arrow).
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DISCI protein. Development of the fusion protein was monitored by removing a
sample of cells at 30 minute intervals during the induction period. The level of
expression shown is representative of all initial inductions performed and there was
no enhancement of the protein expression levels from different colonies.
Before attempting to purify the DISCI fusion protein, the solubility of the DISCI
fusion protein was ascertained. This was performed initially by resuspending the
bacterial cell pellet in PBS and sonicating the cell lysate before centrifugation to
pellet the insoluble bacterial proteins, leaving any soluble proteins in the supernatant.
The DISCI fusion protein was found to be in the insoluble protein fraction (data not
shown). The purification process is made easier if the recombinant protein is in the
soluble fraction, therefore attempts were made to solubilise the DISCI fusion
protein.
Increasing the solubility of a recombinant protein can be achieved by reducing the
temperature at which the induction is performed, however induction of the DISCI
protein at 30°C had no effect on the solubility of the DISCI fusion protein (data not
shown). In addition a number of detergents (Sarkosyl, Triton-X-100 and SDS) were
tested to determine if they aid solubilisation of the fusion protein. Resuspending the
insoluble bacterial protein in a combination of all three detergents (2% Sarkosyl / 1%
Triton-X-100 / 0.1% SDS) followed by heating at 95°C for 30 minutes resulted in the
solubilisation of the DISCI fusion protein (data not shown). However the level of
solubilised protein was not very high and attempts to purify the soluble DISCI
protein via the GST tag were not successful (data not shown). Control purifications
using the GST protein alone were successful and the inability to purify the
recombinant DISCI protein was most likely due to the low level of expressed
protein.
To try and increase the expression levels of the recombinant protein various
modifications of the induction stage were performed. Protein expression was carried
out in JM109 cells, as the level of recombinant protein produced in different bacterial
strains can vary (D.Elliott, personal communication). In addition, the effect of
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altering the stage at which the IPTG was added, as well as the length of the induction
times were examined. Altering the stage of bacterial growth at which the IPTG was
added was to ensure the induction was being started during the exponential phase of
growth, while changing the length of time the bacteria were induced for was to
ensure optimal recombinant protein levels were being harvested. In practice, none of
the above modifications had any effect on the overall protein expression levels (data
not shown). The use of an alternative antibiotic, carbenicillin, was also tested, as
ampicillin in the growth medium is destroyed over time, which allows the growth of
non-transformed bacteria and can lead to the selection against plasmid transformed
cells. Carbenicillin avoids this loss of plasmid effect (Novagen, 1992-2000).
However as for the other modifications performed, the use of carbenicillin did not
improve the expression levels of the recombinant DISCI protein (data not shown)
and the initial approach of expression at 37°C for three hours was deemed optimal.
3.3.2.2 Expression of His-tagged DISC1 protein
The expression level of His-tagged DISCI protein following a three hour induction
at 37°C was difficult to determine (Figure 3.5A). The predicted size of the DISCI
fusion protein is 49kDa, which is smaller than the GST-tagged protein due to the
reduced size of the tag (predicted to be 20kDa). A strong band is seen in the induced
sample at 55kDa, however a band of this size is also seen in the pre-induced sample.
An independent means would be needed to verify this protein as the fusion protein.
3.3.2.3 Conclusions
Due to the lack of success in purifying the GST-tagged protein and also the doubt as
to whether the His-tagged protein had even been induced, it was decided that further
constructs would be made containing smaller DISCI cDNA inserts. The use of
shorter inserts and consequently smaller fusion proteins should maximise the chances
of both a successful induction and subsequent purification as the size of the present
recombinant proteins may be the limiting factor. This is because in general, more
difficulties are encountered as the size of the fusion protein increases, particularly if
the expressed proteins are >50kDa in size (Smith and Corcoran, 1994).
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3.3.3 The use of expression constructs with 426 / 606bp
DISC1 cDNA inserts
In order to express smaller DISCI fusion proteins, constructs were made containing
either the first 426bp or 606bp of cDNA sequence from the N-terminus of DISCI
(Figure 3.3). These constructs were predicted to express GST-tagged proteins of
43kDa or 49kDa and His-tagged proteins of 34kDa or 40kDa respectively.
As for the original 875bp fragment (section 3.3.2), the DISCI inserts were PCR
amplified from plasmid clone FH1, using primers designed with the appropriate
modifications (Table 2.7). Positive subclones for both the pET and pGEX vectors
were again fully sequenced.
3.3.3.1 Expression ofGST-tagged DISC1 protein
To determine the expression levels from each of the pGEX constructs, initial
experiments were conducted using both constructs in four different cell types:
BLR(DE3), BL21(DE3), BL21(DE3)pLySs and BL21. A sample of the cells was
removed after one hour of IPTG induction to monitor the development of the DISCI
fusion proteins. Following a three hour induction at 37°C using BL21(DE3) and
BLR(DE3) cells a low level of expression was obtained from all of the constructs
(Figure 3.6). Similarly the expression levels were low for the other two cell types
(data not shown). The DISCI fusion proteins were expressed at approximately the
size of the predicted fusion proteins: 43kDa (426bp) and 49kDa (606bp), but overall
the use of shorter expression constructs did not greatly increase the protein
expression levels. In addition a breakdown product of approximately 31kDa was
always seen when recombinant DISCI protein was expressed, implying that there is
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No attempts were made to increase the protein expression levels from either the
426bp or 606bp constructs as optimisation using the 875bp construct had previously
been unsuccessful (section 3.3.2.1). Despite the low expression levels, the solubility
of the DISCI fusion proteins was determined. The insoluble bacterial proteins were
pelleted as outlined in section 3.3.2.1, but a different lysis buffer (section 2.2.1.8)
was used. The recipe for this buffer was obtained from Xinsheng Nan (Medical
Genetics Section). The DISCI fusion proteins expressed from both the 426bp and
606bp constructs were partially solubilised using this lysis buffer (Figure 3.7A; data
shown for 606bp construct only), as was the breakdown product.
For purification of the recombinant proteins, glutathione agarose (Sigma) was used
to bind the GST-tagged proteins and then reduced glutathione was used to elute the
bound proteins from the agarose. Several attempts were made before the fusion
protein was successfully eluted and changes to the standard protocol (section 2.2.1.8)
involved increasing the time the protein was allowed to bind to the beads and
changing the elution conditions. As a result of the initial purification problems, a
sample of the beads was taken before eluting the protein to ensure the GST-tagged
DISCI protein had bound to the beads. The use of lOmM reduced glutathione was
sufficient to elute most of the DISCI fusion protein expressed using the 606bp
construct (Figure 3.7A). The breakdown product at 31kDa was also eluted.
3.3.3.2 Expression ofHis-tagged DISC1 protein
Expression levels were determined using BLR(DE3) cells, following a standard three
hour induction at 37°C (Figure 3.5B). As for the GST-tagged proteins, the
development of the fusion proteins was monitored by removing a sample of the cells
after one hour of IPTG induction. The DISCI fusion protein was successfully
expressed from both constructs at approximately the predicted size: 34kDa (426bp)
and 40kDa (606bp). The slight size discrepancy between the predicted sizes and the
actual sizes seen on the gel is due to the slightly larger actual size of the tag protein















FIGURE 3.7: Purification of GST and His-tagged DISCI protein
Purification of recombinant DISCI protein expressed from the 606bp construct using either
GST (A) or His (B) as the purification tag. The DISCI fusion proteins were solubilised (S)
from the total cell protein (T), and then bound to the appropriate matrix. The flow-through
(FT) represents the protein that did not bind to the beads. The beads were washed, before
eluting the DISCI fusion protein using the appropriate solution. In addition, a sample of the
beads (B) was analysed from the GST purification and ensured the fusion protein was bound
to the beads. Equivalent volumes of each sample were analysed on 10% (A) or 12% (B)
SDS-PAGE gels. The purified fusion proteins (arrows) were purified in conjunction with the
breakdown products (arrowheads).
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A breakdown product of approximately 30kDa was always present when the
recombinant DISCI protein was expressed, indicating that as for the GST-tagged
proteins, there is a site within the recombinant DISCI protein which is susceptible to
cleavage by proteases. However, unlike the low levels of protein expression seen for
all three GST-tagged fusion proteins, the expression levels of the His-tagged proteins
from the 426bp and 606bp constructs appear slightly higher than the expression
levels from the 875bp construct.
To determine if the His-tagged fusion proteins were soluble or insoluble, the
procedure detailed previously was performed (section 3.3.2.1), but using a modified
version (section 2.2.1.7) of the lysis buffer obtained from Xinsheng Nan. The use of
imidazole, sodium dihydrogen phosphate and an altered sodium chloride
concentration was necessary to ensure the components were compatible with the Ni-
NTA matrix to be used for purification of the fusion protein (QIAGEN, 2000). The
use of this lysis buffer solubilised the majority of the DISCI fusion protein from both
the 426bp and 606bp constructs (Figure 3.7B; data shown for 606bp construct only).
For purification purposes nickel-nitrilotriacetic acid (Ni-NTA), a metal-affinity
chromatography matrix developed by QIAGEN, was used. The Ni-NTA matrix
binds to His-tagged proteins with at least six consecutive His residues and imidazole
can then be used to elute the bound protein. The use of 250mM imidazole was
sufficient to elute the DISCI fusion protein from both constructs (Figure 3.7B; data
shown for 606bp construct only), as well as the breakdown product of 30kDa.
3.3.3.3 Conclusions
Due to the increased yield of purified protein obtained using the pET vector, it was
decided that the His-tagged DISCI protein would be used for the production of
DISCI antibodies whilst the GST-tagged DISCI protein would be used for
purification of the antibodies. In addition, the use of the 606bp construct was
deemed more suitable as this construct contains the cDNA sequence that
encompasses the peptide used for generation of the anti-peptide antibodies (Figure
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3.3). Therefore it was appropriate to ensure the anti-protein antibodies included this
region as well.
3.3.4 Production of DISC1 anti-protein antiserum
Before starting the immunization program, the identity of the His-tagged DISCI
protein was confirmed using the DISCI anti-peptide antibodies now available
(Figure 4.1).
The anti-protein antibodies were raised in a single sheep at the Scottish Antibody
Production Unit (SAPU). The immunization program involved an initial injection of
250pg protein in complete Freund's adjuvant, followed by three boosters of 250pg
protein in incomplete Freund's adjuvant, every 28 days. A total of lmg of protein
was required for the whole immunization program, and the first elution in the
purification process (Figure 3.7A), typically yielded enough full-length DISCI
fusion protein for one injection. All injections were administered subcutaneously. A
pre-immune test bleed was taken before the start of immunization, and production
bleeds were taken 7 days after each booster injection.
3.4 Discussion
The generation of antibodies to the N-terminus of the human DISCI protein was
performed using both a chemically synthesized peptide and bacterially expressed
recombinant protein as the antigen. To aid in the design of an antigenic peptide, two
computer programs were used to predict antigenic regions within the N-terminus of
DISCI. The programs have been designed using different parameters (Jameson and
Wolf, 1988; Kolaskar and Tongaonkar, 1990) and consequently the regions of
DISCI that were predicted to be antigenic did not show much overlap between the
two programs (Figure 3.1). Despite this, it was possible to select a thirteen amino
acid peptide (191CGPEVPPTPPGSFI203) predicted to be antigenic by both of the
programs.
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The expression of DISCI protein for both antibody production and the subsequent
purification of DISCI-specific anti-protein antibodies was dependent on the use of
two DISCI fusion proteins each with unique purification tags (Figure 3.2).
Ultimately, three constructs were made for each of the vectors containing varying
sizes of DISCI cDNA sequence (Figure 3.3). The overall expression levels of the
His-tagged proteins were higher than the expression levels obtained using the GST-
tagged proteins. This may be due to the strength of the different promoters used by
the vectors, although control inductions performed using empty vector alone show
that both vectors are capable of inducing high levels of recombinant protein (Figures
3.5A & 3.6). To ensure no mutations had been introduced during subcloning of the
DISCI inserts, all of the expression constructs, including the promoter regions, were
fully sequenced. No mutations were found and this ruled out the possibility that a
mutation in the promoter region was responsible for the low levels of expression seen
with the GST-tagged proteins. Attempts were made to increase the protein
expression levels from the original 875bp construct but none of the modifications
were successful. It is possible that if the development of the breakdown product at
31kDa could be minimised the overall yield of the full-length DISCI fusion protein
would be increased. The BL21 derived E.coli strains used for protein expression in
this study (Table 2.1) are deficient in both Ion and ompT proteases. The lack of these
proteases should minimise the appearance of breakdown products, however
alternative protease inhibitors could be tested to determine their use in reducing the
appearance of the breakdown product.
The yield of the purified His-tagged protein was again greater than that achieved for
the GST-tagged protein (Figure 3.7). This was probably due in part to the increased
expression levels of the His-tagged proteins but also to the presence of the
thioredoxin tag on the His-tagged DISCI protein. The main determinant for
successful purification of a recombinant protein is the solubility of the protein and in
this regards, the thioredoxin tag has been engineered to increase the solubility of the
protein (Makrides, 1996), thus aiding the purification process.
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Expression of recombinant DISCI protein from the expression vectors always
resulted in the generation of a breakdown product. The size of the breakdown
product was independent of the size of the DISCI protein contribution but dependent
on the size of the tag. Thus for all of the GST-tagged proteins a breakdown product
of 31kDa was seen, whilst for all of the His-tagged proteins, a breakdown product of
30kDa was present. This would imply that within the DISCI fusion proteins, there is
a site (or sites) which are susceptible to protease cleavage. The site is unlikely to be
within the tag portion of the protein as the size of the breakdown product was
independent of the size of the DISCI protein, remaining the same despite increasing
contributions of the DISCI protein. In addition both of the breakdown products were
purified along with the appropriate fusion proteins which would only be possible
with an intact tag. Therefore the susceptibility site (or sites) must he within the
DISCI protein.
The use of both methods of antigen production has maximised the chances of
producing a successful antibody to DISCI. Furthermore, the generation of both
DISCI anti-peptide and anti-protein antibodies will enable the specificity of the
antibodies for the DISCI protein to be determined.
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CHAPTER 4
CHARACTERISATION OF DISC1 ANTI-PEPTIDE AND
ANTI-PROTEIN ANTIBODIES
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4. Characterisation of DISC1 anti-peptide and anti-
protein antibodies
4.1 Introduction
Previous work on the DISCI protein had been limited to in-silico data (section
1.7.2). This provided certain hints about the DISCI protein but nothing about
endogenous DISCI. As a result careful characterisation of the antibodies was
paramount in order to ensure the resulting data generated could be interpreted with
confidence. The characterisation of any antibody is aided by the use of more than
one independent antibody to the same protein and in this respect, it was expected that
the generation of two separate DISCI antibodies would be useful. In addition,
towards the end of the project DISCI antibodies produced independently in another
lab became available and were used to confirm the DISCI-specific signal. Cell lines
expressing DISCI-tagged proteins were also useful in this respect. Finally,
considerable time was spent sourcing a cell line that did not express DISCI, to use as
a negative control to aid the characterisation process.
4.2 Purification of DISC1 -specific antibodies
The DISCI antisera obtained from both Research Genetics (section 3.2.2) and SAPU
(section 3.3.4), were provided as crude serum preparations. Therefore in addition to
the expected DISCI-specific antibodies, the serum contained many other antibody
molecules as well as contaminating proteins. In order to obtain a DISCI-specific
population of antibodies the serum was immunoaffinity purified, as the presence of
non-specific antibodies and proteins would make interpretation of the DISC1-
specific signal either problematic or impossible.
Both the anti-peptide and anti-protein antisera were initially caprylic acid purified
(Steinbuch and Audran, 1969), to remove contaminating proteins and any non-
immunoglobin G (IgG) antibody molecules. The purified populations of IgG
antibody molecules were then immunoaffinity purified against either the DISCI
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immunizing peptide (section 3.2.1) or the GST-tagged DISCI fusion protein (section
3.3.3.3). Both the DISCI peptide and the recombinant DISCI protein were designed
to incorporate a cysteine residue and this enabled the peptide and protein to be bound
directly to the sulfhydrl activated resin (SulfoLink® Coupling Gel; Pierce) chosen for
the purification ofDISCI-specific antibodies.
Serum from each of the host animals used in the immunization programs was
purified and the majority of the data presented within this thesis has been performed
using the immunoaffinity purified antibodies. Crude DISCI antisera were also tested
in the initial characterisation of the antibodies (section 4.4) and at other times when
necessary.
4.3 ELISA analysis ofDISC1 anti-peptide antisera
ELISA's (Enzyme-Linked Immunosorbent Assay) were performed by Research
Genetics on the crude anti-peptide antiserum to determine the success of the
immunization program. The results received from Research Genetics are shown in
Table 4.1. ELISA's were performed by binding the free peptide in solid phase (lpg
per well), applying serial dilutions of the anti-peptide antiserum and then detecting
the bound antiserum using biotinylated anti-rabbit IgG, HRP-SA conjugate, and
ABTS. The antiserum was diluted in decreasing concentrations, 1:100, 200, 400,
800, 1600, 3200, 6400, 12800, 25600, 51200, 102400, 1:204800, and the titre values
recorded are expressed as the reciprocal of the serum dilution that results in an OD405
of <0.2, an arbitrary cut-off point determined by Research Genetics. Thus a titre
value of 50696 denotes that a serum dilution of 1:50696 results in an absorbance of
<0.2, as calculated from a straight line curve of the data. A titre value of >204800 is
the best value that can be reported with this particular assay.
TABLE 4.1: ELISA analysis of DISCI anti-peptide antisera
Animal # Pre-immune 4 week bleed 8 week bleed 10 week bleed
R99946 <50 50696 >204800 >204800
R99947 <50 39003 >204800 >204800
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Both rabbits produced a strong immune response to the peptide and had reached the
highest titre value by week 8. In contrast the pre-immune serum does not (as
expected) contain any DISCI-specific antibodies, as evidenced by the low titre value.
The ELISA data presented indicates that the host animal responded to the
immunizing peptide but it cannot provide any information regarding whether or not
the antibodies will be able to detect native DISCI protein.
4.4 Characterisation of DISC1 anti-peptide and anti-protein
antibodies using bacterially expressed recombinant protein
The first step in characterising the DISCI antibodies was to determine if they could
detect recombinant DISCI protein. For this purpose, bacterially expressed DISCI
protein (sections 3.3.2 & 3.3.3) was used. The bacterially expressed DISCI fusion
protein was clearly visible on a Coomassie stained gel, therefore it should be obvious
whether or not the antibodies are capable of detecting the recombinant DISCI
protein.
4.4.1 Anti-peptide antibodies
Crude antisera from both of the rabbits were tested using the 8-week bleed. At this
stage the sera contained a high titre of DISCI-specific antibodies as determined by
the ELISA data (section 4.3). Antiserum from both of the rabbits strongly detects the
His-tagged DISCI fusion protein at approximately 45kDa (Figure 4.1A). The pre-
immune serum was used as a negative control and did not detect the DISCI fusion
protein. The specificity of the anti-rabbit secondary antibody was also confirmed
and it did not detect any bands in the absence ofprimary antibody (data not shown).
As expected from the use of crude antisera, a number of additional bands are
detected along with the DISCI-specific band. Titrating the crude antisera had no
effect on the appearance of these bands (Figure 4.1A). These potentially non¬
specific bands are particularly evident at approximately 40kDa (Figure 4.1A & B)
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FIGURE 4.1: Specificity of DISCI anti-peptide antisera for His-tagged
recombinant DISCI protein
Equivalent volumes of bacterial cell lysates were loaded in each lane. Crude DISCI
antiserum (DISCI) from each of the rabbits, R99946 (A) and R99947 (B), was tested at the
indicated dilutions. The pre-immune serum (PRE) was used as a negative control. The
antisera successfully detected the His-tagged recombinant DISCI protein at approximately
45kDa (arrow). A number of non-specific bands were also detected (especially apparent in










































FIGURE 4.2: Specificity of DISCI anti-peptide antibodies for His-tagged
recombinant DISCI protein
Equivalent volumes of bacterial cell lysates were loaded in each lane. For R99946 (A) the
antibodies were diluted 1:100, while for R99947 (B) the antibodies were diluted 1:1000.
The antibodies were tested against His-tagged recombinant DISCI protein. Only the DISCI
fusion protein (arrow) and breakdown products were detected (arrowheads). To ensure the
specificity of the antibodies, bacterial cell lysates containing the His-tag protein only (A) or
recombinant DISCI protein without the appropriate peptide sequence (B) were tested.
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and 60 - 80kDa (Figure 4.1 A). Following immunoaffinity purification, the DISCI
fusion protein and the 40kDa bands are still detected (Figure 4.2A & B). None of the
60 - 80kDa proteins are detected indicating these bands are unrelated to the DISCI
antibodies. The detection of the 40kDa bands by the purified DISCI antibodies, as
well as their close size to the DISCI fusion protein, means these bands were
assumed to represent breakdown products of the full-length DISCI fusion protein.
Interestingly, the 30kDa breakdown product that was always visible by Coomassie
gel analysis of the His-tagged DISCI fusion protein (section 3.3.3.2) was never
detected by the antibodies. Caprylic acid purification alone did not reduce the
number of non-specific bands compared to crude antisera (data not shown).
The purified anti-peptide antibodies also detect the GST-tagged DISCI fusion
protein (data not shown). In addition, further confirmation of the specificity of the
antibodies was obtained by using either recombinant DISCI protein that does not
contain the appropriate peptide sequence (Figure 4.2B) or control bacterial cell
extracts containing the His-tag protein only (Figure 4.2A). No bands were detected
by either batch of the DISCI-specific antibodies. Furthermore the anti-peptide
DISCI signal is completely abolished by preabsorbing the antibodies (Yamamoto et
al., 2000) with increasing concentrations of the immunizing peptide (Figure 4.3).
Preabsorbing the DISCI antibodies with a minimum of O.lpg of peptide per pi of
primary antibody solution is enough to abolish the anti-peptide signal, even after
prolonged exposure to autoradiography film (data not shown). The DISCI antibody
was used at a higher dilution than usual, because of the high localised concentration
of DISCI protein (3.5pg) in combination with the increased sensitivity of the
detection method: the chemiluminescent detection reagent, ECL Plus (Amersham
Biosciences) was used instead ofDAB.
Both batches of the antibodies are comparable in their specificity for the recombinant
DISCI protein, as determined by the lack of background bands in the presence or
absence of the appropriate recombinant DISCI protein. The additional band detected
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FIGURE 4.3: Pre-absorption of purified R99947 DISCI anti-peptide antibodies
using the immunizing peptide
3.5jag of purified recombinant DISCI protein was loaded per lane. Immunodetection was
performed using DISCI antibodies (1:50000), which had been preabsorbed with increasing
concentrations of the DISCI peptide (0.01 - l.Opg of peptide per pi of primary antibody
solution). A control reaction containing DISCI antibodies only was also performed. After a
5 minute exposure, the recombinant DISCI protein was strongly detected in the absence of
peptide, however in the presence of increasing concentrations of peptide this DISCI-specific
signal is abolished. Due to the strength of the signal, it is not clear if the putative breakdown
products identified in Figures 4.1 and 4.2 (arrowheads) are detected in the control lane with
no peptide added (Opg of peptide). Nevertheless in previous immunoblots, these bands were
detected, and subsequently removed following pre-absorption of the purified DISCI
antibodies with the immunizing peptide.
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by the R99947 DISCI-specific antibodies (Figure 4.2B) was also detected using the
R99946 DISCI-specific antibodies (data not shown), and the presence or absence of
this band is most likely due to the quality of the bacterial protein extracts.
The reduced signal intensity seen with the purified R99946 antibodies is a reflection
of the concentration of the purified antibodies. The R99947 antibodies were
approximately four times more concentrated, as determined by calculating the
antibody concentration at an optical density of 280nm (section 2.2.3.6). Due to the
higher concentration of R99947 antibodies, most of the subsequent data presented in
this thesis has been performed using the purified R99947 DISCI anti-peptide
antibodies (unless otherwise stated).
4.4.2 Anti-protein antibodies
The sheep serum from all three bleeds was tested to determine which of the bleeds
would be most suitable for the purification of DISCI-specific antibodies (section
4.2). The crude DISCI antisera were tested on GST-tagged DISCI protein as the
antisera had been raised against the His-tagged DISCI fusion protein and may
therefore contain antibodies to the His-tag protein. It can be seen that the crude
serum from all three bleeds detects the DISCI fusion protein at approximately 50kDa
(Figure 4.4A). No signal was seen with either the pre-immune serum (Figure 4.4A)
or by the anti-sheep secondary antibody alone (data not shown). There was no
difference in the specificity of the bleeds, as determined by the number of additional
bands detected, and likewise the strength of the signal from all three bleeds was
comparable.
Due to the similarity of the three bleeds, no bleed appeared most suitable for
purification of DISCI-specific antibodies, consequently serum from the third bleed
was immunoaffmity purified (section 4.2). Following purification, the additional
bands detected by the crude serum are still detected by the purified antibodies
(Figure 4.4B), and are again likely to represent breakdown products of the full-length
DISCI fusion protein. The lower of the two bands is most likely the 31kDa
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breakdown product visible by Coomassie gel analysis (section 3.3.3.1). Titrating the
purified antibody reduced the background staining (data not shown).
The purified anti-protein antibodies also successfully detected the His-tagged DISCI
protein and did not detect any bands in bacterial cell extracts containing the His-tag
protein alone (data not shown), providing further evidence for the specificity of the











FIGURE 4.4: Specificity of DISCI anti-protein antibodies for GST-tagged
recombinant DISCI protein
Equivalent volumes of bacterial cell lysates were loaded in each lane. Detection of the
DISCI recombinant protein was performed using crude antisera (A) and immunoaffinity
purified antibodies (B); the pre-immune serum was used as a negative control (A). All
dilutions were l :500. Both the crude antisera (A) and the immunoaffinity purified antibodies
(B) were able to detect the DISCI fusion protein at approximately 50kDa (arrow), as well as
two breakdown products of the full-length protein (arrowheads).
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4.5 Characterisation of DISC1 anti-peptide and anti-protein
antibodies using eukaryoticaliy expressed recombinant
DISC1 protein
A strong DISCI-specific signal on bacterially expressed DISCI protein was
encouraging (sections 4.4.1 & 4.4.2), but it was also necessary to determine whether
the DISCI antibodies could detect DISCI protein that had been expressed in a
mammalian expression system. Bacterially expressed recombinant protein may be
structurally and functionally different to the native eukaryotic protein, as bacteria do
not perform the correct post-translational modifications of eukaryotic proteins.
Stable transfected cell lines expressing exogenous human DISCI protein were
generated within the group (Kirsty Millar & Sheila Christie). The expression
construct used for production of the stable cell lines contained the whole DISCI open
reading frame (2.6kb), and therefore these cells express the full-length DISCI
protein. In addition the recombinant protein is fused to a V5 peptide tag as an
additional means to identify the expressed protein. The expression construct was
transfected into a neuroblastoma cell line, SH-SY5Y, and stable cell lines identified
that express the DISCI protein.
Both the anti-peptide and anti-protein antibodies were able to detect recombinant
DISCI protein at the predicted size of approximately llOkDa (Figure 4.5).
Endogenous DISCI protein (section 4.6.1) was not detected, as in these instances,
the 6% SDS-PAGE gels prepared did not resolve any proteins below what is shown.
The pre-immune sera, used as a negative control, did not detect the DISCI fusion
protein; nonetheless the anti-peptide pre-immune serum did detect two bands, one of
very similar size to the DISCI fusion protein. This draws into question the
suitability of pre-immune serum as a negative control for a purified antibody, as the
specificity of an unknown population of antibodies and contaminating proteins is
being compared to a highly specific antibody population, yet spurious cross-reactions









FIGURE 4.5: Both DISCI antibodies detect V5-tagged recombinant DISCI
protein expressed in eukaryotic cells
Lysates from SH-SY5Y cells expressing V5-tagged DISCI protein were loaded in each lane.
Both the anti-peptide (A) and anti-protein (B) antibodies (DISCI) detect the UOkDa
recombinant DISCI protein (arrow). The pre-immune sera (PRE) were used as negative
controls. The pre-immune serum for the anti-peptide antibody (A) detected two unrelated
bands (arrowheads). The same blots were stripped and re-probed using a V5-specific
antibody (V5). The V5 antibody detects recombinant DISCI protein in all of the lanes
(arrow).
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To confirm the identity of the V5-tagged DISCI protein, the blots were stripped and
then re-probed using a V5-specific antibody (Invitrogen). The V5-tagged DISCI
fusion protein was strongly detected in all of the lanes, including those previously
probed with the pre-immune serum.
4.6 Characterisation of DISC1 anti-peptide and anti-protein
antibodies using endogenous DISC1 protein
Both the anti-peptide and anti-protein DISCI antibodies were specific for
recombinantly expressed DISCI protein (sections 4.4.1, 4.4.2 & 4.5). To further
characterise the antibodies their specificity for endogenous DISCI protein was
determined. For this purpose, a number of transformed human cell lines were used.
These had been tested for expression of DISCI by RT-PCR (section 4.7.1). The cell
lines were used firstly to ascertain by immunoblotting if the two antibodies
confirmed one another with respect to the DISCI protein isoforms detected. The
second use of the cell lines was to determine if the subcellular localisation pattern
from both of the antibodies was the same.
4.6.1 Immunoblotting
The DISCI antibodies were tested on protein extracts prepared from a number of cell
lines (Figure 4.6). As has already been discussed (section 1.7.1), a number of
alternative DISCI transcripts were predicted to exist, therefore DISCI protein
isoforms of varying size were possible. Both of the DISCI antibodies detected three
bands in common (Figure 4.6), however the upper band at approximately 75kDa was
detected by the anti-peptide antibodies only (the identity of the bands will be
discussed in chapter 5).
Pre-absorption of the anti-peptide antibodies using the immunizing peptide abolished
the antibody signal (Figure 4.6B), confirming that the additional band is without
doubt due to the DISCI anti-peptide antibodies. A control pre-absorption using a
non-specific peptide directed against the Eefla2 protein (obtained from H.Newbery,
Medical Genetics Section) did not abolish the DISCI anti-peptide signal. The
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FIGURE 4.6: DISCI anti-peptide and anti-protein antibodies detect endogenous
DISCI protein from transformed cell lines
Equivalent concentrations of protein were loaded in each lane. The DISCI antibodies
detected three bands in common (arrows). The DISCI anti-peptide antibodies detected an
additional band (arrowhead) which was not confirmed by the anti-protein antibodies.
A: DISCI anti-peptide antibodies (1:400) were used to detect endogenous DISCI protein in
a number of transformed cell lines: SH-SY5Y (SH), LAN-5 (LA) and TE671 (Te). The pre-
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immune serum was used as a negative control. Different exposures of the same blot are
shown: 10 second (right) or 30 minute (left).
B: DISCI anti-peptide antibodies (1:2000) were preabsorbed with the DISCI immunizing
peptide or a control peptide (Eefla2). O.Olpg of peptide per pi of primary antibody solution
was needed to abolish the signal from the DISCI antibodies. Lane 1: no peptide; 2: DISCI
peptide; 3: Eefla2 peptide.
C: DISCI anti-protein antibodies (1:200) were used to detect endogenous DISCI protein in
the neuroblastoma cell line, SH-SY5Y. The pre-immune serum was used as a negative
control and in addition the specificity of the anti-goat secondary antibody was tested by
omitting the primary antibody. Lane 1: DISC antibody; 2: Pre-immune serum; 3: no primary
antibody.
additional anti-peptide band is not seen in the rabbit pre-immune serum and titrating
the anti-peptide antibody did not reduce the appearance of this band (data not
shown). Neither of the secondary antibodies detected any bands (data shown for the
anti-goat secondary antibody only).
4.6.2 Immunofluorescence
The cell staining pattern detected by both DISCI antibodies was determined using
the SH-SY5Y and U373 MG cell lines. Initial controls were performed to test for
both autofluorescence and any background fluorescence from the secondary
antibodies. The fluorescence seen was negligible (data not shown). For the anti-
peptide antibody, a punctate peri-nuclear, cytoplasmic staining pattern was seen (to
be discussed in chapter 8), after both methanol and paraformaldehyde fixation
(Figure 4.7). No signal was seen with the use of the pre-immune serum (Figure 4.8).
In addition the anti-peptide staining pattern was abolished following incubation of
the DISCI antibodies with the immunizing peptide. A control pre-absorption,
incubating the pre-immune serum with the DISCI peptide had no effect on the pre-
immune signal (Figure 4.8).
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FIGURE 4.7: DISCI anti-peptide antibodies detect a peri-nuclear, cytoplasmic
staining pattern in cell lines
SH-SY5Y (A) and U373 MG (B) cells were fixed in either methanol (Me) or 4%
paraformaldehyde (PFA). The DISCI anti-peptide antibody was detected using an Alexa-





FIGURE 4.8: Specificity of the DISCI anti-peptide antibodies for the
subcellular localisation pattern seen in cell lines
Immunofluorescent detection of the DISCI antibodies (DISCI) and pre-immune serum
(PRE) was performed on methanol-fixed U373 MG cells. The antibodies were preabsorbed
with (+ pep) or without (- pep) the immunizing peptide (0.05pg peptide per pi of primary
antibody solution) and detected using an Alexa-Fluor 594 conjugated secondary antibody
(red). The nuclei were counterstained with DAPI (blue).
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For all of the subsequent data presented in this thesis, the anti-peptide antibodies
were used after methanol fixation, as the use of paraformaldehyde fixation was found
to increase the background signal especially within the nucleus (data not shown). To
reduce paraformaldehyde induced fluorescence, fixed cells were incubated in sodium
borohydride, but this had no effect on the background signal (data not shown). Other
reagents, such as glycine, can also be used to reduce paraformaldehyde induced
fluorescence.
In contrast, the DISCI anti-protein antibody did not produce any signal above
background (data not shown), despite considerable optimisation of the cell staining
procedure (section 2.2.4.10). A number of fixatives were tested including
paraformaldehyde (2 and 4%), methanol, methanokacetone (1:1) and acid-alcohol
(5% glacial acetic acid / 95% ethanol). In addition, following paraformaldehyde
fixation, altering the length of the permeabilisation stage was examined. None of
these modifications had any effect on the antibody signal. The primary antibody
incubation step was increased from a one hour incubation to an overnight incubation
but again no difference in the signal was seen. Finally, the crude DISCI antiserum,
caprylic acid purified serum and another batch of purified anti-protein antibodies
were tested to determine if either the purification stage or the storage of the
antibodies was affecting the specificity of the antibodies for the native DISCI
protein. Again these had no effect and it was concluded that the anti-protein
antibodies were not going to be suitable for determining the subcellular localisation
pattern ofDISCI.
As the localisation of DISCI within the cell is central to determining its function, it
was important to confirm the anti-peptide subcellular localisation pattern. This was
even more crucial because of the additional, potentially non-specific band detected
on immunoblots by the anti-peptide antibodies (section 4.6.1).
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4.7 A DISC1 negative cell line to aid characterisation of the
antisera
The availability of a cell line not expressing DISCI, would aid and simplify
characterisation of the DISCI antibodies. A number of human cell lines were tested
to determine if a DISCI negative cell line could be found. Furthermore, the use of a
rodent cell line enabled the specificity of the human specific anti-peptide antibodies
to be determined.
4.7.1 Multiple cell lines tested for DISC1 expression by RT-
PCR
A number of human cell lines were obtained from various sources (Table 2.3).
H36PE2 RNA was obtained from Simon Cooper (Medical Genetics Section). The
cell lines are all transformed cell lines and have been derived from different tissue
sources. These were tested for expression of DISCI by RT-PCR (Table 4.2) using
primers located within exon 1 and exon 2 of the DISCI gene (Table 2.8). This
ensures that the majority ofDISCI transcripts are identified.
None of the human cell lines tested were found to be DISCI negative (Table 4.2),
and the DISCI transcript is apparently ubiquitously expressed within human cell
lines. This is analogous to the widespread expression pattern of the transcript within
human tissue (section 1.7.1). The expression pattern of specific DISCI transcripts
within the cell lines will be discussed in chapter 5.
111
TABLE 4.2: RT-PCR analysis ofDISCI expression within human cell lines
CELL LINE TISSUE (CELL TYPE) DERIVED FROM RT-PCR
SH-SY5Y brain (neuroblastoma) + !
LAN-5 brain (neuroblastoma) +
TE671 brain (cerebellar medulloblastoma) +
U373 MG brain (glioblastoma) +
MOG-G-CCM brain (astrocytoma) +
HepG2 liver (hepatocellular carcinoma) +
MCF7 mammary gland (adenocarcinoma) +
293 embryonic kidney +
t(l ;11) lymphoblast lymphoblastoid +
CACO-2 colon (colorectal carcinoma) +
H36CE2 lens +
A positive RT-PCR result was recorded if the expected product was seen in both the +RT
reaction and positive control. A negative RT-PCR result would have been recorded if the
expected product was seen only in the positive control. DISCI cDNA clones were used for
positive controls.
4.7.2 A rodent cell line as a negative cell line for a human-
specific antibody
As no human cell line was found that was DISCI negative, CHO (Chinese hamster
ovary) cells were used as a negative cell line for the human-specific anti-peptide
antibody.
CHO cells are derived from a Chinese hamster and consequently it was predicted that
if the DISCI anti-peptide staining pattern seen in human cell lines (Figure 4.7) was
specific for the human DISCI protein, the same staining pattern would not be seen in
CHO cells. The DISCI protein sequence of the Chinese hamster is not known, but it
was assumed to be similar to the mouse DISCI protein which does not contain the
peptide used for immunization (section 3.2.1).
The DISCI anti-peptide antibodies produced a completely non-specific pattern on
CHO cells, which did not preabsorb after incubation of the antibodies with the
peptide (Figure 4.9). A similar pattern was seen with the pre-immune serum and is
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likely to represent a cross-reaction between the rabbit antibodies and the hamster cell
line.
Use of the CHO cells confirmed that the subcellular localisation pattern seen with the
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4.8 The use of independent methods to determine the
subcellular localisation pattern of the DISC1 protein
In addition to the use of protein specific antibodies, the subcellular localisation of a
protein can be determined using recombinantly expressed protein that is partnered to
an appropriate tag. The tag allows independent verification of the localisation of the
protein, either directly by use of a fluorescent tag or indirectly using antibodies
specific to the tag. As described earlier (section 4.5), DISCI cell lines expressing
V5-tagged DISCI protein had been generated. In addition, transient transfected cell
lines expressing DISCI protein fused to GFP had also been generated within the
group. These cell lines provided a potential alternative means of visualising DISCI
within the cell. Finally, towards the end of this project DISCI antibodies generated
independently by another group became available. These were also used to confirm
the DISCI subcellular localisation pattern.
4.8.1 Subcellular localisation of DISC1 cannot be confirmed
by V5-tagged DISC1 protein
The SH-SY5Y cell line expressing V5-tagged DISCI protein (section 4.5), was
examined using the DISCI anti-peptide antibody as well as the V5-specific antibody
(Invitrogen) previously tested by immunoblotting (Figure 4.5).
The cell staining pattern, as determined by use of the DISCI antibody, was the same
in both V5-DISC1 expressing and control SH-SY5Y cell lines (Figure 4.10).
However the signal from the V5 antibody was entirely non-specific and the same
background speckles were seen in both V5-DISC1 expressing and control SH-SY5Y
cells (Figure 4.10), even after various optimisations of the cell staining procedure
(section 2.2.4.10). As described in section 4.6.2, different fixatives were tested as
was the effect of increasing the primary antibody incubation step. Different blocking
buffers were also tested (3% BSA plus 10% serum, 3% BSA alone, 10% serum
alone, 1% casein and 5% Blotto), but these had no effect on the V5 antibody signal.
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DISC1
FIGURE 4.10: V5-tagged recombinant DISCI as an independent method for
the subcellular localisation ofDISCI
V5.DISCI expressing SH-SY5Y (B) and control SH-SY5Y (A) cells were stained using the
DISCI anti-peptide (upper panels; red) and V5 (lower panels; green) antibodies. The nuclei
were counterstained with DAPI (blue). No difference in the staining pattern from either of
the antibodies was seen when comparing control to overexpressing SH-SY5Y cells.
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4.8.2 Subcellular localisation of DISC1 can be partially
confirmed by GFP-tagged DISC1 protein
The following work with GFP-tagged DISCI protein was performed by Kirsty
Millar. Cells expressing GFP-tagged human DISCI protein were generated using a
number of cell lines, including U373 MG (human glioblastoma), HeLa (human
adenocarcinoma), HT-1080 (human fibrosarcoma) and CHO (Chinese hamster
ovary) cells.
GFP-tagged DISCI protein expressed in human cell lines formed aggregate-like
structures and did not produce the expected DISCI subcellular localisation pattern.
In contrast, expression of the GFP-DISC1 fusion protein in non-human cell lines
produced a punctate pattern round the nucleus (Figure 4.11), similar to the pattern
seen with the anti-peptide antibody. The absence of extensive cytoplasmic GFP
expression may reflect the structure of the cell type rather than a difference in
localisation.
As well as providing confirmation of the peri-nuclear localisation of DISCI, co-
localisation of the DISCI anti-peptide signal with the GFP signal, provided
additional evidence for the specificity of the anti-peptide antibodies (data not
shown).
The GFP-DISC1 fusion protein was not analysed by immunoblotting, as both the
anti-peptide and anti-protein antibodies had successfully detected V5 tagged DISCI
protein (Figure 4.5), thus demonstrating the specificity of the antibodies for
eukaryotically expressed DISCI protein.
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CHO
FIGURE 4.11: GFP-tagged recombinant DISCI partially confirms the
subcellular localisation pattern detected by the DISCI anti-peptide antibody
GFP-tagged DISCI protein expressed in CHO cells shows a peri-nuclear localisation similar
to that observed in SH-SY5Y neuroblastoma cells.
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4.8.3 An independent C-terminal DISC1 antibody confirms
DISC1 subcellular localisation
A C-terminal antibody, rabbit anti-DISC 1-C2, was obtained from Akira Sawa
(Department of Psychiatry, John Hopkins University). The antibody had been
generated against bacterially expressed GST-tagged rat DISCI protein. The portion
of the C-terminus selected for recombinant protein expression spans amino acids 601
- 854 of the C-terminus (Figure 4.12).
Anti-DISC 1-C2 was tested using the SH-SY5Y and U373 MG cell lines after both
methanol and paraformaldehyde fixation. The subcellular localisation pattern seen
with this antibody was identical to the DISCI anti-peptide staining pattern (Figure
4.13). As both of the antibodies had been raised in rabbits, co-localisation of the two
antibodies was made possible by conjugating the DISCI anti-peptide antibodies
directly to a fluorescent tag (performed by Kirsty Millar) and then staining as
described (section 2.2.4.10.2).
The merged images are expected to be yellow with the direct co-localisation of a
green and red signal. However regions of the merged images, especially towards the
periphery of the U373 MG cells, do not appear yellow. Nonetheless, examination of
the signal-specific images does show that the pattern is identical but the green signal
is fainter than the red signal. The signal from the anti-DISC1-C2 antibody is
stronger despite increasing the incubation time for the conjugated anti-peptide
antibody. This increased signal strength is due in part to amplification of the anti-
DISC 1-C2 signal from use of the secondary antibody, but probably also reflects the
larger number of epitopes recognised by the anti-DISC1-C2 antibody: 253aa of
recombinant protein was used as the antigen compared to only a 13aa peptide
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4.9 Discussion
Nothing was known about endogenous DISCI expression and consequently
considerable time was spent characterising the signal from both of the DISCI
antibodies. To simplify interpretation of the antibody signal, DISCI-specific
antibodies were immunoaffmity purified from the crude sera and used to detect
recombinant and endogenous DISCI protein. Both of the antibodies were specific
for denatured recombinant DISCI protein and were able to detect multiple isoforms
of endogenous DISCI protein (Figure 4.6), although the anti-peptide antibody also
detected a band at >75kDa which was not confirmed by use of the anti-protein
antibody. The presence of the additional band at >75kDa was also seen with the
purified R99946 anti-peptide antibodies (data not shown). In contrast the specificity
of the DISCI antibodies for native DISCI protein differed. A punctate peri-nuclear,
cytoplasmic staining pattern was seen with use of the anti-peptide antibody (Figure
4.7), while no signal was obtained with the anti-protein antibody (section 4.6.2).
The lack of a DISCI-specific signal from the anti-protein antibody when tested
against native DISCI protein, may reflect the nature of the DISCI protein used as an
antigen: denatured DISCI protein (section 2.2.4.1) was used as the antigen for the
anti-protein antibodies, which may have resulted in the antibodies being unable to
detect the native DISCI protein (Watkins, 1989). If a fixation method or pre-
treatment was used, that was more denaturing to the cells than those tested it may be
possible to overcome this problem. Nonetheless it is common for antibodies to work
in one technique and not another.
An additional detail regarding the use of the anti-protein antibody was that overall its
performance on immunoblots was inconsistent. At times the signal was either absent
or the background so high that no specific bands could be clearly seen. To address
the source of this inconsistency a number of possibilities were examined. To
determine if possible degradation of the DISCI protein was affecting binding of the
antibody, freshly prepared cell lysates were compared to older cell lysates. In
addition storage of the antibodies was examined, by purifying a new batch of
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antibodies. Neither improved the reliability of the signal (data not shown). The
presence or absence of Tween in the blocking buffer and washes was also examined
to ascertain if this was affecting binding of the antibody. Tween was found to be
essential for the anti-protein antibody signal, but the reliability of the signal was not
improved by Tween alone or even with increased Tween in the washes (data not
shown). No explanation could be found for this inconsistency, especially as it
appeared to be related only to the human DISCI protein. As will be shown later, the
anti-protein antibody was reliable when probing mouse and rat tissue (chapter 7).
Expression analysis of human cell lines by RT-PCR, revealed a ubiquitous
distribution of the DISCI transcript. No cell lines were found to be DISCI negative
(Table 4.2), yet a DISCI negative cell line would have greatly aided the
characterisation of the DISCI antibodies. It may be that the only way to generate a
DISCI negative cell line is by knocking out or knocking down the DISCI gene.
Emerging technologies such as RNAi would be useful in this respect (Elbashir et al.,
2001; Hudson et al., 2002). Indeed such a system would still be valuable in
determining the identity of the putative non-specific anti-peptide band.
The use of cell lines expressing tagged DISCI provided an additional opportunity for
confirming the subcellular localisation of DISCI. Expression of the V5-tagged
DISCI protein was confirmed on immunoblots (Figure 4.5) but could not be verified
in immunofluorescence studies by use of the same V5 antibody (Figure 4.10). The
use of an alternative cell line (data not shown), demonstrated that the V5 antibody
was suitable for cell staining studies. A possible explanation for the lack of a V5-
specific signal on recombinant DISCI protein is that the V5 epitope could be masked
by folding of the DISCI recombinant protein rendering the V5 epitope inaccessible
to antibodies.
Confirmation of the punctate peri-nuclear DISCI pattern was obtained using GFP-
tagged protein expressed in non-human cell lines (Figure 4.11). Expression of GFP-
tagged DISCI protein in human cell lines formed aggregate-like structures rather
than the peri-nuclear, cytoplasmic extensions expected. One reason may be that the
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environment of the human cells was not conducive to the expression and correct
localisation of the large GFP-tagged protein. The availability of DISCI antibodies
generated independently within another group successfully confirmed the DISCI
anti-peptide staining pattern (Figure 4.13), and the DISCI subcellular localisation
pattern.
Thorough characterisation of both the anti-peptide and anti-protein DISCI-specific
antibodies enabled their specificity for the endogenous human DISCI protein to be
determined. In turn, data generated from use of the antibodies in their respective
techniques can be viewed with confidence.
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CHAPTER 5
DISCI-RELATED PROTEINS IN HUMAN
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5. DISC1-related proteins in human
5.1 Introduction
The transcript data indicates that several alternative splice variants of DISCI are
found in human (section 1.7.1). Therefore the protein expression pattern of DISCI
was examined in a number of human cell lines and foetal brain tissue to determine
which of the alternative transcripts are likely to be translated into functional proteins.
RT-PCR was then used to ascertain the relationship between the DISCI protein
expression pattern and the DISCI transcripts present in the cell lines and tissue.
5.2 Multiple DISC1-related bands identified in human cell
lines and foetal brain tissue
The protein expression pattern of DISCI was characterised in a number of human
cell lines (Table 5.1). In addition foetal (11.1 weeks gestation) brain tissue was used
to ensure the DISCI proteins observed in the transformed cell lines were
representative of the situation in-vivo. Foetal brain tissue was available within the
group and had been obtained with the appropriate ethical permission from the MRC
Tissue Bank.
5.2.1 DISC1 anti-peptide antibody
In all cell lines examined (Table 5.1), the anti-peptide antibody detected three major
DISCI bands of approximately 95kDa, 80kDa and 75kDa (Figures 5.1 & 4.6A). The
75kDa band is present as a doublet with the lower of the bands being less strongly
detected. In addition a band of approximately 150kDa is frequently detected (Figure
4.6A). All of these bands are also observed in foetal brain tissue. The detection of
these bands is prevented following pre-absorption of the antibody with the
immunizing peptide (Figure 4.6B), suggesting that all the bands contain the DISCI
anti-peptide sequence.
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FIGURE 5.1: DISCl-related bands detected by the anti-peptide antibody in
human cell lines and foetal brain tissue
A: Protein extracts from lymphoblastoid cells (LYMPH) and foetal brain tissue (F.Br) were
analysed on an 8% SDS-PAGE gel. The anti-peptide antibody detects DISCl-related bands
of 95kDa (red arrow), 80kDa (black arrow) and a 75kDa doublet (black arrowheads). Two
putative breakdown products are also detected (red arrowheads). Short (left) and long (right)
exposures of the same blot are shown.
B: Protein extracts from SH-SY5Y (SH), LAN-5 (LA) and TE671 (TE) were analysed on a
15% SDS-PAGE gel. The anti-peptide antibody detects the approximately 75kDa DISCl-
related bands (black arrows), as well as a number of suspected breakdown products (black
arrowheads).
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No cell line showed evidence of up or down regulation of a specific band (data not
shown) and the relative expression levels of the three major bands were unaltered
across all samples examined: 75kDa > 80kDa > 95kDa. This relationship is also
seen in foetal brain tissue.
TABLE 5.1: Detection of three major DISCl-related bands in human cell lines




PEP PRO C2 PEP PRO <2 PEP PRO (''^
SH-SY5Y + + + + - - + + -
LAN-5 + + + + - - + + -
TE671 + n.d. + + n.d. - + n.d. -
U373 MG + n.d. + + n.d. - + n.d. -
MOG-G-CCM + n.d. + + n.d. - + n.d. -
293 + n.d. + + n.d. - + n.d. -
lymphoblast + n.d. + + n.d. - + n.d. -
foetal brain + + + + + - + + +
The presence of the three major DISCl-related bands was determined in a number of human
cell lines and foetal brain tissue using three DISCI antibodies: the N-terminal DISCI anti-
peptide (PEP) and anti-protein (PRO), and the C-terminal anti-DISC 1-C2 (C2). + band
detected - band not detected n.d. not determined.
5.2.2 Other DISC1 antibodies
The expected sizes of the DISCI protein isoforms (Figure 5.2) indicate the 95kDa
band is either the L or Lv isoform. Initially the bands at approximately 75kDa were
expected to represent both the SI and S2 isoforms, however no evidence for the
existence of the S2 isoform was found by RT-PCR (section 5.3.2). Therefore these
bands may represent other molecular forms of DISCI, possibly post-translationally
modified products or alternatively may be non-specific cross-reactions between the
anti-peptide antibody and an unrelated protein. To examine these possibilities, the
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In both the LAN-5 and SH-SY5Y cell line (Table 5.1), the DISCI anti-protein
antibody detected the 150kDa, 95kDa and 75kDa bands (Figure 4.6C). As described
earlier (paragraph 3, section 4.9), the intensity of the bands shown is not
representative of the anti-protein antibody. No evidence for the 80kDa band or a
doublet of the 75kDa band was observed. In foetal brain the 80kDa band is also
weakly detected (Figure 5.3A).
In all cell lines examined (Table 5.1), the anti-DISCl-C2 antibody (section 4.8.3)
detected the 75kDa band (Figure 5.3B) but there was no evidence for a doublet of
this band. Simultaneous identification of DISCI using the anti-peptide and the anti-
DISC1-C2 antibodies confirmed the identity of the band detected by the C-terminal
antibody (Figure 5.3C). The 95kDa band is also weakly detected in foetal brain (data
not shown). Table 5.2 summarises the results obtained using the different DISCI
antibodies for the three major DISCI-related proteins.
TABLE 5.2: Immunoblot intensity of the DISCl-related bands using different
DISCI antibodies
Antihorlies DISCl-related bands (kDa)
75 75 doublet 80* 95 150
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C: human cell line; B: foetal brain tissue.
Symbols designate approximate band intensities: not detectable (-), faint (+), moderate (++),
high (+++), very high (++++).
*
The varied intensity of the 80kDa band, as detected by the anti-peptide antibody, reflects










FIGURE 5.3: DISCl-related bands detected by additional DISCI antibodies in
human cell lines and foetal brain tissue
A: 30jj.g protein extract from foetal brain tissue was analysed on an 8% SDS-PAGE gel.
The N-terminal DISCI anti-protein antibody detects DISCl-related bands of l50kDa (red
arrowhead), 95kDa (red arrow), 80kDa (black arrow) and 75kDa (black arrowhead).
B: 20pg protein extracts from TE671 (TE), SH-SY5Y (SH) and LAN-5 (LA) cell lines were
analysed on an 8% SDS-PAGE gel. The C-terminal anti-DISC 1-C2 antibody detects the
75kDa DISCl-related band (black arrowhead).
C: 20jag protein extract from foetal brain tissue (F.Br) was analysed on an 8% SDS-PAGE
gel. Both the anti-DISC 1-C2 (C2) and the DISCI anti-peptide (PEP) antibody detect the
75kDa protein (black arrowhead). Only the anti-peptide antibody detects the 80kDa protein
(black arrow).
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5.2.3 Evidence of proteolytic degradation of DISC1 in protein
extracts from transformed cell lines
Over the course of this project, additional bands detected by the DISCI anti-peptide
antibody were observed, despite preparing all lysates in the presence of protease
inhibitors (sections 2.2.3.3 & 2.2.3.4). A band of approximately llOkDa is
consistently detected in the lymphoblastoid cell lines and occasionally in other cell
lines (Figure 5.1 A). In addition, multiple bands below the 75kDa bands are
commonly detected in a number of cell lines, but only a single additional band is
seen in foetal brain tissue (Figures 5.1 A). Multiple bands below the 95kDa band are
detected rarely in the cell lines (data not shown) and bands of approximately 50kDa,
37kDa and 25kDa are occasionally detected in a number of cell lines and foetal brain
tissue (Figure 5. IB). A number of observations were made regarding the appearance
of these bands. The long-term storage of the samples is associated with the increased
appearance of the bands, indicative of proteolytic degradation. The appearance of
these bands is most frequently seen in the cell line extracts and only a single band
below the 75kDa band was ever observed in the foetal brain sample despite
prolonged storage of this sample: the same preparation of foetal brain was used
throughout the project and had been stored for longer than the cell extracts. The
appearance ofmultiple bands is also therefore related to either the lysis buffer used
or another component in the preparation of the sample. In support of the first
suggestion, storing the cell line extracts in sample buffer with DTT reduced the
appearance of the multiple bands despite prolonged storage of the samples (data not
shown). It was also observed that the intensity of the 80kDa band varied (Table 5.2),
even with use of the same lysate (data not shown), and the presence of the additional
multiple bands below the 75kDa bands is associated with a reduced intensity of this
band, indicating these additional bands are breakdown products of the 80kDa protein
(data not shown).
To summarise, five DISCl-related proteins are identified in human (Figure 5.4).
Any additional bands detected represent proteolytic breakdown products of one or






FIGURE 5.4: Five DISCl-related proteins are identified in human
A schematic of the DISCI banding pattern in human. Five DISCl-related proteins are
identified and although additional bands are detected (section 5.2.3), these are assumed to
represent proteolytic breakdown products of one or more of these proteins.
5.3 Verification of the DISC1 protein isoforms identified in
human
The immunoblot data suggests that both the L or Lv and SI or S2 transcripts are
translated into functional proteins. To aid in verification of the protein bands, RT-
PCR was performed on the cell lines and human tissue samples using primers
specific for each of the transcripts (Table 5.3; Figure 5.2). The primers were
designed to span introns, with the exceptions of the L and S2 transcripts. cDNA
clones were used to optimise the primers before testing on cell line and tissue cDNA.
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TABLE 5.3: Primer location for RT-PCR verification of DISCI transcripts










Lv exon 11 exon 11/12 AB007926
(Kazuza DNA Research
Institute)








Es2 alternative exon 1 exon 2 AK025293
(University ofTokyo)
1 The sequences of the primers are given in Table 2.8.
2 The exact composition of the Es transcript remains to be determined and in the present
study the Es transcript was assumed to be comprised of an alternative exon 1 in conjunction
with the alternative 3'UTR as suggested from the available cDNA clone EMBL: AK025293.
5.3.1 Cell lines
All the cell lines tested are found to express the L, Lv and SI transcripts (Table 5.4).
No evidence was found for the Es transcript in any of the cell lines (Table 5.4) and
the presence of the S2 transcript was not tested in the cell lines as no evidence for its
existence was found in tissue (section 5.3.2).
5.3.2 Tissue
The SI transcript is detected in all tissues examined (Table 5.4), but no evidence was
found for the existence of the S2 transcript in foetal brain, heart, liver or limb (Table
5.4). The Es transcript has a restricted pattern of expression and is detected in spleen
only (Table 5.4).
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L Lv SI S2 Es
LAN-5 + + + n.d. —
SH-SY5Y + + + n.d —
TE671 + + + n.d —
U373 MG + + + n.d —
MOG-G-CCM + + + n.d —
lymphoblast + + + n.d —
H36CE2 + + + n.d —
brain n.d n.d + — —
heart n.d n.d + — —
liver n.d n.d + — —
limb n.d n.d + — —
spleen n.d n.d + - +
n.d. not determined + positive RT-PCR - negative RT-PCR
A positive RT-PCR result was recorded if a product of the expected size was seen in both the
+RT reaction and positive control, with no product observed in the negative controls. A
negative RT-PCR result was recorded if a product of the expected size was seen in the
positive control only. DISCI cDNA clones (Table 5.3) were used as positive controls. To
ensure the quality of the cDNA GAPDH RT-PCRs were performed.
5.4 Discussion
The DISCI protein expression pattern in human suggests more than one potential
isoform of DISCI exists and the ubiquitous expression of three of the alternative
DISCI transcripts in both cell lines and foetal tissue corroborates this. The 95kDa
band is recognised by all three DISCI antibodies, though the antibodies showed
different affinities for the protein (Table 5.2). This band must represent the full-
length DISCI protein, however it is not clear if it is the L or Lv isoform as both
transcripts are detected in all cell lines tested by RT-PCR (Table 5.4). The L and Lv
isoforms are predicted to be 94kDa or 91kDa respectively (Figure 5.2), therefore the
95kDa band is more consistent in size with the L isoform though the predicted 3kDa
difference between the two isoforms should be visible by immunoblotting. As the L
isoform is not detected strongly by any of the antibodies (possibly reflecting the
cellular concentration of the protein), it is reasonable to assume that if the Lv isoform
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is present in reduced amounts it would not be visible unless increasing
concentrations of protein are used. Alternatively the Lv isoform may have a short
half-life or be particularly prone to proteolytic degradation. In support of the latter
possibility, considerable degradation of the cell line extracts was observed (section
5.2.3). The development of isoform specific antibodies able to recognise either the L
or Lv isoform will be useful in determining the exact identity of this protein, but for
the subsequent data presented in this thesis this band will be referred to as the L
isoform.
Of the major DISCl-related bands, the 75kDa band is most strongly detected by all
three of the DISCI antibodies and the affinity of the antibodies for this band is
comparable (Tables 5.1 & 5.2). In contrast the 80kDa band is consistently detected
by the anti-peptide antibody in all cell lines as well as in foetal brain, but is only
weakly detected in foetal brain by the anti-protein antibody and not detected at all by
the C-terminal antibody (Tables 5.1 & 5.2). Evidence that this band is undoubtedly
DISCl-related was provided following comparison of lymphoblastoid cell lines
derived from t( 1; 11) family members (chapter 6). The level of the 80kDa band is
significantly reduced in cell lines derived from individuals with the translocation and
is strong evidence that this band is DISCl-related. Several possibilities as to the
identity of these proteins are feasible. Firstly, both of these bands are consistent in
size with the 74kDa protein predicted to arise from translation of the S1 transcript.
Secondly, these proteins may represent DISCI protein translated from a downstream
start site. The first ATG start codon ofDISCI occurs in a weak context, CNNatgC,
with the third ATG start codon in a stronger context, GNNatgG (Kozak, 1996). The
translation of a protein from the third ATG start codon would result in a full-length
DISCI protein of either 76 or 78kDa depending on the isoform and is consistent with
the sizes of the bands detected. Nonetheless a third explanation for these proteins is
provided with recent evidence that DISCI is a mitochondrial protein (section
8.4.3.3). Nuclearly encoded precursor proteins are translocated into mitochondria
via specific mitochondrial targeting sequences. Cleavage of the precursor protein
occurs in the mitochondrial matrix, and gives rise to the mature mitochondrial
protein (Hartl and Neupert, 1990; Pfanner and Meijer, 1995). Thus it is probable that
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the 95kDa DISCI protein is the precursor protein with the 80kDa and 75kDa proteins
representing the mature DISCI proteins produced from the two protein isoforms, L
and Lv. Further support for this notion is provided by the approximate size
difference between these two proteins, which is consistent with the predicted 3kDa
size difference between the two full-length protein isoforms. The use of nonactin, an
ammonium ionophore which prevents the translocation of proteins into mitochondria
(Mizzen et al., 1989; Soltys and Gupta, 1996; Varma et al., 1987), would enable this
hypothesis to be tested. Throughout the rest of this thesis, these bands will be
referred to as the 75kDa and 80kDa proteins.
In addition to the three major DISCl-related proteins, a 150kDa protein was often
detected by both of the N-terminal antibodies, as well as the anti-DISC1-C2 antibody
(A.Sawa, personal communication). A protein of this size was not predicted from
any of the known DISCI transcripts yet the presence of intergenic transcripts
between DISCI and the upstream TRAX gene were known to exist (section 1.6.3.2).
A transcript extending from TRAX exon 2 through to DISCI exon 13 had been
detected and if functional would generate a protein of 106kDa. To determine if the
150kDa protein was evidence of an intergenic protein, TRAX antibodies were tested
on SH-SY5Y cell line extracts, but no proteins in addition to the 37kDa TRAX
protein were detected (data not shown). Thus the most probable explanation for this
large protein is that it represents a complex of DISCI either with itself or another
protein. Indeed it is known that DISCI can homodimerize (K.Millar, personal
communication; Ozeki et al., 2002), therefore the complex may represent
dimerization of the 75kDa or 80kDa proteins. Confirmation of this band as a DISCI
complex could be easily tested using denaturing and crosslinking reagents which
would decrease or increase the appearance of this band respectively (Bradford et al.,
2001; Nadeau and Carlson, 2002).
The cell line protein extracts appeared to be susceptible to considerable proteolytic
degradation (section 5.2.3). The storage of these lysates in sample buffer appears to
be one way to avoid this. Due to this suspected degradation, it is not clear if the
doublet at 75kDa (Figure 5.1) detected by the anti-peptide antibody represents a
137
potentially modified form ofDISCI or a breakdown product. The banding pattern is
consistent with that commonly observed following phosphorylation (Sasaki et al.,
2000), and as this band was also detected in the foetal brain extract, which did not
show the same level of degradation as the cell line extracts, it is possible that this
band is a phosphorylated (or other modified) form of the 75kDa protein. The lack of
detection of this band, and the putative breakdown products, by the other DISCI
antibodies may reflect the reduced affinity of these antibodies for the DISCI protein.
As described earlier (paragraph 3, section 4.9), the use of the anti-protein antibody
on the cell lines was known to be limited and similarly the anti-DISC 1-C2 antibody
did not detect either the 80kDa or 95kDa bands (Table 5.1). Therefore the lack of
corroboration from these antibodies may be due to the affinity of the antibody rather
than evidence of a non-specific interaction, especially as all bands detected by the
anti-peptide antibody are reduced in lymphoblastoid cell lines derived from
translocation carriers (chapter 6).
The S2 transcript was not detected in any of the foetal tissues examined (Table 5.4).
In addition to the lack of RT-PCR data, the current support for this transcript is poor,
as the single EST (GenBank: HS833289) representing the transcript has been
withdrawn. Therefore this putative transcript is unlikely to be real.
Utilization of the alternative exon 1 in spleen only (Table 5.4) implies the use of this
exon is tissue-specific. Examination of adult tissue would ascertain if the use of this
exon is also developmentally regulated. Furthermore the alternative exon 1 was not
detected in any of the cell lines examined (Table 5.4), providing more evidence that
the use of this exon is restricted. The presence of both tissue and cell lines that do
not express the alternative exon 1 will be useful if a transcript utilizing this exon is
identified.
Detection of the alternative exon 1 was used to determine the presence of the Es
transcript, as the cDNA clone (GenBank: AK025293) containing this sequence
indicates this exon occurs in conjunction with the alternative 3'UTR of the Es
transcript. However this remains to be determined and additional RT-PCR will
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ascertain if the alternative exon 1 and 3'UTR of the Es transcript are spliced into the
same transcript. This would not rule out the possibility that the alternative exon 1 is
also spliced into either of the longer transcripts in a tissue or developmentally
restricted pattern. If the alternative exon 1 is indicative of the Es transcript, it would
be interesting to examine the protein expression pattern of DISCI in foetal spleen.
The Es transcript is predicted to generate a protein of 39kDa, but no evidence for a
protein of this size is seen in foetal brain or the cell lines examined (Figure 5. IB; but
also U373 MG, data not shown). The appearance of the 37kDa protein in the foetal
brain sample is indicative of proteolytic degradation (section 5.2.3). Thus if
functional the Es transcript shows a restricted pattern of expression.
The protein expression pattern of DISCI in humans is complex and the data
generated in the present study is not able to conclusively determine the identity of all
the bands detected. The most informative DISCI antibody, the N-terminal anti-
peptide antibody, was predicted (section 3.1.2) to detect all of the DISCI protein
isoforms, therefore the use of isoform specific antibodies or isoform negative cell
lines and tissue will be one way of addressing the identity of the proteins.
Furthermore it is unlikely that a protein as large as DISCI is not subjected to post-
translational modification and functional studies examining the potential




DISC1 PROTEIN EXPRESSION LEVELS IN
LYMPHOBLASTOID CELL LINES DERIVED FROM
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6. DISC1 protein expression levels in lymphoblastoid
cell lines derived from t(1; 11) family members
6.11ntroduction
Lymphoblastoid cell lines derived from the members of the t( 1; 11) family (section
1.6.1) were analysed to determine if a truncated DISCI protein is produced from the
translocated chromosome 1, and also to determine the effect of the translocation on
the protein expression levels of DISCI.
6.1.1 Lymphoblastoid cell lines from members of the t(1;11)
family
In the absence of any other tissue, lymphoblastoid cell lines derived from members
of the t( 1; 11) family provide a valuable resource for determining the exact effect of
the translocation on DISCI expression, although it is not known if expression of
DISCI in lymphoblastoid cells reflects DISCI expression within the brain. The cell
lines were generated from members of the t( 1; 11) family (Fletcher et al., 1993) and
two cell lines from affected family members (translocation carriers with
schizophrenia) and one cell line from a control family member (non-translocation
carrier with no psychiatric diagnosis) were available.
6.1.2 Dominant-negative or haploinsufficiency?
The aim of this chapter was to determine the effect of the translocation on DISCI. It
is assumed that the non-translocated DISCI locus is functioning as normal but the
effect of the translocation on the disrupted DISCI locus may have many possible
effects, of which the two most likely mechanisms are considered here. Firstly a
truncated protein may be produced from the disrupted DISCI locus which has the
potential to exert a dominant-negative effect on the normal DISCI protein, resulting
in loss of DISCI function. In addition, the truncated protein may have an abnormal
function of its own. Secondly, haploinsufficiency may occur, whereby the intact
141
DISCI locus does not produce enough protein for normal functioning of DISCI. In
both models the prediction would be that the levels of normal DISCI protein are
reduced in translocation carriers compared to those without the translocation. The
distinction between the two mechanisms will be the presence or absence of a
truncated DISCI protein.
6.2 No truncated DISC1 protein was found in translocation
carriers
The truncated DISCI protein produced from the translocation is predicted to be
64.5kDa. No evidence for a truncated protein is seen in either of the cell lines
derived from the translocation carriers (Figure 6.1; data shown for one cell line only).
In addition there is no evidence for any protein(s) of less than 65kDa which implies
the lack of a truncated protein is not due to proteolytic degradation. GAPDH was
used to ensure equivalent amounts of protein were analysed.
6.3 DISC1 protein expression levels are reduced in
translocation carriers
In both of the cell lines derived from translocation carriers, there was a significant
reduction in the levels of all DISCI-related proteins (Figure 6.2; data shown for one
cell line only). Of note, the potentially peptide specific proteins of 80kDa and the
lower 75kDa doublet (Table 5.2), as well as the putative llOkDa breakdown product
(section 5.2.3) are all reduced, providing strong evidence that these bands are
DISCI-related. An approximate estimate would be that the levels of DISCI protein
in the affected individuals are reduced two to three fold relative to the control, a-
tubulin was used to ensure equivalent amounts of protein were analysed. The
reduction in expression levels of all DISCI-related proteins was obtained
consistently and with independent preparations of lymphoblastoid cell extracts.
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FIGURE 6.1: No evidence for a DISCI truncated protein in lymphoblastoid cell
lines derived from translocation carriers
30)ng of protein was loaded per lane on a 10% SDS-PAGE gel. The anti-peptide antibody
(upper) was used to detect DISCI. The DISCI-related bands detected are the 75kDa protein,
present as a doublet (arrowheads), and the 80kDa protein (arrow). The blot was stripped and
re-probed using GAPDH (lower).
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FIGURE 6.2: Expression levels of all DISCl-related bands are reduced in
lymphoblastoid cell lines derived from translocation carriers
30pg of protein was loaded per lane on an 8% SDS-PAGE gel. The DISCI anti-peptide
antibody was used to detect DISCI (A & B). The two images represent longer (A) and
shorter (B) exposures of the same blot. The DISCl-related bands detected are the L isoform
(red arrowhead), 75kDa protein, present as a doublet (black arrowheads), the 80kDa protein
(black arrow) and the 11 OkDa putative breakdown product (red arrow). The blot was
stripped and re-probed using a-tubulin (B).
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6.4 Discussion
In the absence of a truncated DISCI protein (Figure 6.1), the reduction in the levels
of DISCI is consistent with a haploinsufficiency model. All DISCl-related bands
are reduced (Figure 6.2) including the potentially peptide specific proteins, providing
support to the notion that these are DISCl-related proteins. Indeed examination of
TRAX, a protein in close proximity to the translocation breakpoint (section 1.6.3.2),
did not reveal any alteration in the protein levels between affected and control family
members (K.Millar, personal communication), suggesting that only DISCl-related
proteins are affected by the translocation.
The present data does not allow an accurate estimate of the reduction in the levels of
the individual DISCl-related proteins and the use of densitometry would be useful in
this regard. It remains to be determined if any of the DISCI proteins are
preferentially affected by the translocation. In the absence of isoform specific
antibodies, the specificity afforded by quantitative RT-PCR methods such as the
LightCycler™ or the TaqMan® assay (Freeman et al., 1999; Bustin, 2000), would
allow examination of the individual DISCI transcripts. Nonetheless, the data does
indicate a >50% reduction in DISCI expression in translocation carriers relative to
controls. If as hypothesised (section 1.6.3.1), DISC2 is involved in regulation of
DISCI, it is possible that loss of DISC2 from the disrupted locus leads to reduced
DISCI expression from the normal locus.
Recent studies (Hayes et al., 2002; Ozeki et al., 2003) have focussed on the
production of a mutant DISCI protein as the disease causing mechanism. Though it
is impossible to rule out the production of a truncated DISCI protein within the
brain, no evidence for a truncated DISCI protein is found in translocation carriers
and instead the disease causing mechanism is likely to be related to the reduction in
DISCI protein and haploinsufficiency. Recapitulating the effect of reduced DISCI
protein in cell lines or transgenic mice will enable the effect of the translocation on
DISCI to be examined.
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CHAPTER 7
DISC1-RELATED PROTEINS IN MOUSE AND RAT
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7. DISC1-related proteins in mouse and rat
7.7 Introduction
As described earlier (section 3.2.1), the DISCI anti-peptide antibody was designed to
be human-specific, whereas the anti-protein antibody was generated to the first 292
amino acids of the N-terminus, thereby increasing the chances of producing an
antibody which will cross-react with DISCI in other species. At the time the
experiments for this chapter were performed, nothing was known about DISCI
protein expression in mouse or rat. Consequently the anti-protein antibody was used
to examine the DISCI expression pattern in mouse and rat, to determine if the
multiple protein isoforms identified in human were also present in mouse and rat.
The data presented in this chapter represents the first investigations into mouse and
rat DISCI by our group, and the data is discussed as such. However while writing
my thesis, papers describing DISCI in rodent were published by other groups (Ma et
al., 2002; Ozeki et al., 2003).
7.2 DISC1 in mouse and rat
Recent data demonstrated the presence of two putative DISCI protein isoforms in rat
tissue (Ozeki et al., 2003). In addition Northern blot analysis ofmouse and rat tissue
identified two transcripts (Ma et al., 2002), and data generated within the group
(Taylor et al., 2003), suggested the involvement of three alternative DISCI
transcripts in mouse. Therefore as in human, the DISCI gene in mouse and rat is
alternatively spliced (Figure 7.1), though it is unclear at present exactly which
transcripts are functional. To date the L, SV and Es transcripts have been identified
in mouse (Ma et al., 2002; Ozeki et al., 2003; Taylor et al., 2003), whilst in rat only
the Lv transcript has been identified (Ozeki et al., 2003). Nevertheless due to the
high amino acid sequence conservation between mouse and rat DISCI (Ozeki et al.,
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7.3 The DISC1 protein expression pattern in mouse and rat
tissue does not confirm the presence of DISC1 splice
variants
The tissues analysed are outlined in Table 7.1. Rat brain tissue was obtained from
David Brown (Molecular Endocrinology Section, MMC) and multiple mouse tissues
were obtained from Richard Moore (Medical Genetics Section).
TABLE 7.1: Mouse and rat tissue analysed for DISCI expression
TISSUE MOUSE STRAIN STAGE
whole embryo CD-I embryo (14.5d)
whole embryo CD-I embryo (18.5d)
whole brain CD-I adult (8-12w)
kidney pool adult (8-12w)
spleen CD-I adult (8-12w)
heart not recorded adult (8-12w)
liver not recorded adult (8-12w)
TISSUE RAT STRAIN STAGE
whole brain Wistar embryo (18.5d)
cortex Wistar adult
cerebellum Wistar adult
In both mouse and rat, the anti-protein antibody revealed a restricted pattern of
DISCI expression (Figure 7.2A & B). A DISCI band of approximately 95kDa is
detected in mouse brain and the two brain regions from rat. The band detected in rat
is 1 - 2 kDa smaller than the band detected in mouse, but both bands are consistent
in size with the putative L isoform in human. Furthermore a DISCI band of
approximately 120kDa is detected in mouse heart only, while a 150kDa band, similar
in size to the band observed in human, is detected in rat cortex and cerebellum as
well as mouse heart and brain. In all tissues, except rat embryonic brain, additional
bands are detected (black arrowheads in Figure 7.2A & B). However titration of the
secondary antibody abolishes the appearance of these bands (data not shown),
therefore they are likely to represent non-specific background bands. No convincing
DISCI bands are detected in any of the embryonic stages examined (lanes 1, 4 & 6;
149
FIGURE 7.2: DISCI protein in expression in multiple mouse tissues and rat
brain
A & B: 30pg protein was loaded per lane on an 8% SDS-PAGE gel and the DISCI anti-
protein antibody was used to detect DISCI. The tissues analysed are: rat embryonic brain
(1), adult cortex (2) & cerebellum (3), mouse whole embryo 14.5d (4), 18.5d (5), adult
kidney (6), spleen (7), liver (8), heart (9) & brain (10). Human foetal brain tissue (11) was
used as positive control. The images in A & B represent a longer exposure (A) & shorter (B)
exposure of the same blot. The DISCI-related bands detected in mouse & rat are 95kDa
(black arrow), 120kDa (red arrow) & 150kDa (red arrowhead) in size. A number of
additional bands (black arrowheads) were also detected at this concentration of secondary
antibody.
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Figure 7.2A & B). Neither the pre-immune serum nor the secondary antibody
detects any of the DISCI-related bands (data not shown).
The expected size of the protein generated from the Es transcript is 41.1kDa. No
evidence for the presence of a DISCI-related protein of this size is detected (Figure
7.3). In addition no suspected breakdown products are observed and as for the
human tissue protein extract, none of the rodent tissue extracts appear susceptible to
the considerable proteolytic degradation observed in the cell line extracts (section
5.2.3).
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FIGURE 7.3: No evidence for a small DISCI protein in multiple mouse tissues
or rat brain
20pg protein was loaded per lane on a 10% SDS-PAGE gel and the DISCI anti-protein
antibody was used to detect DISCI. The tissues analysed are: rat embryonic brain (1), adult
cortex (2) & cerebellum (3), mouse whole embryo I4.5d (4), 18.5d (5), adult brain (6),
kidney (7), spleen (8), heart (9) & liver (10). Human foetal brain tissue (11) was used as
positive control. The 95kDa (black arrow) & 120kDa (red arrow) DISCI-related mouse and
rat bands are detected, as is the potentially non-specific band at 85kDa (black arrowhead).
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7.4 Discussion
In contrast to the ubiquitous expression pattern of DISCI in human cell lines, the
results obtained with the DISCI anti-protein antibody, indicate that in mouse tissue,
DISCI shows a restricted pattern of expression in both tissue specificity and
developmental stage (Figure 7.2A & B). DISCI is present in adult brain and heart
only and the DISCI-related bands detected in the two tissues are not the same. The
DISCI band in brain is consistent in size with translation of the full-length splice
variants, whilst the identity of the band detected in heart is unknown but could
represent a post-translational modification of DISCI. The tissue specificity of
DISCI in rat was not determined due to the limited number of tissues available.
Nevertheless, the data demonstrate that as in mouse, DISCI exists as a single isoform
in adult rat brain and is not detected in embryonic (E18.5) brain (Figure 7.2A & B).
The examination of additional rat tissues will be needed to ascertain if the limited
tissue expression and identification of a potentially novel DISCI protein in mouse is
also observed in rat. It was noted that the approximately 95kDa band detected in
mouse and rat is not the same size. Prediction of the molecular weight of the mouse
L and rat Lv DISCI isoforms (GenBank: AY177673 & AY177674; section 7.2), is
92.6kDa and 90.4kDa respectively, consistent with the 1 - 2kDa size difference
observed.
The data from the DISCI anti-protein antibody indicates that the 75kDa and 80kDa
proteins are human specific proteins. Nevertheless, the recent paper from the Sawa
lab suggest otherwise, and in adult rat brain, heart, liver, kidney and thymus, two
DISCI bands of 75kDa and lOOkDa were detected (Ozeki et al., 2003), arguing
against the restricted expression pattern of DISCI in rodent. There are two possible
explanations for this discrepancy. Firstly, as the two tested antibodies are raised
against different termini of the DISCI protein, it is possible that the 75kDa band
could represent a transcript which does not utilize the known N-terminus. The
DISCI transcript data at present is incomplete, and an alternative exon 1 has already
been identified in mouse (K.Millar, personal communication; Ozeki et al., 2003), as
well as evidence for exon skipping (Ma et al., 2002). The second possibility is the
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75kDa protein does not contain any of the conserved epitopes between human and
mouse or rat. The level of sequence homology between human and rat or mouse
DISCI is low, particularly within the N-terminus (Figure 7.4). If as suggested earlier
(paragraph 2, section 5.4), the 75kDa protein represents a mitochondrially cleaved
form of DISCI, the conserved epitopes between human and mouse or rat may have
been removed, preventing detection of this protein by the human DISCI anti-protein
antibodies. Despite this anomaly, the current data does support the notion that there
are human specific DISCI proteins. Only a single protein of approximately 75kDa is
detected in mouse and rat compared to three proteins between 75 - 80kDa in human.
The use of cell lines or tissue derived from other species, and in particular primates
would be useful to determine if these are indeed human specific DISCI proteins.
The transcript data from adult mouse (Ma et al., 2002) suggested DISCI is expressed
in adult mouse heart, brain, kidney and testis. Two transcripts of 7.0 and 4.4kb are
identified in heart, while only a 7.0kb transcript is found in brain and a 4.4kb
transcript in kidney and testis. This study also reported the identification of a splice
variant which skipped exon 9. The predicted size of this alternative isoform is
85kDa, which makes detection of one of the additional bands (middle black
arrowhead in Figure 7.2A & B) in all of the mouse tissues except brain and liver
intriguing, as this band is of the correct approximate size for this isoform. The
identification of this band, and the other additional bands, as DISCI-related was
excluded due to the disappearance of the bands following titration of the secondary
antibody. Nonetheless the possibility that this band represents this alternative
transcript cannot be ruled out until further mouse and rat specific antibodies have
been developed. Alternatively pre-absorption of the anti-protein antibodies with
recombinant DISCI protein would determine if this band is DISCI-related or a non¬
specific interaction due to the secondary antibody.
The lack of a smaller protein (Figure 7.3) representing the Es isoform suggests that at
least in the tissues examined it does not exist. The lack of an Es isoform in mouse is
















































FIGURE 7.4: Sequence alignment of human, mouse and rat DISCI protein
The human L (Genbank: AF222980), mouse L (Genbank: AY177673) and rat Lv (GenBank:
AY177674) DISCI amino acid sequences were aligned using ClustalW. BOXSHADE was
used for a graphical output of the alignment. Residues conserved between all three species
are highlighted in black, while similar residues are highlighted in grey. The boundary
between the N- and C-termini is marked with a blue arrow. The region of the human DISCI
protein used for generation of the anti-protein antibodies is indicated with a solid red line.
The alternatively spliced residues of the L and Lv isoforms are underlined with a dashed red
line.
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(M.Taylor, personal communication). If functional the Es isoform is highly
restricted in either its developmental pattern of expression or tissue specificity,
possibly even representing a cell-type specific isoform.
The 150kDa putative DISCI complex identified in human was also detected in
mouse and rat (Figure 7.2A & B). It was previously suggested (paragraph 4, section
5.4) that this protein represents a complex of DISCI either with itself or another
protein. If the complex represents an interaction between DISCI and an unidentified
protein, the similar size of the complex across all three species would imply this was
an evolutionarily conserved interaction.
The expression pattern of DISCI in mouse and rat shows similarities to that seen in
human. However discrepancies between the N-terminal human DISCI and the C-
terminal rat DISCI antibodies exist. The reason for this is not clear at present.
Nonetheless, at least two proteins identified appear to show species specificity. The
120kDa protein identified in mouse heart was not seen in the human protein extracts
examined. The analysis of human heart tissue or an appropriate cell line will
ascertain if this is a species specific or tissue specific protein. Furthermore the
80kDa protein ubiquitously expressed in human is not found in either mouse or rat.
Elucidation of the identity of this protein will determine if this is a human specific
protein. Knowledge of the DISCI expression pattern in non-human species is vital
for the investigation ofDISCI function in mouse or rat model systems.
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CHAPTER 8
SUBCELLULAR LOCALISATION OF DISC1
8. Subcellular localisation of DISC1
8.11ntroduction
The cellular compartment a protein operates within enables inferences to be made
about its function within the cell. For this reason the subcellular localisation of
DISCI was studied in a number of transformed human cell lines and the relationship
of DISCI to specific cellular compartments was determined. In addition further
investigation of the relationship of DISCI to the cytoskeleton was examined using
drugs that disrupt specific cytoskeletal proteins.
8.2 Morphology and chromosome 1q content of the
neuroblastoma and glioblastoma cell lines
All human cell lines tested were found to express the DISCI transcript (section
4.7.1). Furthermore, the number of DISCI protein isoforms detected within the cell
lines did not vary (Table 5.1), and the relative expression levels of the isoforms also
remained constant (section 5.2.1). To determine the subcellular localisation pattern
ofDISCI, neuroblastoma (SH-SY5Y and LAN-5) and glioblastoma (U373 MG) cell
lines were studied predominantly as it was anticipated that these cell lines were most
likely to be representative of the cells in the nervous system. Most of the subsequent
data has been presented using the SH-SY5Y and U373 MG cell lines only.
8.2.1 Morphology
The LAN-5 and U373 MG cell lines contain a single population of cells which are
either neuroblast or epithelial in morphology respectively. Conversely, the SH-
SY5Y cell line contains at least two cell types which are described as being either N
(neuroblastic) or S (substrate-adherent) cells (Encinas et al., 2000). The N and S
cells are readily distinguishable from one another by their morphology: N cells are
neuroblast-like whereas S cells are epithelial in appearance (Ross et al., 1983;
Ciccarone et al., 1989).
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8.2.2 Chromosome 1q content
It was reported in the ATCC database that the SH-SY5Y cell line contains a trisomy
of the chromosome lq region. As this is the region of chromosome 1 where the
DISCI gene is located (section 1.6), FISH analysis using a chromosome lq paint and
also a BAC from within the DISCI region was performed on both the original SH-
SY5Y cell line obtained from Organon Laboratories NV and the cell line obtained
latterly from the ECACC (performed and data provided by Jude Fantes & Pat
Malloy, Medical Genetics Section). The SH-SY5Y cell line was found to have a
duplication of the lq region, including the DISCI locus, on one of the chromosomes
(Figure 8.1A). To determine if a cell line could be found that did not contain an
abnormal chromosome lq content, additional cell lines were karyotyped (performed
and data provided by Jude Fantes), namely the LAN-5, U373 MG and TE671 cell
lines (Figure 8.1B-D). This revealed that the LAN-5 neuroblastoma cell line also
contained the same duplicated chromosome 1 as the SH-SY5Y cell line.
Furthermore, both the U373 MG and TE671 cell lines were found to contain at least
three copies of the lq region including the DISCI locus.
It was decided that the likelihood of finding a transformed cell line with a normal
karyotype was minimal and as previously reported (section 5.2.1), the DISCI protein
expression levels from different cell lines appeared to be fairly comparable and
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FIGURE 8.1: FISH analysis of chromosome lq in four human transformed cell
lines
The chromosome lq karyotype of four human cell lines was determined using a chromosome
lq paint (green) and a BAC (135H6) from within the DISCI locus (red). The positions of
the hybridised BAC are indicated in each cell type (arrowhead). The chromosomes are
stained with DAPI (blue). In C & D only a metaphase spread is shown whilst in A & B
interphase nuclei can also be seen.
The cell lines examined were: SH-SY5Y (A), LAN-5 (B), U373 MG (C) & TE671 (D).
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8.3 The subcellular localisation of DISC1 within human cell
lines
The in-silico data (section 1.7.2) did not reveal any strong indications as to the
predicted cellular compartment that DISCI would occupy. A putative nuclear
localisation signal had been identified within the N-terminus of the protein, but it
was not known if this was a functionally significant motif in-vivo.
In all the cell lines examined, DISCI extends from a peri-nuclear location into the
cytoplasm of the cells (Figure 8.2). DISCI is organised within the cell in a
potentially cytoskeletal associated pattern. The peri-nuclear structure of DISCI is
more evident in the neuroblastoma cell lines than in the glioblastoma cell line. The
neuroblastoma cells display a clear peri-nuclear ring of DISCI staining, which is
either continuous or intermittent. Large puncta are commonly detected around the
nucleus of the neuroblastoma cell lines and these large puncta often extend into the
cytoplasm. The large cytoplasmic puncta are particularly evident within the
epithelial-like cells of the SH-SY5Y cell line and it was noted that these puncta-like
structures were not as common following paraformaldehyde fixation.
DISCI is both filamentous and punctate in structure. The punctate pattern is
particularly noticeable in the more flattened epithelial-like cells and in the extended
processes of the neuroblast cells. These puncta are much smaller and dot-like
compared to the large puncta observed in the neuroblastoma cells. The filamentous
structures are of varied size and small filaments of DISCI are seen over, but not
within, the nuclear area. No evidence of a nuclear localisation of DISCI was
observed.
The exact distribution and structure of DISCI within the cell is specific to the cell-
type examined, most likely reflecting the cell shape and concomitant organisation of
the cytoskeleton. Nonetheless, the overall organization ofDISCI within the different
cell types is comparable.
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FIGURE 8.2: The subcellular localisation pattern of DISCI within SH-SY5Y
and U373 MG human cell lines
SH-SY5Y (A) and U373 MG (B) cells were fixed in methanol and DISCI was detected
using an Alexa-Fluor conjugated secondary antibody (red). The nuclei were counterstained
with DAPI (blue). Punctate and fibrous DISCI structures were observed within the
cytoplasm of both cell types. In the SH-SY5Y cell line, large puncta (arrowhead) were also
observed, and the peri-nuclear ring of DISCI was clearly visible surrounding the nucleus
(right).
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8.4 The relationship of DISC1 to specific cellular
compartments
To further examine the intracellular distribution of DISCI, colocalisation studies
were performed using markers for specific cellular components.
8.4.1 The cytoskeleton
The initial focus was on the cytoskeleton as the organisation of DISCI within the
cytoplasm (Figure 8.2) appeared to be influenced by the cytoskeleton. The
cytoskeleton is composed of three types of protein filaments, microtubules,
microfilaments and intermediate filaments. All three filaments were examined using
various antibodies: a-tubulin (microtubules), p-actin (microfilaments), GFAP and NF
(glial fibrillary acidic protein & neurofilament respectively; both types of
intermediate filaments).
8.4.1.1 Microtubules
There is no direct colocalisation between DISCI and a-tubulin (Figure 8.3A),
however the cytoplasmic structure of DISCI is organised along the microtubules.
This is particularly evident in the epithelial-like cells due to their more flattened
appearance, and is most obvious towards the edges of the cells where there is
increased resolution of individual microtubules.
8.4.1.2 Microfilaments
As for the microtubules, there is no direct colocalisation of DISCI with P-actin
(Figure 8.3B) but again there were regions of the cell where DISCI is organised
along the actin filaments. The association of DISCI with actin is not as widespread
as for tubulin.
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8.4.1.3 Intermediate filaments
In the SH-SY5Y and LAN-5 cell lines the relationship between DISCI and NF is not
clear (Figure 8.3C). Within the nuclear region of the cell the merged image of
DISCI and NF appeared yellow. However it is not clear if this is evidence of
genuine colocalisation or a reflection of the proximity of the two proteins within this
region. Furthermore there is no obvious relationship between the two proteins within
the neurites of the neuroblast cells, though the reduced diameter of the neurites
makes the determination of a relationship between DISCI and specific components
of the cytoskeleton problematic at the current resolution.
In the U373 MG cell line DISCI is organised along the GFAP filaments (Figure
8.3D), as for the microtubules. In contrast to the microtubules (Figure 8.3A), this
relationship is more obvious around the nucleus due to the better visualisation of the
GFAP filaments in this region.
8.4.1.4 Conclusions
The organisation of DISCI within the cytoplasm is shaped by the cytoskeleton,
though the identification of a specific cytoskeletal component was not possible from
the colocalisation data. DISCI is most convincingly organised along microtubules
but the involvement of microfilaments and intermediate filaments can not be
excluded.
8.4.2 Proteins associated with microtubule function
To determine if a more specific relationship between DISCI and the microtubules
was evident, various other proteins related to microtubule function were examined
using appropriate antibodies: y-tubulin (centrosome), MAP2B (dendrite specific




DISCI does not colocalise with y-tubulin but is clustered around the centrosome
(Figure 8.4A). In addition, DISCI extends into the cytoplasm from the centrosome
region. The y-tubulin antibody produced a strong background signal which was not
reduced despite optimisation of the antibody signal.
8.4.2.2 MAP2B
In undifferentiated SH-SY5Y and LAN-5 cells, there is no specific MAP2B signal
(data not shown), indicating that neither of the cell types are representative of a
mature neuronal phenotype. In differentiated SH-SY5Y and LAN-5 cells (section
9.2.1), a specific MAP2B signal is seen in some of the differentiated cells. However
there is no colocalisation with DISCI (Figure 8.4B). The yellow signal in the
merged image is due to the proximity of the two proteins within this region as
analysis of the individual signals revealed MAP2B surrounded the nucleus while
DISCI does not. As for the y-tubulin antibody, the MAP2B antibody produced a
high background signal that was not reduced by titrating the antibody.
8.4.2.3 Dynein
No specific signal was seen for this antibody on any of the cell types examined (data
not shown) and the relationship of DISCI to dynein could not be determined.
Various modifications of the cell staining procedure were attempted (section
2.2.4.10), including altering the fixative and blocking buffer, increasing the
incubation time and following a previously published protocol using the same
antibody (Niethammer et al., 2000). Nonetheless no signal above background was
seen.
8.4.2.4 Conclusions
No colocalisation is observed between DISCI and y-tubulin or MAP2B. However a
speculative relationship with y-tubulin and the centrosome is observed. The
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8.4.3 Organelles
The relationship of DISCI to specific organelles was also investigated. The
organelles were visualised using either antibodies, GM130 (cA-golgi) or fluorescent
probes, rhodamine B (endoplasmic reticulum) and MitoTracker® Deep Red 633
(mitochondria).
8.4.3.1 cis-golgi
There is no colocalisation between DISCI and GM130 (Figure 8.4C), but DISCI and
the cA-golgi are in close proximity to one another in the peri-nuclear region of the
cell.
8.4.3.2 Endoplasmic reticulum
Direct colocalisation between DISCI and rhodamine B is observed throughout the
cytoplasm including the peri-nuclear region (Figure 8.5). However it cannot be
concluded that DISCI colocalises to the endoplasmic reticulum (ER) as rhodamine B
also labels mitochondria, therefore an ER-specific marker would be needed to
confirm this relationship. The structure labeled by rhodamine B is diffuse and
representative of the ER (A Web Atlas of Cellular Structures;
http://www.itg.uiuc.edu/technology/atlas/structures/reticulum/), but the correlation
with DISCI is less evident. Nonetheless regions of fibrous structure are observed in
both the SH-SY5Y and U373 MG cell lines which show good structural correlation
with DISCI and the rhodamine B structure.
8.4.3.3 Mitochondria
Initial studies were performed using MitoTracker® (Molecular Probes), a
mitochondrial specific fluorescent dye. No mitochondrial signal was obtained on
fixed cells (data not shown), despite optimisation of the fixation method and also the
incubation time and concentration of the MitoTracker dye. However the use of this
dye on live cells revealed a direct colocalisation between DISCI and mitochondria
(data not shown; performed by Kirsty Millar & Sheila Christie). A mitochondrial
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specific antibody, cytochrome oxidase subunit Vic (COX6c), confirmed this result
(Figure 8.6; performed by Kirsty Millar & Sheila Christie). The nature of DISCI
and COX6c immunostaining is not identical. COX6c appears diffuse compared to
the predominantly punctate DISCI. Nonetheless the pattern of the two proteins
within the cell shows good correlation and the proteins are clearly localised to the
same structure.
8.4.3.4 Conclusions
The use of two mitochondrial-specific reagents reveals that DISCI colocalises to
mitochondria. A tentative colocalisation to the ER is also observed but confirmation
of this result is needed. No colocalisation with the cA-golgi is observed.
8.5 Examination of the effect on DISC1 following disruption of
the cytoskeieton
The localisation of DISCI to the mitochondria and possibly also the endoplasmic
reticulum (section 8.4.3.4), only became known towards the end of this project,
therefore the initial conclusion from the colocalisation experiments was that DISCI
is associated with the cytoskeieton (section 8.4.1.4). However it is not apparent from
the colocalisation studies which component, or components, of the cytoskeieton are
more important to the function of DISCI. To further investigate the relationship
between DISCI and the cytoskeieton, drugs that disrupt microtubules and
microfilaments were employed to determine if this had any effect on the localisation
of DISCI. The lack of specific drugs to disrupt either GFAP or NF prevented the
relationship between DISCI and these intermediate filaments from being studied
further. In addition, the relationship of DISCI to cold-stable microtubules was
examined and experiments were undertaken to evaluate the effect on DISCI
following disruption and subsequent reformation of the tubulin network. These
experiments were performed using the SH-SY5Y and U373 MG cell lines.
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8.5.1 Microtubule disruption using nocodazole and taxol
Nocodazole completely disrupts the microtubules and no filament structure is seen
(Figure 8.7A & C). This is accompanied by a reduction in a-tubulin fluorescence.
On the other hand, taxol results in disorganisation of the microtubules, with no clear
radiation from the centrosome and fragmentation of the microtubules at the edges of
the cell (Figure 8.8A). After administration of both drugs, no neurites extend from
the neuroblast SH-SY5Y cells (data not shown).
Following nocodazole treatment, the organisation of DISCI within the cell is
disrupted (Figure 8.7B & D), but the overall structure of DISCI is maintained. At
higher concentrations of nocodazole (^pgmT1), complete dissociation of DISCI
from the nucleus is seen in some cells (Figure 8.7D). The peri-nuclear ring is still
present and is visible in the U373 MG cells (Figure 8.7B), possibly due to
dissociation of DISCI from the nucleus. Control cells treated with DMSO alone
show none of these changes in DISCI organisation (data not shown).
Treatment of the cells with taxol results in the complete loss of the normal
organisation of DISCI within the cytoplasm (Figure 8.8B). The effect of taxol is
more pronounced than nocodazole. DISCI is present as small puncta only and the
filamentous DISCI structure is lost. In addition none of the large puncta are
observed in the SH-SY5Y cells. The punctate pattern of DISCI is scattered
throughout the cytoplasm but at higher concentrations of taxol (>50pM), DISCI
clusters around the nucleus. Again the control cells treated with DMSO alone show
none of these effects (data not shown).
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FIGURE 8.7: The organisation of DISCI is disrupted following nocodazole
treatment
U373 MG cells were treated with 2pgmr' (upper) or lOpgrnl"1 (lower) nocodazole, before
fixing the cells and double-staining using antibodies for a-tubulin (A & C; green) and DISCI
(B & D; red). The nuclei were counterstained with DAPI (blue). DAP1 staining is not
shown in B to reveal the presence of the peri-nuclear ring, not usually visible with this cell
type. The effect of nocodazole on SH-SY5Y cells was the same (data not shown).
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FIGURE8.8:Taxoltreatmentresultsinco pletelo sfhorganisationDISCI U373MGcellsw retreatedithlOgMaxolbeforfixinghllnddoubst iningsinnti odies- tubulin(A;green)andDISCIBred).Thnuc iwercounterstainedithAP1(bleff ctftaxol SH-SY5Ycellswathesame(d tanothown).
8.5.2 Microfilament disruption using cytochalasin B
Cytochalasin B treatment results in an abnormal distribution of the microfilaments
(Figure 8.9A & C). There is an overall reduction in p-actin fluorescence
accompanied by intermittent regions of bright fluorescence. In contrast to
microtubule disruption (section 8.5.1), neurites are still visible in the SH-SY5Y
neuroblast cells.
Following cytochalasin B treatment, there is an intense clustering of DISCI around
the nucleus (Figure 8.9B & D), which was difficult to image, and in the SH-SY5Y
cells the peri-nuclear ring is not seen. DISCI is still organised within the cytoplasm
in a cytoskeletal associated pattern, however there is a loss of the filamentous
structure and only small DISCI puncta are visible, similar to what was observed
following taxol treatment (Figure 8.8B). Within the U373 MG cells a rearrangement
of the cytoplasmic distribution of DISCI is observed. DISCI is arranged in a star¬
like orientation (Figure 8.9D), especially at higher concentrations of cytochalasin B
(>50pM). These star-like structures are never seen in untreated cells or in those
treated with DMSO alone. Examination of the microtubules following cytochalasin
B treatment reveals the microtubules are also arranged into star-like structures, along
which DISCI is distributed (data not shown). The effect of cytochalasin B is more
pronounced in the SH-SY5Y cells and at higher concentrations of cytochalsin B
(>50pM), there is loss of the organisation of DISCI (Figure 8.9B), and the effect is
similar to taxol disruption of microtubules (Figure 8.8). The control cells treated






FIGURE 8.9: The structure of DISCI is predominantly disrupted following
cytochalasin B treatment
SH-SY5Y (upper) or U373 MG (lower) cells were treated with 50pM cytochalasin B before
fixing the cells and double-staining using antibodies for P-actin (A & C; green) and DISCI
(B & D; red). The nuclei were counterstained with DAPI (blue). The poor resolution of
DISCI, particularly around the nucleus, was due to difficulties in visualisation of the
fluorescent tag.
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8.5.3 Exposure of cold-stable microtubules
In certain cell types, including neurons and fibroblasts, there are subpopulations of
microtubules that resist depolymerizing conditions including exposure to the cold
(Denarier et al., 1998; Andrieux et al., 2002). These cold-stable microtubules are
believed to be important to the morphology and function of the cell. The relationship
ofDISCI to cold-stable microtubules was examined in SH-SY5Y cells.
The initial protocols followed (Denarier et al., 1998; Bosc et al., 2001) used a
permeabilisation buffer before fixing the cells. However the permeabilisation buffer
was found to completely destroy the cells, therefore immediately after exposing the
cells to ice (section 2.2.2.7), the cells were fixed and processed as usual.
Following exposure to the cold, no microtubules are visible (Figure 8.1OA) and the
a-tubulin signal is similar to that observed after nocodazole treatment (Figure 8.7A
& C). DISCI is still present (Figure 8.1 OB) but there is only a partial maintenance of
the organisation of DISCI, again similar to the disruption of DISCI following
nocodazole treatment (Figure 8.7B & D).
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FIGURE 8.10: Disorganisation of DISCI is observed following exposure to the
cold
SH-SY5Y cells were exposed to the cold for 30 minutes before fixing the cells and double-
staining for a-tubulin (A; green) and DISCI (B; red). The nuclei were counterstained
using DAPI (blue).
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8.6 The effect on DISC1 following reformation of the tubulin
network
The organisation of DISCI within the cell is clearly dependent upon the
microtubules (section 8.5.1), therefore an experiment was undertaken to determine
the effect on DISCI following the disruption and subsequent reformation of the
tubulin network. The published protocol (Zmuda and Rivas, 1998) was used to
determine the location of the centrosome: nocodazole induced depolymerization of
microtubules, which were removed in an extraction buffer allowing visualization of
repolymerizing microtubules from the centrosome. In the present study the protocol
was used to examine reformation of the tubulin network by allowing the cells to
recover in drug-free medium for longer than the published incubation times (section
2.2.2.8). SH-SY5Y cells were used for the following experiment.
After a 3 - 5 minute recovery period, the developing tubulin network was visible in
some cells, clearly emanating from the centrosome (Figure 8.11A). After a 15
minute recovery period, the tubulin network appeared fully mature in all of the cells
(Figure 8.1 IB). However the effect of DISCI could not be studied as it was found
that the use of the extraction buffer in the absence of any other treatment, completely
removed DISCI from the cell (Figure 8.11C). Incubation in the extraction buffer for
only 10 seconds was enough to completely remove DISCI. The fibrous structures
visible were also seen in the absence of the DISCI antibody (data not shown) and
must represent a non-specific cellular structure. It was not possible to alter the stage
at which the extraction buffer was used, as it is unlikely that the cells would survive
exposure to gluteraldehyde. In addition this step was necessary to remove
depolymerized microtubules present after nocodazole treatment alone (compare a-
tubulin staining in Figure 8.7A & C with Figure 8.11A). The microtubules were not
affected by the use of extraction buffer alone (Figure 811C).
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8.8 Discussion
DISCI was found to colocalise with mitochondria within the cell (Figure 8.6; Ozeki
et al., 2003). Mitochondria have been found to adopt many structures within the cell,
dependent not only on the cell type but also on the condition of the cells, state of the
cell cycle and also the fixation method (Bereiter-Hahn, 1990). In line with the latter
point, the presence of the large puncta observed in the neuroblastoma cell lines was
dependent on the fixative used and the puncta were only observed following
methanol fixation. Nevertheless these puncta, as with all structures observed, are
mitochondrial, as evidenced by complete colocalisation ofDISCI with mitochondrial
markers. Although DISCI adopted a characteristic cytoskeletal associated
organisation within the cell, the exact structure and distribution of DISCI was
dependent on the cell type examined. DISCI within the 293 cell line was present as
large peri-nuclear puncta only (data not shown), similar to the puncta observed in the
neuroblastoma cell lines but dissimilar to the pattern of DISCI within the
glioblastoma cell line.
In addition to the mitochondria, potential colocalisation was observed between
DISCI and the ER (Figure 8.5). Rhodamine B, the fluorescent dye used to stain the
ER, is marketed as a mitochondrial probe (Molecular Probes), however at the
concentrations used (section 2.2.4.11), rhodamine B has been reported as exclusively
staining the ER (Yang et al., 1997). In addition colocalisation of rhodamine B with
known ER-specific markers has been reported (Terasaki and Reese, 1992; Yang et
al., 1997) and rhodamine B has been used as a direct ER marker in other studies
(Arregui et al., 1998; Northwood et al., 1999). Therefore it is possible that the
colocalisation of DISCI to the ER is real but confirmation with an independent ER-
specific marker, such as the antibody BiP would be useful in this respect. In support
of a genuine relationship between DISCI and the ER, there is considerable overlap in
the distribution of the ER and mitochondria, and in Xenopus endothelial cells
mitochondria were only found in areas where the ER was present (Bereiter-Hahn,
1990).
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The original observation from the subcellular localisation pattern of DISCI (section
8.3) was that the distribution ofDISCI within the cytoplasm was being influenced by
the cytoskeleton. However the colocalisation studies using antibodies for specific
components of the cytoskeleton did not enable a more specific conclusion to be made
regarding which, if any, of the filaments was more important to the function of
DISCI. More direct evidence for the involvement of DISCI with both the
microtubules and microfilaments was provided by the use of drugs that disrupt either
microtubules or microfilaments. Nocodazole and taxol both disrupt microtubules but
do so by different mechanisms, nocodazole causes depolymerization of the existing
tubulin network by blocking assembly of microtubules from tubulin (Baas et al.,
1994), while taxol stimulates polymerization of tubulin into microtubules, thereby
stabilizing existing microtubules (Carson et al., 1997). The third drug tested,
cytochalasin B, disrupts microfilaments by blocking actin polymerization and
causing depolymerization ofmicrofilaments (Carson et al., 1997). All of these drugs
had an effect on the normal distribution pattern of DISCI (Figures 8.7 - 8.9).
Nocodazole and taxol resulted in disorganisation of DISCI within the cell. The level
of disorganisation seen after nocodazole treatment was related to the concentration of
nocodazole used, while the effect of taxol on the organisation of DISCI was more
pronounced and a complete loss of the normal distribution of DISCI was seen using
low concentrations of taxol (lOpM). The effect seen following cytochalasin B
treatment was more complex and was predominantly characterised by loss of normal
DISCI structure. There was maintenance of the distribution of DISCI within the
cytoplasm, although in the case of the U373 MG cells, the morphology of the cells
had been altered into star-shaped structures (Figure 8.9). However at higher
concentrations (>50pM) of cytochalasin B the distribution of DISCI was lost and the
pattern was similar to that seen following taxol treatment. This effect was most
pronounced in the SH-SY5Y cell line and may reflect a greater interdependence of
microtubules and microfilaments in this cell line.
Further support for the association of DISCI with microtubules was provided
following disruption of cold-labile microtubules. In SH-SY5Y cells exposure to cold
resulted in the complete loss of microtubules (Figure 8.10) and as for the nocodazole
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induced loss ofmicrotubules, a concomitant disorganisation of DISCI was observed.
The lack of cold-stable microtubules has been reported for HeLa cells (Denarier et
al., 1998) and could therefore also be a feature of SH-SY5Y cells. Alternatively the
absence of microtubules following depolymerizing treatments may reflect the
detection reagent used: the association of acetylated a-tubulin with cold-stable
microtubules has been reported (Cambray-Deakin et al., 1988), while other groups
have used P-tubulin to detect cold-stable microtubules (Denarier et al., 1998;
Andrieux et al., 2002). The use of another tubulin antibody would be necessary
before conclusively determining the presence or absence of cold-stable microtubules
in this cell line.
Disruption of the cytoskeleton provides direct evidence that both the structure and
organisation of DISCI is closely associated with microtubules. In particular
stabilization of microtubules seen after taxol treatment appears to be crucial for the
normal pattern ofDISCI within the cell. Association with the cytoskeleton is known
to be important for the distribution of mitochondria within the cell. Mitochondria
have long been linked with microtubules (Bereiter-Hahn, 1990) but there is also
evidence indicating microfilaments (Morris and Hollenbeck, 1995; Hollenbeck,
1996) and neurofilaments (Straube-West et al., 1996) may also be involved.
The effect on DISCI following depolymerization and reformation of the tubulin
network could not be examined due to the complete removal of DISCI following
incubation in the extraction buffer (Figure 8.11). This result, though not informative
towards the initial aim of the experiment, may be important in determining the
strength of the interaction between DISCI and microtubules. Other proteins would
need to be studied before any conclusion could be made. Examination of both
mitochondria directly and other microtubule-associated proteins would be useful in
this regards.
Identification of the subcellular localisation of DISCI has begun to offer the
opportunity to unravel its function. Mitochondria have been extensively studied and
consequently much is known about their function within the cell. The next challenge
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will be to determine where DISCI fits into the role of the mitochondria and how this
relates to both the function and subsequent dysfunction of the nervous system.
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CHAPTER 9
DISC1 LOCALISATION DURING DIFFERENTIATION
OF NEUROBLASTOMA CELL LINES
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9. DISC1 localisation during differentiation of
neuroblastoma cell lines
9.11ntroduction
DISCI colocalises with mitochondria in transformed cell lines (section 8.4.3.3), but
the function of this association is not known. In order to investigate DISCI in a
more neuronal-like cell, human neuroblastoma cell lines were differentiated
according to published protocols, to determine which strategy produces the most
neuronal-like cells. Subsequently, the subcellular localisation and protein expression
pattern ofDISCI was examined during differentiation.
9.1.1 The suitability of cell culture systems for the study of
endogenous human proteins
Cell lines, such as those used in the present study (Table 2.3) are a useful resource
for examining the function of a protein. However as cell lines are usually
karyotypically abnormal, primary cell cultures are often utilized in order to confirm
the data generated using cell lines, as they are deemed to be more representative of
the biological context. Nonetheless, the use of primary cell cultures is limited by
both the heterogeneity of the cultures and difficulties in obtaining sufficient amounts
of cells (Whittemore and Snyder, 1996). In particular, the study of endogenous
human proteins, such as DISCI, is restricted and more often than not prevented by
the lack of availability of appropriate tissue. In the study of the nervous system one
approach to overcome the lack of tissue availability, has been to differentiate
neuroblastoma derived cell lines to a neuronal phenotype, with the rationale being
that the closer a cell line mimics the behaviour of a primary neuron, the more valid
are the conclusions.
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9.1.2 Differentiation of human neuroblastoma cell lines
The SH-SY5Y and LAN-5 neuroblastoma cell lines have both been studied as a
model system for neuronal differentiation. The SH-SY5Y cell line can be
differentiated to a neuronal phenotype using a number of inducing reagents, ofwhich
retinoic acid (RA) and the phorbol ester, 12-0-tetradecanoyl-13-phorbol-acetate
(TPA), are the most common. The phenotype of the differentiated SH-SY5Y cell
differs depending upon the inducing agent (Pahlman et al., 1995). RA treatment
drives SH-SY5Y cells to differentiate along a sympathetic chromaffin lineage,
whereas TPA induces differentiation along a sympathetic adrenergic lineage. In
addition, the morphology of the differentiated SH-SY5Y cells differs. RA treated
cells appear more spread out and polar with longer neurites compared to TPA treated
cells (Feng and Porter, 1999; Guarneri et al., 2000). However, as described earlier
(section 8.2.1), one drawback to the use of the SH-SY5Y cell line is that it contains
at least two starting populations of cell types thus complicating interpretation of
neuronal differentiation. To overcome this problem, Encinas et al (Encinas et al.,
2000) described the differentiation of SH-SY5Y cells using a combination ofRA and
brain-derived neurotrophic factor (BDNF), to produce a homogenous population of
differentiated cells.
The differentiation of the LAN-5 neuroblastoma cell line has not been studied as
extensively as the SH-SY5Y cell line, but differentiation to a mature neuronal
phenotype has been reported following both RA (Lanciotti et al., 1992; Hill and
Robertson, 1997; Hill and Robertson, 1998) and TPA treatment (Lanciotti et al.,
1992). Phenotypic analysis of RA treated LAN-5 cells suggest they differentiate
along a sympathetic cholinergic lineage, while morphologically they extend long
axonal-like processes (Hill and Robertson, 1997).
In the present study RA induced differentiation of both cell lines was performed, as
well as BDNF treatment of the SH-SY5Y cells.
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9.2 Defining a neuronal-like cell
In order to determine the success of the differentiation strategy, it was necessary to
define features of a neuronal-like cell. The neuron is a highly polarized cell and
extends elongated cellular processes, termed axons and dendrites. The establishment
of this polarity begins very soon after the initiation of neurite outgrowth (Mattson,
1999), although the mechanisms responsible for neuronal polarization are largely
unknown. A typical vertebrate neuron extends a single axon and many dendrites
(Baas, 1999), the structure and function of which differ in many aspects.
Morphologically, axons are long thin processes with few branches, whereas dendrites
are short thick processes with a tapered appearance and numerous branches (Crino
and Eberwine, 1996; Zmuda and Rivas, 1998). Axons and dendrites contain domain
specific proteins, such as GAP43 and MAP2, which can be used to selectively label
axons and dendrites respectively.
Therefore in order to determine if the differentiated neuroblastoma cells adopted
neuronal characteristics, the neuronal specific marker, neurofilament (NF) and the
dendrite specific marker, MAP2B were examined. The morphology of the
differentiated cells was also determined.
9.2.1 Neurofilament
NF had previously identified (section 8.4.1.3) a subset of NF positive cells in both
the SH-SY5Y and FAN-5 cell lines, with more NF positive cells observed in the
LAN-5 cell line (Table 9.1). Following RA induced differentiation, the number of
NF positive cells is reduced in both the SH-SY5Y and FAN-5 cell lines (Table 9.1)
with increasing days in culture. In contrast, addition of BDNF to RA treated SH-
SY5Y cells results in an increase in the number ofNF positive cells (Table 9.1).
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TABLE 9.1: Neurofilament expression during differentiation
DIFFERENTIATION NF +VE NF +VE NF +VE
STRATEGY CELLS 0 CELLS 1 CELLS 2
SH-SY5Y / RA* 24% 26% 9%
SH-SY5Y / RA + BDNFT 24% 20% 39%
LAN-5 / RAt 38% 32% 20%
The approximate % ofNF positive cells was determined by selecting random fields of view
for counting. The % above represents the average of 3. Stage 0: before differentiation;
Stage 1: 2 days differentiation; Stage 2: 6 days'" or 7 days' days differentiation. For the SH-
SY5Y cells sequentially treated with RA and BDNF, the number of NF positive cells at
stages 1 & 2 was determined during BDNF differentiation.
In undifferentiated cells, NF is confined to the cell body, whereas in differentiated
cells NF extends throughout the processes (Figure 9.1; data shown for SH-SY5Y
cells only), reflecting the mature neuronal-like phenotype of these cells.
9.2.1 MAP2B
Overall the use of the present MAP2B antibody (BD Transduction) was problematic
due to the considerable background seen with the antibody. Utilization of this
antibody on U373 MG cells enabled the background signal to be identified (data not
shown), as glioblastoma cells do not express MAP2B.
On the assumption that the low intensity speckled signal is background, no MAP2B
staining is seen in undifferentiated or RA treated SH-SY5Y cells (data not shown).
However BDNF treatment clearly resulted in the expression of MAP2B around the
cell body and within the neurites of some cells (Figure 9.2). Likewise no MAP2B
staining is seen in undifferentiated LAN-5 cells (data not shown), but expression of
MAP2B is seen in RA treated LAN-5 cells (Figure 9.2). The unlabelled cells show
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FIGURE 9.1: Neurofilament distribution in SH-SY5Y cells
SH-SY5Y cells were fixed in methanol and stained for NF (green). The nuclei were
counterstained with DAPI (blue). In untreated and 6d RA treated cells, NF is predominantly
localised to the cell body. However in 7d BDNF treated cells NF extends into the processes,
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FIGURE 9.2: MAP2B expression in differentiated SH-SY5Y and LAN-5 cells
After 7d differentiation in BDNF (SH-SY5Y) or RA (LAN-5), the cells were fixed in
methanol and stained using the dendrite specific marker, MAP2B (green). The nuclei were
counterstained with DAPI (blue). MAP2B positive cells (arrowhead) extend a single
dendritic process. The background signal is evident in the unlabelled cells.
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9.2.3 The morphology of differentiated neuroblastoma cells
The majority of differentiated SH-SY5Y and LAN-5 cells are small rounded bipolar
cells (Figure 9.3; upper panels). Multipolar pyramidal shaped cells (Figure 9.5B) are
observed in earlier stages of differentiation and are possibly indicative of an early
developmental stage, with retraction of one or more of the processes providing the
mature bipolar morphology. Fully differentiated RA treated LAN-5 and BDNF
treated SH-SY5Y cultures form an extensive network of cells with well connected
neurites (Figure 9.3; upper panels).
9.2.4 Overgrowth ofRA treated SH-SY5Y cultures
RA induced differentiation of the SH-SY5Y cell line, is known to result in
overgrowth of the culture with non-differentiating epithelial S cells (Encinas et al.,
2000). This overgrowth can be prevented by sequential treatment of the cells with
RA followed by BDNF in a serum-free medium. The absence of serum prevents
survival of non-differentiating S cells, while BDNF ensures survival of differentiated
neuronal-like cells. Therefore, approximate cell numbers were determined during
treatment of the SH-SY5Y cell line with RA and BDNF to ensure the cells were not
proliferating in the presence ofBDNF.
Overgrowth of the RA treated SH-SY5Y culture by the epithelial S cells is observed
(Figure 9.4). At day 5, approximately the same number of cells is seen in control and
differentiated cell cultures. After addition of BDNF to the cultures, the number of
cells does not increase while the number of control cells increases linearly. This
provides further support that addition of BDNF to these cultures is supporting their
differentiation along a neuronal lineage.
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FIGURE 9.3: A network of neuronal-Iike cells is observed in fully differentiated
neuroblastoma cells
SH-SY5Y and LAN-5 cells were fixed in methanol and microtubules detected using a-
tubulin (green). The nuclei were counterstained with DAPI (blue).
A: SH-SY5Y cells treated with (upper) or without (lower) RA + BDNF and cultured for 12
days.
B: LAN-5 cells treated with (upper) or without (lower) RA and cultured for 7 days.
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days in culture
FIGURE 9.4: Growth of SH-SY5Y cells treated sequentially with RA and BDNF
The number of cells after growth in the absence (control cells) or presence (differentiated
cells) of the differentiation reagents was determined. Random fields of view were selected
for counting and the numbers above represent the average of 3. The cells were treated with
RA from days 1 - 5 and BDNF (in serum-free medium) from days 5 - 12: the arrow
represents the change from RA to BDNF.
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9.3 DISC1 localisation during neurite outgrowth
A neurite is defined as being a cytoplasmic extension with a growth cone at the distal
tip that lacks clear characteristics of an axon or dendrite (da Silva and Dotti, 2002).
Neuronal growth cones are the structures responsible for guiding the neurite towards
the appropriate targets, thus ensuring the development of the correct neuronal
pathways. Once the target has been reached growth cones are important in synapse
formation. Growth cones are characterised by a microtubule core surrounded by an
actin based microfilament network. The actin network is comprised of a
lamellipodium domain with filopodia protrusions. Larger elaborate growth cones are
associated with growth of the neurite whilst small growth cones with little protrusive
activity are associated with non-growing neurites (Ruthel and Hollenbeck, 2000).
Furthermore the microtubule network adopts a characteristic configuration, either
looped or splayed, depending on if the growth cone is paused or advancing
respectively (Dent et al., 1999). Splaying of the microtubule bundle along the
neurite shaft is also associated with the development of interstitial branches (Dent et
al., 1999).
In the present study, the subcellular localisation of DISCI was examined during
neurite outgrowth to determine if the characteristic peri-nuclear localisation pattern
in undifferentiated neuroblastoma cells (section 8.3) was altered in differentiated
cells. In addition, the association of DISCI with features of the growth cone, as
described above, was also examined by double staining with a-tubulin
(microtubules), (3-actin (lamellipodium and filopodia) and synaptotagmin (synapse
formation).
9.3.1 DISC1 extends into the neurites of differentiating
neuroblastoma cells
In a typical culture, a number of SH-SY5Y and LAN-5 cells spontaneously exhibit
short neurites. Following differentiation, the number of cells exhibiting this
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phenotype increases and the overall length of the neurites also increases (Figure 9.3),
which is apparent after 2 days in RA.
Upon differentiation DISCI extends into the neurites and appears as punctate
structures within the neurite shaft (Figures 9.6 & 9.7). DISCI is often present at the
base of a developing neurite and there is a frequent absence of the peri-nuclear ring
(Figure 9.5A). In cells with multiple neurites (Figure 9.5B), DISCI is usually
detected in all the neurites but varied amounts ofDISCI are seen within each neurite,
possibly representative of the energy demand of the neurite.
9.3.2 DISC1 localises to the growth cones of differentiating
neuroblastoma cells
Growth cone-like structures are visible after 2 days RA treatment in both SH-SY5Y
and LAN-5 cultures. Detection of microtubules reveals the presence of both looped
and splayed growth cones (Figures 9.5A & 9.6A respectively), while the actin
network shows extensive filopodia protrusions from the lamellipodium (Figure
9.7B). Growth cone-like structures are visible throughout RA induced differentiation
of SH-SY5Y cells but are diminished in appearance in later stages (7 days) of RA
treated LAN-5 and early stages (2 days) of BDNF treated SH-SY5Y cultures, when
extensive neurite networks (Figure 9.3) are visible.
DISCI is localised to the tips of neurites and is present in all growth cone-like
structures (Figures 9.6 & 9.7), but is not found within the filopodia-like protrusions
F
of differentiated cells (Figure 9.7B). Within the large flattened tubulin growth cone-
like structures, DISCI is distributed around the periphery of the growth cone (Figure
jy 9.7B). The localisation of DISCI within the differentiating cells is more closely







FIGURE 9.5: DISCI localisation during differentiation of SH-SY5Y cells
Differentiated SH-SY5Y cells were fixed in methanol and double-stained using antibodies
for a-tubulin (green) and DISCI (red). The nuclei were counterstained with DAPI (blue).
Merged (left) and DISCI only (right) images are shown.
A: DISCI is present at the base of developing neurites (arrow), with frequent absence of the
peri-nuclear ring also observed.
B: DISCI is present in all the neurites but is seen at increased levels in one of the neurites
(arrowhead). In addition, DISCI clusters at branch points (arrow).
C: DISCI is present at the putative connection sites (arrow) between cells.
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FIGURE 9.6: DISCI is present at microtubule growth-cone like structures
After 2 days differentiation in RA, SH-SY5Y cells were fixed in methanol and double-
stained using antibodies for a-tubulin (green) and DISCI (red). The nuclei were
counterstained with DAP1 (blue). Merged (left) and DISCI only (right) images are shown.
A: DISCI is present within neurites in a punctate pattern and is localised to splaying growth-
cone like structures (arrowheads). DISCI is also clustered at points within the neurite shaft
which show microtubule splaying (arrow).
B: DISCI is present within flattened growth-cone like structures (arrow) and is distributed at
the periphery of the growth cone as well as within the branches (arrowheads).
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9.3.3 DISC1 is associated with the branch points of
differentiating neuroblastoma cells
Branching is a feature of the differentiated cells and is not observed in
undifferentiated cells. Branching of microtubules and microfilaments is observed
both along the neurite shaft (Figure 9.5B) and at growth cone-like structures (Figures
9.6B & 9.7B). Splaying of the microtubules along the neurite shaft is also observed
(Figure 9.6A).
DISCI is commonly observed to cluster at both the branch points within neurite
shafts (Figure 9.5B), and at points where splaying of the microtubules is evident
(Figure 9.6A). DISCI is distributed along the branches of tubulin growth cone-like
structures (Figure 9.6B), but as described above (section 9.3.2), is not seen in
filopodia-like branches.
9.3.4 The association between DISC1 and sites of synapse
formation could not be studied
In both RA treated LAN-5 and SH-SY5Y cells, connections between cells were
formed after 4-7 days in culture (Figure 9.5C). Furthermore in RA treated LAN-5
and BDNF treated SH-SY5Y cultures, networks of cells are formed with extensive
connections between cells (Figure 9.3).
DISCI is often present at the putative connections sites between cells (Figure 9.5C).
To determine if DISCI is localised to areas of the neurite involved in synapse
formation, colocalisation with synaptotagmin (BD Transduction), a synaptic vesicle
protein, was attempted. Both methanol and paraformaldehyde fixation were tested
along with titration of the antibody. However, no synaptotagmin positive signal was
observed in SH-SY5Y cells after 4 days ofRA induced differentiation.
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FIGURE 9.7: DISCI relationship to microfilaments during SH-SY5Y
differentiation
Differentiated SH-SY5Y cells were fixed in methanol and double-stained using antibodies
for p-actin (green) and DISCI (red). The nuclei were counterstained with DAPI (blue).
Merged (left) and DISCI only (right) images are shown.
A: DISCI is present at the tips of developing neurites in a punctate pattern. Large puncta
(arrow) possibly reflects increased energy demands of the cell within these regions.
B: DISCI is restricted to the lamellipodium (arrow) and does not localise to filopodia
(arrowheads).
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9.4 DISC1 protein expression pattern during differentiation
A number of DISCI-related proteins were identified in human (chapter 5). It is
likely that these proteins have different, yet unknown functions, therefore to
determine if one of the DISCI-related proteins is preferentially involved in
differentiation of the neuroblastoma cell lines, the DISCI expression pattern was
examined during differentiation. Protein analysis of the transformed cell lines and
foetal brain tissue had shown that the levels of the DISCI-related bands were fairly
uniform: the approximately 75kDa bands are most strongly detected with the 95kDa
band being less strongly detected (Table 5.2).
A single well of a 6 well plate was removed every day during RA induced
differentiation of LAN-5 cell lines (section 2.2.2.5). The cells were pelleted, protein
lysates prepared in 10pl RIPA buffer (section 2.2.3.3), and the entire lOpl analysed
by immunoblotting. The DISCI anti-peptide antibody was incubated overnight as
the resulting protein yield was expected to be low.
Neither the 95kDa or 80kDa and 75kDa DISCI-related bands are detected at any of
the days examined (Figure 9.8), but replication is needed to determine if this is a
genuine feature of the cells. During differentiation (days 2-7; Figure 9.8A), the
predominant DISCI protein detected is a potentially novel band of approximately
65kDa. The multiple bands detected (day 1; Figure 9.8A) at <75kDa are similar to
the putative proteolytic products detected previously (section 5.2.3). However, it
would be unwise to place too much emphasis on the findings, as the protein content
of the samples, as determined by a-tubulin, is dramatically varied. This variation in
tubulin content is likely to reflect lower than expected yield of protein, although the
reason for this is not known. No DISCI or a-tubulin signal is seen in the cells
harvested before differentiation (day 0; Figure 9.8), though the DISCI expression
pattern is expected to be the same as that detected previously (Figure 4.6A). The day
1 sample does not show the novel DISCI band but contains a high tubulin content,
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FIGURE 9.8: Identification of a novel DISCl-related band during RA induced
differentiation of LAN-5 cells
Equivalent volumes of protein were loaded per lane and the blot probed consecutively using
DISCI anti-peptide (upper) and a-tubulin (lower) antibodies. 0: day 0, before addition of
RA; 1 - 7: days 1 - 7 of RA differentiation. A potentially novel DISCl-related band of
65kDa (arrow) was detected from 2-7 days of differentiation.
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9.5 Discussion
The differentiation of neuroblastoma cell lines provided an opportunity to examine
DISCI in a neuronal-like cell, therefore the initial aim of this study was to determine
which differentiation strategy produced the most neuronal-like cell population.
Sequential treatment of the SH-SY5Y cell line with RA and BDNF resulted in the
most neuronal-like population of cells. The culture had the highest proportion ofNF
positive cells (39%; Table 9.1) with MAP2B expression in a subset of cells (Figure
9.2), suggesting there is neuronal differentiation towards a polarized cell type. Use
of an axonal specific marker would allow the extent of polarization to be determined.
In addition, the extensive network of cells formed in the SH-SY5Y BDNF treated
cultures (Figure 9.3A) is consistent with the adoption of neuronal characteristics.
However not all of the cells differentiated neuronally, as evidenced by NF
expression, and prolonged culture (>12 days) may be needed to produce a fully
homogenous neuronal cell population.
RA treatment of the SH-SY5Y cell line produced the least neuronal-like cultures,
with few NF positive cells (9%; Table 9.1), no MAP2B staining (section 9.2.1) and
no extensive network of cells forming (data not shown). There was a reduction in
the number of NF positive cells as differentiation progressed (Table 9.1), likely due
to the overgrowth of the culture with the epithelial-like cells (Figure 9.4). The
absence of MAP2B staining may reflect the phenotype of the cells: as described
earlier (section 9.1.2), RA treated SH-SY5Y cells differentiate along a sympathetic
chromaffin lineage. Chromaffin cells are neuroendocrine cells and share features in
common with neurons but do not polarize into dendritic and axonal compartments.
MAP2 staining was observed in TPA treated SH-SY5Y cells (Meyerson et ai, 1994)
and though not tested in the present study, utilization of this differentiating reagent
may generate a more neuronal-like SH-SY5Y cell population than RA alone.
RA treatment of the LAN-5 cell line produced a differentiated cell population that
was comparable in morphology to the BDNF treated SH-SY5Y culture. The cells
formed an extensive network (Figure 9.3B), and a subset of the cells are MAP2B
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positive (Figure 9.2). However as for the RA treated SH-SY5Y cell line, the number
of cells expressing NF was reduced in the 7 day differentiated cell population,
compared to the undifferentiated cell population (Table 9.1). The reason for this is
unclear but unlike the RA treated SH-SY5Y cell line, the NF in the differentiated cell
line is expressed in the neurites (data not shown), analogous to the BDNF treated
SH-SY5Y cell line (Figure 9.1), suggesting there is differentiation to a more
neuronal cell type with addition of RA. A possible explanation for the overall
reduction in NF expression in the RA treated LAN-5 cell line may be related to the
NF antibody, as the NF antibody detects the NF-H and NF-L forms of NF. It was
previously reported (Encinas et al., 2000) in the SH-SY5Y cell line that NF triplet
expression changed during acquisition of a neuronal phenotype. It may be that the
reduction in NF expression reflects the acquisition of NF-M in the cells.
Alternatively it may suggest that RA treated LAN-5 cells do not differentiate to a
homogenous neuronal cell population. Utilization of a more stable neuronal marker,
such as neuron-specific enolase, may be better for determination of a neuronal cell.
As described (section 9.1.2), the RA treated LAN-5 cells are known to differentiate
to a sympathetic cholinergic phenotype. The phenotype of the BDNF treated SH-
SY5Y cell line has not been examined, though it would be expected to be of a
sympathetic lineage. Examination of a neuronal cell type derived from the central
rather than the peripheral nervous system may provide a better model system within
which to study DISCI function, due to the predicted dysfunction of CNS (central
nervous system) cell types in psychiatric illness. Utilization of a CNS derived cell
culture would require DISCI to be examined in other species, such as rat or mouse,
where cortical and hippocampal primary neurons are routinely cultured.
The redistribution ofDISCI from a predominantly peri-nuclear location to the shafts
and tips of developing neurites (sections 9.3.1 - 9.3.3) is consistent with the
localisation of DISCI to mitochondria and provides further support for this
relationship. The clustering of mitochondria at the base of the axon has been
described (Mattson, 1999), and is consistent with the presence of DISCI at the base
of developing neurites (Figure 9.5A). Furthermore movement ofmitochondria along
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axons and dendrites is well studied (Hollenbeck, 1996; Overly et al., 1996), as is
their presence at growth cones (Morris and Hollenbeck, 1993; Dent et al., 1999).
DISCI is definitely localised to tubulin growth cone-like structures (Figure 9.6)
including both putative looped, pausing growth cones and flattened, active growth
cones. The observed preferential association of DISCI to tubulin, rather than actin
associated structures (section 9.3.2), is consistent with a study (Morris and
Hollenbeck, 1995) which found mitochondria do not move into neurites containing
microfilaments only, but will move into neurites containing microtubules only.
Direct colocalisation of DISCI and mitochondria in differentiated SH-SY5Y cells
was confirmed (K.Millar, personal communication).
The localisation ofDISCI to sites of synapse formation could not be studied (section
9.3.4), but this may reflect the phenotype of the differentiated cells (RA treated SH-
SY5Y cell line), rather than the antibody. Examination of synaptotagmin expression
in the definitely neuronal-like BDNF treated SH-SY5Y cell line would be more
suitable as it is not clear how neuronal the RA treated SH-SY5Y cells are.
Nevertheless, synaptotagmin has previously been detected in undifferentiated SH-
SY5Y cells (Goodall et al., 1997). Localisation of DISCI to the synapse is
important, as schizophrenia at least, is believed to be a disorder related to synaptic
defects (section 1.3.3.2).
The identification of a potentially novel DISCI-related protein during RA induced
differentiation of the LAN-5 cell line (Figure 9.8) is intriguing, though the
experiment would need to be replicated, to ensure the validity of the result. The
translation of a specific protein during neuronal differentiation would imply a role
for this unidentified DISCI protein in neurite outgrowth, though no such protein was
reported in differentiated rat PC 12 cells (Ozeki et al., 2003). As for the protein
identification of the other DISCI-related bands (section 5.4), possibilities for the
production of an alternative protein include translation of an unidentified DISCI
transcript, ormodification and processing of the translated DISCI protein.
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The use of differentiated neuroblastoma cells provides the opportunity to study the
function ofDISCI, and its relationship to the mitochondria, in an easily manipulated
neuronal-like cell. As development of the nervous system is believed to be important
to the subsequent dysfunction associated with schizophrenia, investigation ofDISCI
in processes such as neurite outgrowth and synapse formation will be of value.
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CONCLUDING REMARKS AND FUTURE WORK
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10. Concluding remarks & future work
10.1 Summary
At the time of starting this project, DISCI had been identified from a translocation
breakpoint associated with psychiatric illness in a large Scottish family, and was thus
being investigated within the group as a candidate gene for psychiatric illness. In-
silico studies had been performed on DISCI, but had shed few clues to the function
of DISCI in-vivo. Therefore the main aim of this thesis was to generate DISCI
antibodies and to begin investigations into the function ofDISCI.
To this end, an anti-peptide antibody was produced (chapter 3) which has been
shown to be highly specific for endogenous and exogenous DISCI (chapter 4). A
number of protein species of DISCI were identified in human (chapter 5), explained
in part but not completely by current knowledge about DISCI transcripts.
Preliminary investigations into the consequence of the translocation on DISCI
suggest the disease causing mechanism is due to haploinsufficiency (chapter 6). In
addition, the relationship between DISCI and a number of cellular compartments
was determined (chapter 8). The subcellular localisation of DISCI was also
examined during differentiation of neuroblastoma cells (chapter 9).
In addition, an anti-protein antibody was also generated (chapter 3), though there are
concerns about the reliability of this antibody (chapter 4). In comparison to the
DISCI expression pattern in human, only a single DISCI isoform was identified in
mouse and rat (chapter 7). Thus the development of DISCI antibodies and the data
presented within this thesis has begun to provide insights into endogenous DISCI.
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10.2 Generation ofDISC1 specific antibodies
10.2.1 Concluding remarks
Anti-peptide and anti-protein antibodies were generated to the N-terminus of DISCI
to ensure detection of all known DISCI proteins. The generation of two antibodies
was to maximize the chance of an informative antibody and to enable validation of
the antibody signals. As nothing was known about endogenous DISCI,
characterisation of the antibodies was paramount. Consequently, the anti-peptide
antibody has proved to be the most informative and reliable in all techniques tested,
including immunohistochemistry (data not shown).
Although the development of each and every antibody involves an element of
chance, with unknown variables being involved at every stage of production, from
the work performed for this thesis, I see no advantage in adopting the more time
consuming approach of generating recombinant protein for use as the antigen. The
increased cost of producing several anti-peptide antibodies was a disadvantage to the
generation of multiple anti-peptide antibodies, yet the cost can be minimized by
immunization ofmore than one peptide at once into the same animal.
The development of a specific antibody is hindered by the possibility of cross-
reactions between the antibody and unknown proteins. With anti-peptide antibodies
this risk is increased due to the reduced size of the immunizing agent. Cross-
reactions identified on immunoblots pose considerable interpretation problems for
immunocytochemistry, especially as in the case of DISCI, when there is no prior
knowledge about the cellular location of the protein. Indeed this was a concern for a
long time with the anti-peptide antibody, and highlights the advantage of a negative
control. The t(l;l 1) derived lymphoblastoid cell lines were useful in this respect, but
were not available until the end of this project.
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10.2.2 Future work
The generation of more DISCI antibodies is needed and is being performed within
the group. The need for selective isoform specific antibodies, rather than a generic
antibody is now the focus. Consequently the selection of appropriate peptides will
be simplified as the choice is limited to regions of the isoforms which differ (Figure
1.5). The need for extensive characterisation of these antibodies is not as necessary
due to knowledge of the anticipated DISCI expression pattern.
10.3 DISC1-related proteins in human
10.3.1. Concluding Remarks
Immunoblotting coupled to RT-PCR was used to determine the potential DISCI
isoforms detected in human. Human cell lines were used predominantly but a foetal
brain sample was used as an reference for endogenous expression. The anti-peptide
antibody generated in this project was the most informative antibody, although
additional anti-protein antibodies were used to confirm (or not) the proteins detected.
Three major DISCl-related proteins of 95kDa, 80kDa and 75kDa were identified,
with a doublet of the 75kDa protein also reported. Furthermore RT-PCR detected
the L, Lv and S1 transcripts in all cell lines. Due to the detection of three bands of
similar size at approximately 75kDa, it was not possible to absolutely identify the SI
isoform.
Although all DISCl-related proteins detected by the anti-peptide antibody are likely
to be real (chapter 6), only the 75kDa and lOOkDa proteins were ever confirmed by
either of the other two antibodies. With no knowledge regarding the epitopes these
antibodies detect, it is difficult to ascertain if this is due to the composition of the
proteins, and is therefore an informative result, or if this is due to the affinity of the
antibodies. Furthermore the proteolytic degradation observed in the cell line
protein extracts, hampered interpretation of genuine DISCI proteins. Subsequent
work within the group has found the lower band of the 75kDa doublet to be the
predominant DISCI isoform in mitochondria (K.Millar, personal communication),
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yet the possibility this protein was a breakdown product could not be excluded from
the present study.
10.3.2 Future Work
Determining the identity of the human DISCI proteins is a priority. The
development of isoform specific antibodies for the L, Lv and SI proteins is
underway. Nonetheless, current transcription data cannot account for two of the
approximately 75kDa proteins, therefore at present it seems likely these proteins
represent alternative forms of the full-length isoforms. Two likely suggestions
include use of alternative translation initiation sites and protein cleavage. The
development of full-length constructs with the downstream translation initiation sites
mutated would address the first suggestion. The use of downstream translation
initiation sites was reported to be unlikely (Kozak, 1996), yet alternative translation
initiation sites have contributed to the protein diversity of the WT1 protein
(Scharnhorst et al., 1999), and post-transcriptional modification of WT1 produces at
least 24 different protein isoforms (Wagner et al., 2003). Furthermore two DISCI
promoters were predicted from in-silico data, and the use of alternative promoters
has been reported as a possible mechanism to utilize alternative downstream
translation initiation sites (Ayoubi and Van De Ven, 1996). The second suggestion
is related to cleavage of the full-length DISCI protein. Numerous protease cleavage
sites are identified within DISCI, therefore the inhibition of potential proteases may
not be a simple task to investigate.
Complementary techniques for determining the proteins detected by immunoblotting
include immunoprecipitation coupled to mass spectrometry and cell culture
experiments examining the effect of knocking out or knocking down the transcripts.
The latter would be a time consuming process by conventional gene targeting
strategies, and the reduced time scale afforded by RNAi may be a more suitable
approach (Hudson et al., 2002).
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10.4 DISC1 protein expression levels in lymphoblastoid cell
lines derived from t(1;11) family members
10.4.1 Concluding Remarks
Lymphoblastoid cell lines derived from t( 1; 11) family members offered an
opportunity to examine the effect of the translocation on DISCI. The reduction in
DISCI expression levels and lack of truncated protein suggest the development of
illness is associated with reduced levels of DISCI. Though there are some concerns
about relating DISCI expression in lymphoblastoid cell lines to the brain, no
difference in DISCI expression has been detected in a wide range of cell lines.
Furthermore platelets, another component of peripheral blood, are well studied for
their involvement in determining biochemical changes within the brain (Camacho
and Dimsdale, 2000).
10.4.2 Future Work
The lack of a truncated protein in t( 1; 11) carriers will focus subsequent animal
models of DISCI. The best approach would be either to knock-down DISCI to
similar levels found in t( 1; 11) carriers or alternatively model the translocation using
Cre-loxP gene targeting strategies (Smith et al., 1995). The Cre-loxP site-specific
recombination system provides a powerful means for exactly recapitulating human
chromosomal rearrangements in the mouse (Yu and Bradley, 2001). The P300
amplitude and latency is reduced in all translocation carriers including those with no
evidence of a psychiatric disturbance (Blackwood et al., 2001), therefore the
functional suitability of a DISCI transgenic mouse could be determined by
measurement of the P300 ERP (Ehlers and Somes, 2002). Replication for the
involvement ofDISCI in independent psychiatric populations is a must, and from the
protein level, will include examining DISCI expression levels in brain tissue from
collections such as the Stanley Foundation.
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10.5 DISC1-related proteins in mouse and rat
10.5.1 Concluding Remarks
Generation of the anti-protein antibody provided a means to investigate DISCI in
other species, due to the potential for cross-reactivity of this antibody with DISCI
orthologues. In various mouse tissue and rat brain, a full-length DISCI isoform of
approximately lOOkDa was detected in adult brain only. A protein of 120kDa was
also detected in mouse heart.
The data generated in this project shows considerable differences to data already
published (Ozeki et al., 2003), and work subsequently performed in this group (data
not shown). There are a number of caveats to the suitability of the strategy adopted.
Firstly, considerable characterisation of both DISCI antibodies for human DISCI
was performed, whereas no such characterisation was performed to determine the
specificity of the anti-protein antibody for mouse or rat DISCI. Secondly the anti-
protein antibody has been found to be unreliable for interpretation of human DISCI.
Though due to some unknown factor, it appeared to be reliable for detection of
mouse and rat DISCI, the results should be viewed with some caution until there is
independent confirmation. Thirdly, the considerable lack of DISCI protein
conservation between human and mouse or rat poses problems, again especially as
the epitopes recognised by the anti-protein antibody are not known. Despite this the
predicted size difference between rat and mouse DISCI was detected by the anti-
protein antibody suggesting at least this protein is definitely DISCI. Therefore it is a
mystery why this full-length protein has not been detected in the other tissue
samples, as has been found with use of a mouse specific anti-peptide antibody (data
not shown).
10.5.2 Future work
The examination of DISCI in mouse and rat is a must due to the limitations of work
in humans. The development of species specific antibodies is underway. The use of
a model system offers many opportunities for determining the function of DISCI.
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The development of transgenic mice will be invaluable in determining the function
of DISCI, with reduction (section 10.4.2) and overexpression of DISCI allowing
complementary phenotypes to be examined. The use of promoters with restricted or
inducible expression would allow DISCI function to be examined in a temporally
and spatially controlled manner. The promoter of the Camk2a gene would be one
suitable promoter, with restricted expression in the postnatal mouse forebrain
(Dragatsis et al., 2000), a region likely to be important in the pathogenesis of
schziophrenia (section 1.3.2).
Moreover, cell culture studies in human are limited and necessitate the move to
primary and organotypic cultures. Although the use of human primary and
organotypic cultures is reported (Bakhiet et al., 2001; Letinic and Rakic, 2001), the
regulations surrounding this type of work make it very prohibitive. The
differentiation of human neuroblastoma cell lines, suggest the end phenotype may
not be particularly representative of CNS-derived neurons, therefore the need to
examine DISCI in a more functionally relevant cell type, such as hippocampal or
cortical primary cultures, is necessary.
10.6 Subcellular localisation ofDISC1
10.6.1 Concluding Remarks
The subcellular location ofDISCI was determined by systematic examination of the
relationship between DISCI and various cellular organelles or compartments. In
addition the intracellular distribution of DISCI in differentiated neuroblastoma cell
lines was examined. Use of differentiated neuroblastoma cell lines enabled DISCI to
be examined in a more functionally relevant cell type. DISCI was found to adopt a
predominantly mitochondrial location, supported directly by colocalisation with
mitochondrial markers and also indirectly by its relationship with the cytoskeleton
and intracellular distribution during neuroblastoma differentiation.
The initial conclusion from these studies had been that DISCI was cytoskeletal.
Though correct in light of the known interaction between mitochondria and the
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cytoskeleton, the mitochondrial localisation ofDISCI only became known at the end
of this project and thereby prevented this relationship from being examined further.
10.6.2 Future work
The mitochondrial localisation of DISCI is confirmed by two DISCI antibodies
generated to opposite ends of the protein: the N-terminal anti-peptide antibody and
the C-terminal anti-protein antibody, suggesting this is the predominant cellular
location (discussed below). Subcellular fractionation would be an obvious next step
to confirm the mitochondrial location of DISCI. Specific elucidation of DISCI
function in mitochondria will require knowledge of interacting proteins, a task which
is being undertaken concurrently within the group, and a move into more amenable
and functionally relevant culture systems (section 10.5.2).
Nonetheless, the most important prerequisite for determining the function of DISCI
appears to be teasing out the identification and function of the DISCI protein
isoforms, as initial data from the lab suggests DISCI is not wholly mitochondrial
(K.Millar, personal communication). Development of tagged constructs for the full-
length L, Lv and SI isoforms would enable the independent locations of these
proteins to be studied in complementation to the development of antibodies (section
10.2.2).
It will also be of interest to determine how similar yet distinct proteins are targeted to
different cellular regions. It is intriguing in this respect that the C-termini show the
most pronounced differences between the isoforms. The presence or absence of
certain protein-protein interaction domains may alter the interaction between DISCI
and proteins important for cellular targeting such as transport and anchoring proteins.
Furthermore the 3'UTR of a transcript is known to be important for subcellular
targeting (Conne et al., 2000), and as two of the DISCI transcripts utilize alternative
3'UTRs, such a role may prove to be of relevance. Finally the only functionally
conserved motif identified in DISCI was an N-terminal NLS. Although no evidence
for DISCI nuclear localisation was observed, the nuclear targeting of adenomatous
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polyposis coli (APC), another multi-compartmentalized protein, was found to be
dependent on the phosphorylation status of the NLS (Bienz, 2002). Thus the
subcellular targeting of a protein is complex and likely to be mediated by many
factors. To begin to investigate subcellular targeting of DISCI, the easiest strategy
may be to develop a panel of DISCI constructs with different N- and C- terminal
contributions, although multiple lines of investigation could be pursued.
In conclusion, the generation of DISCI antibodies and the preliminary investigations
of DISCI presented within this thesis have provided the initial stepping stones for
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